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ABSTRACT
THE ROLE OF THE EXTRACELLULAR MATRIX
IN MEDIATING MUSCLE SORENESS
FEBRUARY 2015
KAREN L. RISKA, B.S., UNIVERSITY OF MINNESOTA DULUTH
M.S., ST. CLOUD STATE UNIVERSITY
Ph.D. UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Barry Braun
The goal of this dissertation was to examine the role of the extracellular matrix
(ECM) in muscle soreness. Study 1 examined how the disruption of the ECM from a
minor surgery (e.g. muscle biopsy) affected muscle soreness. Study 1 showed that
soreness levels increased at 24 h post-biopsy compared to baseline and resolved within
96 h. However, the level of muscle soreness at 24 h post-biopsy (20 mm) was lower than
that reported for performing a strenuous and naïve exercise (40–80 mm). These results
will help review boards at institutions where muscle biopsies are performed understand
how a muscle biopsy affects individuals. Additionally, these results will help
investigators better articulate the effects of a muscle biopsy to a study volunteer.
Study 2 examined the molecular changes of ECM molecules in response to a
single and repeated bout of exercise. Muscle biopsies were analyzed from baseline, 24 h
post-Bout 1, and 24 h post-Bout 2 using qRT-PCR, western blotting, and zymography
techniques. In this study, eight individuals (4 men and 4 women) performed the
exercise—descending 10 flights of stairs 15 times—and four individuals (2 men and 2
women) were controls and did not exercise. The exercise and control group both had
changes in gene expression and in one protein compared to baseline. However, no
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differences were found for either group in zymography. These results indicate that gene
expression is the prominent alteration ECM molecules in skeletal muscle at 24 h after
eccentric exercise.
Study 3 used microarray analysis to examine the difference in gene expression
between individuals (n=30, men) who presented with high-soreness levels (n=5)
compared to low-soreness levels (n=7) after eccentric exercise. Muscle biopsies for
microarray analysis were collected from the exercised leg at 3 h post-exercise and the
non-exercised leg served as control. The 546 genes differentially regulated were imported
into Ingenuity Pathway Analysis, which created networks and allowed for the
identification of the top 100 up- and down-regulated genes. Despite finding that the upregulated genes had more significant correlations and a greater number of genes with
significant correlations compared to the down-regulated genes, these up-regulated genes
were not more commonly found in one pathway compared to another. These results
might suggest that the variability of muscle soreness after eccentric exercise is a
consequence of the variability in the repair and adaptation of skeletal muscle after
eccentric exercise.
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CHAPTER 1
AIMS AND HYPOTHESES
Introduction
Many individuals develop muscle pain and soreness after leisure time or workrelated activities (e.g. snow shoveling and raking). On average, 6,000 individuals are
treated each year for a musculoskeletal soft tissue injury at an emergency room because
of snow shoveling (63). In the clinical setting, chronic soreness can be a side effect of
medications (61), and/or an indicator of musculoskeletal (48) and connective tissue
diseases (34). Muscle soreness has been studied by muscle physiologists since the early
1900s (20), and it results from strenuous and naïve exercise involving musclelengthening actions, known as eccentric actions, that place increased strain on muscle
fibers.
The underlying mechanisms of muscle soreness are not well understood, but
inflammation and oxidative processes are thought to play a primary role in soreness
development (5,7,10,13,21,30,37,40,50). Therefore, these two processes have been the
main targets of research examining muscle soreness (3,35,41,44–47). This focus has
resulted in numerous studies that tested various modalities aimed at reducing either
inflammation or oxidative-stress processes (e.g. stretching, ice, vibration, supplements,
vitamins, NSAIDs, and varying exercise load) (15–17,42,55). However, the biochemical
and functional results of these studies have not demonstrated that the anti-inflammatory
or antioxidant modalities were able to counter the muscle soreness development found
after a bout of eccentric exercise (1,2,4,8,19,24,54,55,58,66). Despite these studies using
anti-oxidative and/or anti-inflammatory modalities, none of these studies have had an
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effect on muscle soreness and inflammation or oxidative stress markers after eccentric
exercise (1,2,8,58–60). Thus, it is likely that the underlying causes of muscle soreness
development include additional pathways and processes that are aside from or in addition
to inflammation and oxidative processes that reside within skeletal muscle.
Muscle soreness is the result of damage to skeletal muscle from strenuous
exercise, especially exercises involving eccentric muscle actions that place increased
strain on muscle fibers (14,28,36). Damage is evidenced by analysis of muscle biopsy
samples (20,31,38,39), which has been primarily focused of intracellular components
such as myofibrillar and cytoskeletal proteins (29,31,67). This focus has produced an
informative but limited view of the changes that occur to the skeletal muscle after
eccentric exercise. Skeletal muscle is confined within an intricate and highly organized
lattice of fibrous and non-fibrous proteins (27,49,53). This lattice network, also known as
the extracellular matrix (ECM), has received little attention, and its role in the adaptive
response to eccentric exercise is largely unknown.
The ECM of skeletal muscle maintains functional integrity of the muscle fiber and
provides structural support (27). The ECM surrounds individual muscle cells, bundles of
these cells (a fascicle), and finally around bundles of fascicles (49,53). The location and
architecture of the ECM provides a scaffold for vessels and nerve fibers that serve
skeletal muscle (49,53).The quality and architecture of the ECM can be affected by
mechanical stress and the magnitude of that stress (26). Because the ECM is sensitive to
mechanical stress, increased or decreased stress to the ECM would likely transfer to
components that interact with the ECM (e.g. the cytoskeleton via dystrophin-associated
glycoprotein complex and integrin α7 β1) (62). Because damage to these components
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would likely be involved in the muscle soreness development process, the primary goal
of this dissertation was to examine the role of changes to the skeletal muscle ECM in the
development of muscle soreness.
The focus of the studies described in this dissertation was to examine the
development of muscle soreness and its relationship to events (e.g. muscle biopsies and
eccentric exercise) that disrupt the ECM. Sample size estimates were used to determine
the number of individuals needed to detect a difference between soreness levels among
bouts/muscle biopsies and mRNA and protein levels (Appendix A). I approached the
examination of the ECM and its relationship with muscle soreness in three ways. First, I
used questionnaires and visual analog scales to examine affective and sensory levels of
muscle soreness before and after muscle biopsies, eccentric exercise bouts, or eccentric
exercise and muscle biopsies; physical activity was also measured to determine if
biopsies or eccentric exercise and their resultant soreness affected physical activity levels.
Second, I sought to examine the molecular alterations (e.g. gene and protein expression)
of ECM molecules after a single and a second bout of eccentric exercise. Finally, I used a
systems approach to identify novel genes in high-soreness responders that were either upor down-regulated when compared to the genes of low-soreness responders after a single
bout of exercise.
The first aim of the dissertation was to compare the effects of a single and
repeated muscle biopsy on muscle soreness to a single and repeated bout of eccentric
exercise. Because the muscle biopsy procedure affects the ECM, my first goal was to
determine if the muscle soreness after a single muscle biopsy was similar to muscle
soreness after a single bout of exercise. If muscle soreness levels after a muscle biopsy
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are the same or greater than the level of muscle soreness after eccentric exercise, then the
examination of molecular factors underlying the delayed onset of muscle soreness
(DOMS) after eccentric exercise would be moot. To compare the soreness level after a
single muscle biopsy to a bout of eccentric exercise, I measured in Study 1 the levels of
muscle soreness after a biopsy and the levels of muscles soreness after a bout of eccentric
exercise at 24 h after the events (e.g. biopsy or exercise). I found that muscle soreness
was increased by 23% after a biopsy and 40% after eccentric exercise. We had reported
previously in our lab a 40–80% increase of peak soreness at 24 h post-eccentric exercise
(21,23). Additionally, physical activity monitors showed that the muscle biopsy did not
significantly change the physical activity levels (sedentary, light, moderate, and vigorous)
from the baseline activity level. A repeated muscle biopsy resulted in an 18% muscle
soreness increase compared to a 23% increase after a repeated bout of eccentric exercise.
In conclusion, muscle soreness after single and repeated muscle biopsies was less than
single or repeated bouts of eccentric exercise. Because the soreness levels after biopsies
were significantly lower than soreness levels reported for eccentric exercise (6,22). I
became curious about differences in the ECM that could help explain these two soreness
responses.
The second aim of this dissertation was to examine the effects of a single and
repeated muscle biopsy and eccentric exercise bout to changes in gene and protein
products of the ECM. Because DOMS is “less severe” after a second bout of exercise,
examining gene and protein expression between Bout 1 and Bout 2 would provide a
better understanding of the relationship between the ECM molecules and DOMS. The
adaptation process of skeletal muscle is evident by 120 h post-exercise (12), but it is
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possible this adaptation could begin much earlier (48 h post-exercise) (56). At present,
only one study has investigated changes in the ECM molecules after a repeated bout (32),
but Mackey et al. (32) electrically stimulated (eSTIM) the muscle to perform the
eccentric exercise. One of the hallmarks of the “repeated bout effect” is the reduction in
DOMS, and the eSTIM exercise model did not find a reduction in DOMS after a second
bout eSTIM (32).
Previous examinations of skeletal muscle ECM molecules after exercise have
shown an increase in gene, protein, and enzyme activity levels (9,18,32,33,52). However,
these studies have examined changes of the ECM molecules after many weeks of training
with an aerobic exercise model (51), or after a single bout of eccentric exercise at time
points ranging from 2 h to 96 h post-eccentric exercise (9,18,33). Furthermore, the focus
of these studies has been on changes of the ECM and not on the relationship between
these changes and DOMS. To address the potential relationship between ECM changes
and DOMS, I examined in Study 2 the alterations at both the gene and protein level of
ECM molecules, which transmit the force of eccentric exercise and act as a scaffold for
nerve fibers. ECM molecules are likely affected by the muscle biopsy procedure as well
as by eccentric exercise protocol, but they are less affected after a repeated bout given the
decreased level of DOMS after a second bout of eccentric exercise.
In Study 1 after Bout 2, I found that muscle soreness measures were less severe
and did not last as long and that maximal isometric strength was not decreased to the
same extent it was after Bout 1. Nine ECM genes and their protein products were
examined (MMP9, MMP2, TIMP1/2, collagen 3, collagen 4, integrin α7, integrin β1,
tenascin-C, laminin α2). At 24 h after eccentric exercise, four (MMP9, collagen 3,
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integrin α7, tenascin-C) of the nine genes of interest were differentially regulated and the
protein product of one of these genes (integrin α7) was significantly altered. There was a
decrease in the mRNA levels of tenascin-C after Bout 2 when compared to Bout 1. I
found that collagen 3 and MMP9 mRNA levels were different between Bout 1 and Bout
2 for both the control and exercise groups. I also found that collagen 3 and MMP9
mRNA levels were different between men and women. Another novel finding was that
integrin α7 mRNA levels were elevated in the left leg compared to the right leg, despite
group (e.g. exercise or control [no-exercise] groups). In addition, the integrin α7 levels
were elevated in the exercise group compared to the control group. These results for
integrin α7 mRNA levels and the fact that all subjects were right-leg dominant suggest
that integrin α7 may be elevated in the exercise group in response to load and/or strain
placed upon the muscle. Furthermore, I also found an increase of integrin α7 isoform
X2B from baseline in Bout 1 and Bout 2. These results demonstrated that within 24 h of
eccentric exercise there are changes in the ECM at both the gene and protein level.
However, the only association found at 24 h post-exercise in Bout 1 and Bout 2 was for
tenascin-C mRNA levels and muscle soreness. Because very few associations were found
between the selected ECM molecules and DOMS after a single and repeated bout of
eccentric exercise, these results suggested that the ECM may not be involved in the
DOMS process after eccentric exercise. Therefore, I decided to expand the examination
of potential targets related to muscle soreness after eccentric exercise.
Targeting nine genes and their protein products, as in the second aim, allowed me
to identify one molecule (e.g. tenascin-C) that had a positive relationship with DOMS for
the repeated bout effect. However, this focused approach did not allow me to determine
6

the role of the ECM in DOMS. It is likely that there are myriad factors, including and in
addition to the ECM, that are involved in the development of muscle soreness after
eccentric exercise. Therefore my third aim was to use a systems approach to identify
novel genes that were differentially expressed in individuals who had either high soreness
levels or low soreness levels after eccentric exercise. The systems approach identified
numerous genes that were either up-regulated or down-regulated in the high-soreness
group (HSG) compared to the low-soreness group (LSG) after eccentric exercise. Some
of the top up-regulated genes have functions that are involved in tissue morphology, cell
signaling, cell growth and proliferation, lipid metabolism, and nervous system
development and function. The top down-regulated genes were involved in transcription
regulation, cell-to-cell signaling, immunological chemotaxis, and maintenance and
remodeling of blood vessels. Surprisingly, I found that serine protease inhibitor Kazaltype 1 (SPINK1) was increased by 18.67-fold in the HSG compared to the LSG. There
was also a moderately strong correlation between SPINK1 and muscle soreness. SPINK1
mutations have been shown to be associated with pancreatic cancer,(11,43,64,65) and
while it is expressed in skeletal muscle, the SPINK1 protein product was first identified
as a protease secreted by pancreatic acinar cells (25,57). These results will provide future
skeletal muscle researchers with many potential targets to examine when investigating
the variability in muscle soreness development among individuals.
Summary
The overall purpose of this dissertation was to examine the role of the
extracellular matrix in the development of muscle soreness after eccentric exercise. I
approached this by first examining the level of muscle soreness experienced due to a
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muscle biopsy. Because I proposed that the ECM is involved in the development of
muscle soreness after eccentric exercise and a muscle biopsy would disrupt the ECM, it
was important to determine if the disruption to the ECM via the muscle biopsy produced
a level of muscle soreness that is found after eccentric exercise. If the soreness levels
were similar, then any molecular analysis of muscle soreness after eccentric exercise
would actually be an examination of muscle soreness after a biopsy. Results from Study 1
established that muscle soreness was significantly elevated at 24 h after a muscle biopsy,
but that this soreness level was lower than that after eccentric exercise with or without a
biopsy. In fact, no differences were found for muscle soreness between the biopsied and
non-biopsied legs of the exercise group and after a repeated bout of eccentric exercise,
the muscle soreness levels of both legs were similar to the level of soreness after a single
muscle biopsy. These muscle soreness results from a single biopsy and repeated muscle
biopsies and eccentric exercise bouts and the desire to understand the potential role of the
extracellular matrix in the development of muscle soreness led to my second study. Study
2 also provided me with the opportunity to examine molecular changes of the ECM
associated with soreness levels because I examined muscle biopsies and soreness levels
after single and repeated bouts. I found that at 24 h after eccentric exercise mRNA levels
of four of the nine genes of interest were differentially regulated and that the protein
product of one of these genes was also significantly altered. Because Study 2 indicated
that very few of the genes that I targeted were significantly altered at 24 h after eccentric
exercise, I decided that to better understand the molecules associated with muscle
soreness I would need to take a systems approach. Study 3 revealed that there were
distinct differences in gene expression between individuals who have high levels of
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muscle soreness compared to individuals who have low levels of muscle soreness after
eccentric exercise. Study 2 and 3 revealed that the ECM is associated with muscle
soreness development after eccentric exercise, but the exact triggers of muscle soreness
development are still unknown. Results of these studies will provide investigators with a
foundation for future research in the field of muscle soreness. Moreover, it is likely that if
the triggers of muscle soreness reside within the ECM, the studies from this dissertation
will also benefit researchers examining ECM disorders such as fibromyalgia.
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CHAPTER 2
REVIEW OF THE LITERATURE
Introduction
Eccentric skeletal muscle contractions produce prolonged strength loss, delayed
muscle soreness, and the release of muscle proteins from the muscle cell into the
blood—changes indicating muscle damage (23,29,40,58,149). The mechanisms
underlying these muscle damage events have not been fully elucidated. Many mechanisms
have been proposed (110,149) but few mechanisms can incorporate explanations for all
the functional and structural alterations to skeletal muscle after eccentric exercise. The
muscle damage events initiate a remodeling process in the exercised skeletal muscle
(8,26,28,30,32,97,172), and remodeled skeletal muscle is less susceptible to future
muscle-damaging exercises (40,44,69,84,120). The use of molecular techniques has
allowed investigators to examine changes in gene and protein expression that may
elucidate the mechanism(s) underlying functional and structural alterations to skeletal
muscle as a result of eccentric exercise (8,30,84,97,107,129).
The following sections provide information on muscle structure, the effects of
eccentric exercise on skeletal muscle, and the current understanding of the underlying
mechanism(s), particularly with regard to the extracellular matrix.
Skeletal Muscle Structure
Skeletal muscle has the unique capability of being able to generate force and
allow for movement of the skeleton. While skeletal muscle can also assist in other bodily
functions, e.g. maintain body temperature or serve as a vascular pump (144), it is the
ability of the skeletal muscle to produce force and its ability to remodel in response to
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use that are discussed in this review (86,100,117). The force generation by skeletal muscle
and the ability of skeletal muscle to remodel in response to use is a result of its intra- and
extracellular structure.
Skeletal muscle is composed of bundles of muscle fascicles containing bundles of
muscle fibers, the single cell units of the muscle (140). Each muscle fiber is
surrounded by a membrane called the sarcolemma and is organized into myofibrils that
contain the basic contractile unit called the sarcomere (140). The surface of the muscle
fiber is covered by the sarcolemma, and the innermost layer of the sarcolemma is the bilipid plasma membrane. The sarcolemma is one structure within the extracellular matrix
surrounding the muscle fiber. Next to the plasma membrane is a thin layer called the
glycocalyx, above which is the multicomponent basement membrane (140). The extracellular
layers, proteins, and molecules within these layers assist in the skeletal muscle remodeling
process by transmitting extracellular signals to the intracellular side and ultimately to the
nucleus (81,89,93).
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Figure 2.1: Skeletal muscle and extracellular matrix organization.
The intracellular side of the sarcolemma contains the extrasarcomeric cytoskeletal
framework (talin, veniculin, a-actinin, and the dystrophin glycoprotein complex)
(2,4,93). These structures, along with the intermediate filaments (desmin, vimentin, and
synemin), maintain the structure of the muscle fiber and transmit the force from the
contractile unit to the surrounding network of the basement membrane and muscle
fascicles (23). Additionally, the cytoskeletal and intermediate filament network are
necessary for the transmission of the extracellular signals (2,4,93). These proteins have
either a direct or indirect ability to transmit extracellular signals (2,92). Signals may
occur via a protein attaching to an intermembrane protein (e.g. an integrin associated with
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the dystrophin glycoprotein complex), and this process results in activating the
intermembrane protein or activates a secondary messenger protein that then
biochemically transmits the mechanical signal (2). Extracellular signals are transmitted via
this framework allowing for the remodeling of the skeletal muscle (50,89). Attached to the
cytoskeletal framework is the sarcomere, which produces muscle contraction and allows
the muscle to generate force.
Effects of Eccentric Exercise
The muscle can perform contractions without limb movement, and these
contractions are called isometric (153). The muscle can also produce force while the
muscle contracts, called concentric actions, or force can be produced while the muscle is
lengthened, called eccentric actions (153). While the force production of the muscle
cells is generated by the sarcomere, all components (intermediate filaments,
cytoskeleton, and the sarcolemma) are inherently involved in each muscle action.
Eccentric exercise is generally used as a model to induce muscle damage.
Eccentric Exercise Models and Strength Loss
Strength loss generally peaks immediately after the eccentric exercise, yet soreness
does not peak until 24 h after the eccentric exercise (40,58). Cytosolic muscle proteins,
such as creatine kinase and myoglobin, are found to peak in the blood 96–120 h after
high-force eccentric exercise (23,58,113,150). At the ultrastructural level, the appearance
of Z-disc streaming occurs within the first 15 min of eccentric exercise (49,65). The
timeline of the appearance of functional and structural alterations to skeletal muscle after
eccentric exercise is vastly different; however, these muscle damage events are generally
resolved within 10–14 d after eccentric exercise (49,65,124). The peak occurrence for
18

these muscle damage events is affected by the novelty and the intensity of the eccentric
exercise (30,40). Because the muscle damage indicators are not all present immediately
post-eccentric exercise, it has been difficult to determine which process (mechanical or
chemical) initiates the muscle damage events (110,116,170).
After performing a novel eccentric exercise, immediate isometric strength loss can
range 15–80% (22,29,30,58,68,103), and recovery of strength has been shown to range
4–40 d (43,83). Chemical and mechanical stresses mediating the muscle-damage
events have been used to explain the immediate loss of strength and the delayed
recovery of strength after eccentric exercise (76,77,130,132). An additional component
involved in immediate strength loss after eccentric exercise is low-frequency fatigue.
Low-frequency fatigue is characterized by a greater loss in force when the muscle is
activated at low frequencies (20 Hz) compared to higher frequencies (50Hz)
(56,59,126,146).
For the upper body, eccentric exercise models commonly target the elbow flexors
(biceps brachii) muscle and for the lower body, eccentric exercise models target the
knee extensors (vastus lateralis, rectus femoris, vastus medialis, and vastus
intermedius) muscles. The vastus lateralis is the most commonly investigated knee
extensor (via biopsy and EMG) in eccentric exercise models (84,88,108); this is likely
due to its size and location. In addition to allowing different treatments to be analyzed
by exercising each limb separately, these muscles (biceps brachii and vastus lateralis)
have been used for performing a muscle biopsy, and thus, allow for assessment of
muscle damage events via biochemical and molecular techniques (84,107). Because this
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dissertation uses eccentric exercise of the legs, this review focuses on models of eccentric
exercise using leg muscles.
Eccentric exercise models that target the knee flexors of the leg result in a 15–
50% loss in muscle strength immediately after the exercise (51,31,128,135,141,164). The
difference between a 15% loss compared to a 52% percent loss in muscle strength after
eccentric is due to the novelty, number of eccentric actions, intensity of the eccentric
actions, mode of eccentric actions, and also the angle of knee extension used when
performing the post-exercise isometric muscle strength test (31,51,135,141,164).
Individuals who were recreationally active and whose activities or training included muscle
actions similar to the eccentric exercise model showed less of a loss in muscle strength
immediately after the exercise bout compared to individuals who were naïve to the
exercise (40).
Eccentric exercise models of the leg have ranged from employing familiar
activities (e.g. walking down stairs, step-down activities, and stand-to-sit activities) to
gym-specific exercise machines (e.g. downhill treadmill running, modified cycle
ergometer, inverted squats, and leg extension). Additionally, a few researchers (26,49)
have tried to recreate the morphological muscle damage results seen in animal literature
by using electrically stimulated eccentric actions during knee extension isokinetic
actions in human studies. Many animal models of eccentric exercise have used
electrical stimulation to produce the eccentric actions. The results from these animal
studies have shown vastly different morphological responses to eccentric exercise
compared to the morphological responses commonly seen in human studies with
voluntary eccentric actions (100,108,166,174).
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The first few eccentric exercise models used in human studies were based on
everyday actions and were voluntary eccentric actions. Friden et al. used a walkingdown-stairs model and a modified cycle ergometer model (63). Other researchers have
varied the eccentric exercise model depending on the type of exercise and/or the
amount of damage they wanted to produce (41,65,66,85,88,174).
Eccentric actions that required individuals to descend stairs or run on a declined
treadmill have been used to induce a moderate amount of damage to the muscle. While
Friden et al. (65) and Yu et al. (174) used this protocol to induce a moderate amount of
muscle damage, neither reported the amount of induced strength loss or documented the
muscle damage by morphology. Neither Friden et al. (65) nor Yu et al. (174) measured
muscle strength loss after the stair descent exercise model and instead used muscle
soreness measures to indicate that the stair descent exercise model induced a moderate
amount of damage. However, Friden et al. (65) did measure strength loss with the
bicycle ergometer model and found a 20% loss after the exercise. They reported that the
bicycle ergometer model was an intense muscle damage model and the stair descent
exercise model was only moderate (66).
Other types of eccentric exercise models, such as the step-down or stand-to-sit
exercise models, have routinely found a 15–30% immediate loss in muscle strength
(62,84,97). For example, 300 eccentric to concentric (stand-to-sit-to-stand) actions
performed with one leg (e.g. right leg) compared to 300 concentric-only actions (sit-tostand) performed with the opposite leg (e.g. left leg) resulted in an immediate 33% and 15%
loss respectively in muscle strength (31). Completing a quarter of the above volume (e.g.
60 step actions) in an effort to produce a moderate amount of damage resulted in a 15%
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loss in muscle strength (164). However, performing 300 eccentric actions using an
exercise model with maximal resistance instead of one’s body weight and isokinetic
dynamometer resulted in a 47% loss in strength (128). Cycle ergometer exercise models
have routinely shown a 20–30% loss in muscle strength (66) and isokinetic dynamometer
exercise models have shown a 20–50% loss (88,128). These studies indicate that
eccentric exercise models of the leg produce a moderate amount of damage if they use
the individual’s body weight or involved 100 or fewer eccentric actions.
The intensity of the eccentric exercise was suggested by Nosaka et al. (120) to
have a greater correlation to muscle damage markers than the duration. Varying the
intensity of the exercise while maintaining the number of eccentric actions showed that
30 eccentric actions at 100% of maximal intensity resulted in a 50% loss in immediate
muscle strength; while at 40% of maximal intensity, a 30% loss in immediate muscle
strength was found (29). When eccentric exercise was performed at longer muscle lengths
(joint angle 120°–40°, full knee extension is 180°) compared to shorter muscle lengths (joint
angle 160°–80°), a greater strength decrement was elicited (19,118). No significant
difference has been shown in the overall pattern of strength loss and recovery between the
sexes (41,142).
Measuring Strength Loss and Recovery
The measurement of immediate strength loss at different joint angles allows
for an indirect measurement of the force-length relationship of the contractile
elements within the sarcomere. This relationship was first identified in 1940 by
Ramsey and Street (136) and was further described by Gordon, Huxley (AF), and
Julian in 1966 (71). The force-generating capacity of skeletal muscle has been

22

measured at different muscle lengths (33,115,118) and the relationship between force
and length is depicted as a bell-shaped curve. The force/tension is located on the y axis
and muscle length on the x axis. When the contractile elements, specifically actin and
myosin, are entirely overlapped they generate little force as shown in the force-length
curve. As the contractile elements move further apart in the force-length curve, as occurs
in an eccentric contraction, the force-generating capacity increases until the sarcomeres
reach their optimal length or the top of the bell-shaped curve. In addition to the role of the
force-length tension curve in eccentric contractions, the detachment and re-attachment of
the myosin heads from actin during the eccentric action contributes to the force generated
in eccentric contractions and allows eccentric force to be higher than concentric isometric
force 149). For the elbow flexors, the optimal length is at 90º degrees of elbow flexion
(166) and for the knee extensors, the optimal length is at 60º of knee extension (54).
Muscle Strength Measures
Measures of strength immediately after eccentric exercise show a similar rate of
strength loss after a fatiguing or concentric exercise (118,146,153). Measures of
isometric strength using electrical stimulation at low frequencies show similar losses in
maximal isometric strength after eccentric and concentric exercise (59,91,147). Because of
these similarities, it has been proposed that metabolic and/or chemical processes underlie
the immediate strength loss. However, the eccentric exercise low-frequency fatigue
persists for up to 5 d and the concentric exercise low-frequency fatigue persists for only
4 h (59,147,167). Although the rate and magnitude of the loss in strength during lowfrequency stimulation is similar in these two exercises post-exercise, the mechanism
underlying this loss in strength does not need to be the same. It is likely that the long
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lasting (>4 h) low-frequency fatigue evident after eccentric exercise is a result of damage
to the sarcomere and/or the sarcoplasmic reticulum and t-tubules, and damage to a muscle
cell is not synonymous with fatigue (e.g. traditional definition of metabolic fatigue).
Furthermore, passive muscle strength measures, muscle actions theoretically
independent of fatigue, show a delay in passive tension generation after eccentric
exercise (74,79,168,169). This delay in development of passive tension is present
immediately after eccentric exercise and has been proposed to be the result of contracture
resulting from the excess of Ca2+ within the sarcomere and or the mechanical
disruption to the sarcomere (5,10,34). Only a few studies have investigated passive
muscle tension; however, passive tension effects are evident for up to 4 d post-exercise
(170), and one investigator has shown that the level of maximal passive muscle tension
prior to eccentric exercise is correlated with the severity of muscle damage after
eccentric exercise (110).
While a majority of eccentric exercise studies have evaluated muscle strength loss
via isometric strength tests, which measure muscle strength loss at just one muscle length
or joint angle (35,45,48,118,119,165), some investigators have used isokinetic tests or
isometric strength tests with multiple muscle lengths or joint angles to assess alterations in
the force-length curve (22,115). Isokinetic strength tests assess maximal muscle force
throughout an entire range of motion and at a constant velocity. It is important to
measure muscle force at different muscle lengths before and after eccentric exercise
because a shift in the force-length relationship of skeletal muscle occurs after eccentric
exercise (115). This measurement allows for a comparison of the force-length curve
pattern (54,133), where alterations in these patterns could indicate a greater disturbance
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in the force-generating capacity of muscle when in a lengthened position vs. shortened
position.
In addition to measuring muscle strength at different angles, it is also
important to address how alterations in the force-velocity relationship could impact the
immediate loss in muscle strength and its recovery after eccentric exercise. The forcevelocity relationship allowed researchers to differentiate between fast-twitch and slowtwitch muscle fibers. Based on the force-velocity relationship for fast-twitch and slowtwitch muscle fibers, the fast-twitch muscle fibers are predominantly used in eccentric
actions (22). It is expected that the fast-twitch muscle fibers incur more stress during the
muscle-lengthening contractions and are more likely to be damaged (66,90,102).
Increased phosphorylation of proteins involved in protein synthesis (154) and activated
satellite cells (27) were found in Type II muscle fibers compared to Type I after eccentric
exercise. Because the force generated during an isometric contraction may not adequately
assess the alterations to fast-twitch muscle fibers, it has been proposed that measurements
of strength loss should include isokinetic actions at slow (0.52 rad·sec-1) and fast
velocities (3.14 rad·sec-1) (22).
Eccentric, or muscle-lengthening, contractions are thought to damage the muscle
because the muscle is signaled to continue generating maximal force while lengthening
past the optimal length (e.g. >80º of knee extension) or on the descending limb of the bellshaped curve. The overstretching of a sarcomere during the eccentric exercise action
(while the contractile elements are activated) generates tension within the sarcomere and
could cause mechanical damage to a sarcomere and/or allow for the leakage of Ca2+ and
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Na+ into the muscle cell (11,12,148,170). The increased level of Ca2+ in the muscle
cell could perpetuate the muscle damage via activating proteases (160,175).
The rightward shift in the force-length curve indicates that the muscle length
increases after the eccentric exercise (12,21,74). The shift is thought to occur because of
chemical and/or mechanical alterations to skeletal muscle during the eccentric exercise
actions (110). Chemical alterations have been proposed to degrade components of the
cytoskeletal and contractile apparatus via Ca2+ activated protein kinase and thus produce
the rightward shift in the length-tension curve (10,12,175). Mechanical alterations have
also been proposed to explain the rightward shift in the length-tension curve (74,79,116).
In the mechanical process, stress to the sarcomere during the lengthening contraction results
in the sarcomere popping; this popping is thought to occur to multiple sarcomeres
throughout the muscle fiber (115). Because the elastic components within the sarcomere
cannot withstand the tension, the elastic spring(s) (specifically the titan molecule) detaches
from the myosin in the affected sarcomeres, which results in an inability of these
sarcomeres to realign, an inability to produce force, and thus a shift of the length-tension
curve (115,127).
Muscle Strength Recovery
Muscle strength recovery is assessed by measuring muscle strength using the
methods described previously (e.g. isometric, isokinetic and passive measures) at
multiple time points after the exercise protocol. Most investigators have measured
muscle strength recovery by assessing muscle strength at 24 h increments after the
eccentric exercise bout (36,42,44,49,122,142). These studies indicate maximal muscle
strength returns to the baseline 7–10 d after exercise (29,44,49,58,124,142). A few
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individuals, referred to as high-responders, showed a prolonged recovery of muscle
strength, as muscle strength had not returned to baseline by 30 d post-exercise (43).
Additionally, one study that measured muscle strength at 2 h, 4 h, and 20 h after
eccentric exercise showed a return of muscle strength to almost baseline values at 2 h
and 4 h post-exercise. However, at 20 h post-exercise, strength loss decreased back to
the level of immediate strength loss (103). The return of muscle strength to almost 50%
of its baseline value at 2 h and 4 h post-exercise and then the loss of strength at 20 h
strongly suggest that a secondary damage event occurs to the muscle after the eccentric
exercise.
Delayed Muscle Soreness
Muscle soreness after performing eccentric contractions is referred to clinically as
mechanical hyperalgesia because the muscle is tender to touch and the soreness presents
only when the muscle moves or is palpated (6,7). Delayed onset muscle soreness
(DOMS) peaks 24–48 h after strenuous, unaccustomed exercise and generally resolves 7–
10 d after exercise (43,49,84,124,149). The novelty of the exercise and the intensity of the
repetitions will affect the time to peak and the resolution of muscle soreness. The
mechanism to explain how muscle soreness develops after the muscle-damaging event is
not well understood.
DOMS is commonly measured using a visual analog scale (VAS) where an
individual marks his/her soreness level with a vertical dash on a 100 mm horizontal line
(0 mm=no soreness and 100 mm=very sore). The VAS can measure the sensory part of
muscle soreness, but it is thought that DOMS also has an affective component. The
affective component encompasses the individual’s perception of unpleasantness, and
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this perception has been shown to peak at 48 h after eccentric exercise (103). The
affective component of DOMS is measured with either the Descriptor Differential Scale
(DDS) or the McGill Pain Questionnaire (MGPQ) (72,103,111). Measuring both the
sensory and affective components of muscle soreness thus provides a more
comprehensive assessment.
The development of muscle soreness is thought to result from a combination
of mechanical and biochemical events after a muscle-damaging exercise that sensitizes or
stimulates the pain afferents (Type III and IV nerve endings). The Type IV nerve afferents
respond to mechanical and noxious chemical stimuli (47,58,149,150,152). The
mechanical event initiates biochemical changes producing muscle soreness. However, it
has also been proposed that mechanical disruption to the extracellular matrix (ECM)—a
layer of the basement membrane that resides above the sarcolemma—itself is sufficient to
sensitize the nerve endings because they are located in the ECM (149).
The damage process has an acute (minutes after the exercise) and longer lasting
(>12 h until 10–12 d after the exercise) inflammatory phase (103). In the acute phase,
cytokines (signaling molecules involved in the immune process) and chemical stimulants
(prostaglandins, histamine, bradykinin, and nitric oxide) either directly or indirectly
initiate a process that culminates in sensitizing or stimulating the nerve endings in the
ECM, producing muscle soreness (112,150). The acute phase of the inflammation process
results in increased permeability, increased muscle protein degradation, and increased
inflammatory cell adherence to the damaged sarcolemma area (103,112). All of the abovelisted chemical stimulants have been implicated in sensitizing the pain afferents, but
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prostaglandin E2 (PGE2) is the best candidate to directly affect nerve sensitivity (103,147).
PGE2 has been shown to cause increased nerve ending sensitivity (147).
Resident macrophages of the ECM have the capability to synthesize PGE2
(147), and it has been reported that neutrophils provide essential products for PGE2
synthesis (13). While PGE2 is a prime candidate in contributing to the development of
muscle soreness, it is not the only factor involved in muscle soreness development.
The chemical stimulant histamine acts indirectly to sensitize the nerve endings. Histamine
increases capillary permeability, which allows neutrophils to leak out of the capillary at
the site of muscle injury (13,103). The increased permeability would also allow
fluid to accumulate at the site of the injury and could result in increasing the pressure
upon the nerve endings and thus promote sensitization of the nerve endings (13,103). The
chemical stimulants bradykinin and nitric oxide have less well understood roles in the
development of DOMS as their actions are commonly involved in the development of
acute inflammatory pain and not delayed pain or soreness (13,103).
The chemical stimulants released during the acute phase result in neutrophil
chemotaxis, monocyte chemotaxis, and secondary tissue injury (103). The neutrophils
and the monocytes travel to the site of injury via the bloodstream and have the capacity to
ingest foreign substances, or in the case of muscle damage, the parts of the damaged
myofiber are ingested (103,150). Upon ingestion of damaged tissue of foreign substances,
the neutrophils release cathepsin and gelatinase granules (13,103). Cathepsin is
involved in the degradation of the intracellular components of the muscle, and the
gelatinase degrades the components of the ECM (93). In this manner, the inflammatory
factors involved in removing the damaged parts of the myofiber can initiate secondary
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damage to the eccentrically exercised muscle fiber. Because this secondary damage event
is a result of the longer lasting inflammatory process that occurs 12–24 h after eccentric
exercise it is possible that the peak muscle soreness that occurs 24–48 h after eccentric
exercise is related to the longer lasting inflammatory phase of inflammation.
Several studies examined the treatment of muscle soreness with non-steroidal
anti-inflammatory drugs (NSAIDs) (78,103,132,159,162) or antioxidants (15,70), but
results of effectiveness of these treatments have been inconsistent
(78,103,132,157,158,162). Stauber et al. (149) indicated that the mechanical strain to
the ECM from the eccentric exercise may be sufficient to sensitize the nerve endings
within the ECM. Hough in 1902 (82) was the first to propose that the soreness after
a naïve exercise bout may result in damage to the connective tissue that surrounds
the muscle fiber. A treatment that could increase the ability of the ECM to resist the
strain during or after eccentric exercise could reduce the sensitization of the nerve endings
within the ECM. There are relatively few studies that have examined alterations to the
ECM from the high-strain eccentric exercise protocols (25,49,105,106,149).
Blood Indices of Eccentric Exercise Damage
Other indirect indicators of muscle damage after exercise are level of cytosolic
muscle-specific proteins in the blood (41,58,113). Two such proteins, myoglobin and
creatine kinase (CK), commonly increase in the blood after eccentric exercise (38,150).
The levels of these proteins in the blood do not indicate the amount of damage the skeletal
muscle has incurred, but they do imply that the sarcolemma has been compromised as a
result of the eccentric exercise (18,121,162). These proteins are too large to passively
diffuse through the muscle sarcolemma, and high levels of these proteins can only be
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detected in the blood if the sarcolemma has been damaged (18,150). Because eccentric
exercise imposes strain on muscle connective tissue studies have investigated collagenbreakdown products and levels of proteins that regulate collagen degradation in the
blood after eccentric exercise (1,9,18,33,163).
Cytosolic Muscle Proteins
Myoglobin and CK levels are not increased in the blood immediately after
exercise but peak 4–7 d post-eccentric exercise (37,40,142). The peak of myoglobin
concentration and CK activity levels in the blood after maximal eccentric exercise does not
correlate with the peak of maximal strength loss or peak muscle soreness (58,121). This
suggests that the mechanisms underlying the release of these cytosolic muscle proteins may
be different from those that produce strength loss and muscle soreness. Because the peak
occurs many days after the damaging bout of exercise, it may result from secondary
damage to the muscle induced by the inflammatory process. The initial damage to the
sarcolemma from the damaging exercise may not produce an area sufficient to allow
for the release of cytosolic muscle proteins. However, it is thought that infiltrating
macrophages may cause further damage to the ECM and the sarcolemma allowing for
the cytosolic muscle proteins to be released into the blood (103,150).
Two studies have shown lower blood CK activity after eccentric exercise when
ibuprofen was administered (55,87,131). When individuals were given a prophylactic dose
(for 5 d before, 2.4 mg/d) of ibuprofen versus a placebo, lower CK activity level was
observed 72 h post-exercise in the NSAID group (130). A therapeutic 400 mg dose of
ibuprofen was administered every 8 h after eccentric exercise for 48 h; the ibuprofen
group showed a lower CK activity level compared to the placebo group at 48 h post31

exercise (156). These two studies that demonstrated NSAID’s effectiveness at reducing
CK levels after eccentric exercise indicate that reducing the anti-inflammatory
response could blunt the secondary damage process proposed to occur. Attenuation of an
exaggerated inflammatory response may allow the muscle to repair at a faster rate and
return to baseline quicker.
Connective Tissue Proteins
Treatments aimed at attenuating the strain to the muscle during eccentric exercise
might inhibit the secondary damage event induced by an exaggerated inflammatory
response. The intimacy of the ECM to the muscle plasma membrane and the appearance of
cytosolic muscle proteins in blood after eccentric exercise indicate that the collagen matrix
supporting skeletal muscle is most likely damaged by eccentric exercise. Results
indicate that high-intensity exercise that produces strain can induce collagen turnover (52)
that can lead to increased levels of collagen-breakdown products in the blood after
eccentric exercise.
Levels of collagen-breakdown products and the enzymes that degrade collagen
or inhibitors of the collagen-degrading enzymes have been shown to be elevated after
eccentric exercise (17,18,155). In humans, serum measurements after eccentric exercise
showed serum hydroxyproline peaked 48 h post-exercise and remained elevated until 72 h
post-exercise (155). Within tendons, the collagen fractional synthesis rate increases after
exercise (114). Evaluation of the collagen-degrading enzymes’ (MMP-2 and MMP-9) serum
levels showed an increase in MMP-9 immediately after eccentric exercise (96). The
levels of the tissue-inhibitor of metalloproteinases (TIMPs)—inhibitors of collagendegrading enzymes—in serum showed an increase in TIMP-1, but not TIMP-2
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immediately after exercise (95). These results indicate the ECM and intramuscular
connective tissue are sensitive to the strain of eccentric exercise.
Morphological Alterations to Skeletal Muscle
Eccentric exercise imposes a considerable amount of strain upon skeletal muscle
because the muscle, connective tissue, and tendon are lengthening while the sarcomeres
within the muscle are shortening. Stauber et al. (149) proposed that strain to the muscle
fiber from eccentric exercise could result in the following: 1) breaking the connective
tissue “struts” that link adjacent myofibers; 2) the basal lamina being peeled away from the
muscle fiber, exposing the plasma membrane; 3) plasma membrane rupture; 4) the
sarcomere being pulled apart, potentially disrupting the sarcoplasmic reticulum or the
plasma membrane; and 5) a break in the myofiber without disrupting the basal lamina
(149). Incidentally, all or just a few of the above possibilities could occur in a number of
combinations due to the eccentric exercise (149). Skeletal muscle biopsy studies have
allowed for the investigation of histochemical, immunohistochemical, and ultrastructural
alterations to skeletal muscle after eccentric exercise.
Cross-sectional analysis of muscle biopsies allows for the investigation of
structural associations or loss of associations within and surrounding muscle fibers
after a damage-inducing stimulus. Longitudinal analysis of skeletal muscle biopsies
indicates gross alterations to skeletal muscle organization. Protein targets commonly
used to assess structural organization of skeletal muscle are desmin, dystrophin, and Zdiscs (49,65,174). Their location and their functional roles within the muscle fibers have
made them prime targets to investigate how a stimulus (e.g. eccentric exercise) affects
the organization of skeletal muscle components and potentially the functional outcomes
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after eccentric exercise. Desmin anchors the repeating Z-disc structures to one another
and, therefore, desmin is thought to play an important role in the structural
organization of skeletal muscle and assist in force transmission (101,104). The Z-discs
integrate the contractile (actin and myosin) and passive components (titin and nebulin) of
the muscle myofilaments with the cytoskeletal apparatus via the binding of desmin to
the Z-disc (66,73,100).
This integration allows for mechanical transmission of forces within the active and
passive elements of the myofilaments and the cytoskeleton (24,53,143). This location
positions desmin and the Z-discs in the area where the greatest strain from the
eccentric action occurs. Desmin also assists in linking the cytoskeletal-contractile
system to the dystrophin-associated proteoglycans complex (DAPC) (66,101).
Differential alterations in desmin staining of muscle cross-sections have been seen after
eccentric exercise (49,174). Dystrophin, the main protein in the DAPC, is critical in
the relay of signals (mechanical or chemical) to the nucleus from areas that arise external
of the sarcolemma (e.g. ECM) (46,99). Loss of dystrophin results in gross muscle
disturbances, which include loss of muscle strength and increased serum CK levels
(99,101). Immediately after eccentric exercise, longitudinal muscle sections show focal
disturbances in the cross-striated band pattern of muscle fibers (65). These focal
disturbances occur at the Z-disc of the muscle fiber and are commonly referred to as Z-disc
streaming (66,149,174).
Changes to the structural architecture of skeletal muscle have been proposed to
explain the immediate strength loss and the delayed recovery of muscle strength after
performing eccentric exercise (64,94,118). However, no definitive relationship has been
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determined between morphological alterations to muscle fibers and functional alterations to
skeletal muscle after eccentric exercise (e.g. immediate strength loss, delayed recovery of
muscle strength, or DOMS).
Immunohistochemical Alterations
Myofiber
Staining of muscle fibers with antibodies specific to protein targets has allowed
researchers to examine structural alterations at the microscopic level. A decrease in
staining for selected proteins could indicate a decrease or damage to that protein within
the skeletal muscle architecture.
After eccentric exercise, skeletal muscle biopsies from animals showed an increase in
the absence of staining for desmin (desmin-negative) and dystrophin (100,129). In humans,
desmin and dystrophin have been investigated to assess alterations to skeletal muscle
architecture after eccentric exercise (50,171). The absence of desmin staining after eccentric
exercise has not been consistently demonstrated in humans (49,171,174). Crameri et al. (49)
showed a decrease in desmin-stained fibers by 24 h that continued to decrease up to 192 h
after eccentric exercise. Yu et al. (171) showed an increase in desmin-stained fibers at
24–48 h and again at 168–210 h post-eccentric exercise. The difference in desmin
staining between these two studies could be a result of differences in the eccentric exercise
intensity. Crameri et al. (49) used a novel approach to investigate exercise-induced
alterations to skeletal muscle where one leg performed the eccentric exercise voluntarily
(VOL) and the other leg was electrically stimulated (eSTIM) to perform the eccentric
exercise (49). The eSTIM leg showed an increase in necrotic fibers and desmin-negative
fibers at 24 h and an increase in the amount of desmin-negative fibers at 96 h after
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eccentric exercise, while the VOL leg did not show any necrotic fibers or alteration in
desmin staining (49). Crameri et al. (49) found less post-exercise strength loss for the
eSTIM leg than the VOL leg. Therefore, the extensive morphological disruption seen in
the eSTIM leg compared with the VOL leg is not associated with muscle strength loss.
Additionally, muscle soreness was the same in the eSTIM and VOL legs. These results
indicate that the extent of disruption to the myofiber (e.g. Z-disk streaming) is not related
to strength loss or muscle soreness.
Intramuscular Connective Tissue and Extracellular Matrix
While Hough in 1902 (82) proposed that alterations to the connective tissue of
muscle play a role in the functional changes to skeletal muscle after eccentric exercise,
few studies have investigated alterations to the intramuscular connective tissue
(IMCT) and the ECM of skeletal muscle after eccentric exercise. The endomysium, which
is closely integrated with the ECM, is markedly disturbed after eccentric exercise (149).
After eccentric exercise, chondroitin 6-sulfate proteoglycan staining was found to be
diffuse instead of sharp around muscle fibers at 24 h, and at 48 h chondroitin 6-sulfate was
absent from the damaged edge of the myofiber (149). Skeletal muscle biopsies at 48 h after
eccentric exercise showed a widening of the perimysial area between fascicles (149). The
widening of the perimysial area indicates that the eccentric exercise produced connective
tissue damage. IMCT has recently received attention for its ability to enable lateral force
transmission between contracting muscle fibers (93,134). These studies demonstrate that
the IMCT contributes to the generation of skeletal muscle force. Therefore, alterations
found in the organization of IMCT after eccentric exercise likely play a role in muscle
strength loss and recovery after eccentric exercise.
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Ultrastructural Alterations
Alterations to skeletal muscle after eccentric exercise have been documented
by examining the number and extent of myofibrillar disruptions (66,68,172). Analysis of
the ultrastructural alterations to skeletal muscle shows eccentric exercise initiates a process
that produces gross disturbances to the organization of sarcomeres, particularly at the level
of the Z-disk. For this review, the ultrastructural alterations are characterized in three
ways: as Z-disk disturbances if the Z-disc appears widened and irregular; as Z-disc
smearing if the Z-disc extends irregularly into the A and I band and involves one or more
sarcomeres; and as Z-disc streaming if the Z-disc smearing is evident in multiple myofibrils
(64).
The Z-disc disturbances appear within 15 min after eccentric exercise (49).
Evaluation of the Z-disc disruption in skeletal muscle biopsies showed a greater amount of
Z-disc streaming at 2–3 d compared to 1 h post-eccentric exercise (66,171). These results
indicate that even though morphological alterations of skeletal muscle occur immediately
after eccentric exercise this appearance of disruption to the myofiber continues to increase
after muscle soreness and muscle strength have begun to return to baseline. These
ultrastructural alterations to skeletal muscle after eccentric exercise occur despite using
eccentric exercise protocols with low-intensity vs. high-intensity actions and despite the
limb (arm vs. leg) being exercised (65,68,118,125,173). Additionally, no difference has
been seen in the extent or amount of disruption to the Z-disc between men and women
after eccentric exercise (150).
Greater disturbances to the Z-disc were evident in muscle biopsies of the leg
eccentrically exercised via eSTIM compared to the leg wherein the VOL eccentric exercise
actions were performed (49). As mentioned earlier, there was less strength loss post37

exercise for the eSTIM leg compared with the VOL leg. These results indicate that
disruption within the myofiber as evident in the Z-disc streaming does not affect muscle
strength loss and, therefore, morphological alterations to the myofiber cannot fully
explain the functional alterations to skeletal muscle after eccentric exercise.
Furthermore, a muscle biopsy can only assess morphological, biochemical, and
molecular alterations to the 250–500 mg sample of muscle biopsied and may thus not be
representative of the entire skeletal muscle. Muscle biopsies provide beneficial information
regarding the events that occur within the tissue after eccentric, but these results must be
kept in context, as the procedure to procure biopsy sample may itself produce damage to the
fibers, cause an increase in serum cytosolic muscle proteins, initiate an inflammatory
response, and alter gene expression (174).
Connective Tissue, the Extracellular Matrix, and the Transmembrane System
This section provides an overview of the components within connective tissue
of skeletal muscle, ECM, and the cytoskeletal transmembrane system. The effects of
eccentric exercise are also addressed.
Connective Tissue of Skeletal Muscle
The ECM is intimately connected to the sarcolemma of skeletal muscle fibers and
is also integrated with a collagen fiber network to form the connective tissue of skeletal
muscle (93,134,140). The outermost layer of the collagen fiber network organizing skeletal
muscle is the epimysium. The epimysium is commonly referred to as the fascia of
skeletal muscle, and this layer envelops the bundles of muscle fascicles (93,134,140). The
individual fascicles of skeletal muscle are enveloped in a collagen fiber network called the
perimysium, and the individual myofibers within the fascicles are ensheathed in the
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endomysium (93,134,140). The collagen network surrounding these levels of organization
within skeletal muscle contains different amounts of collagen subtypes and acellular
material (98,134,140). In addition, to having within the layers different amounts of
collagen subtypes (e.g. collagen Type I, Type III, Type IV, etc.), the layers have a
different structural organization of the collagen subtypes.
The composition and structure of the collagen fiber network-organizing skeletal
muscle allow it to provide the following: tensile strength and support for skeletal
muscle (93,140), and a scaffold for capillaries (140), fine motor and sympathetic nerve
branches. The network contains cellular (e.g. macrophages and fibroblasts) (93,140)
and acellular material (e.g. fibrils, matrix metalloproteinases); it determines the
elasticity skeletal muscle exhibits; and it coordinates the transmission of mechanical
forces generated by the sarcomeres to the tendon (49,124,140). The epimysial and
perimysial layers of the collagen fiber network contain Types I and III collagen, and the
endomysial layer has Types I and III collagen in its reticular layer and Type IV collagen in
the basement membrane (93). The endomysium collagen fibers are organized in a
random arrangement, which allows for movement during muscle contractions. The
perimysial collagen fibers are organized into multisheet layers that run transverse to the
myofibers, this structural arrangement allowing the collagen fibers to hold the
myofibers in place (93). The epimysium collagen fibers are organized into two layers of
wavy collagen fibrils that form a sheetlike structure at the tendon (140). In addition to
different amounts of collagen types and their organization within the layers of the
muscle connective tissue, there are differing amounts of protein and carbohydrate within
these regions (113). Eccentric exercise places considerable strain upon muscle, and the
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intimacy of the connective tissue to skeletal muscle results in strain to the connective
tissue. The composition of the connective tissue network assists the muscle in absorbing
and distributing the strain. All three layers of connective tissue are affected by eccentric
exercise; however, it is expected that gross disturbances to the connective tissue are
localized to the muscle fibers activated during the eccentric action, and thus the
endomysial region would be most profoundly affected. In fact, Stauber et al. (149)
showed gross disturbances to the once tightly organized endomysial region after
eccentric exercise. It is expected that eccentric exercise will promote expression of genes
whose protein products contribute to the structural integrity of connective tissue.
Therefore, this overview of the components within connective tissue of skeletal muscle,
ECM, and the cytoskeletal transmembrane system focuses on molecular alterations that
support the connective tissue in the endomysial region and will pay particular attention to
the ECM layer, which begins at the bi-lipid plasma membrane of skeletal muscle and
extends into the IMCT layer of the endomysium.
Extracellular Matrix of Skeletal Muscle
The ECM is sandwiched between the endomysium and the plasma membrane
and includes the sarcolemma that surrounds the plasma membrane of skeletal muscle
fibers (93,134,140). The sarcolemma itself, is composed of layers that contain collagenous
(fibrils of Types I, II, III, and IV collagen) and non-collagenous material (proteins and
proteoglycans) (140). The innermost layer of the sarcolemma that is next to the bi-lipid
membrane is a glycocalyx layer; following the glycocalyx is the basal lamina, which
consists of the lamina reticular region and the lamina densa region. Following the basal
lamina is the reticular layer (140).
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The glycocalyx coats the bi-lipid membrane with proteoglycans, predominantly
heparan sulfate (140). The layers of the basal lamina contain different amounts of
collagen, proteoglycans, and cells. The lamina reticular layer of the basal lamina is
proposed to contain the protein fibronectin and Types I and III collagen; the fibronectin
assists in the adhesion of cells (e.g. fibroblasts and myoblasts) to collagen material
(molecules, polypeptides, and fibrils) (140). Fibroblasts synthesize collagen peptides,
matrix metalloproteinases (MMPs), and TIMPs (93). MMPs have substrate specificity
for the collagen and ECM components they degrade. MMP-1 and MMP-8 are
collagenases that predominantly degrade Types I and III collagen, while MMP-2 and
MMP-9 are gelatinases that primarily degrade Type IV collagen and other ECM
components (e.g. laminin, aggrecan, decorin, and fibrillin) (2,26,93). TIMPs are synthesized
by muscle fibers and inhibit the conversion of the pro-MMP peptide to the cleaved and
activated MMP, and thus TIMPs inhibit the degradation action of MMPs (95). The activity
of TIMPs has been shown to change in parallel with MMP activity (26,145).
The two most commonly studied MMPs in skeletal muscle are MMP-2 and
MMP-9 and the most commonly studied TIMPs in skeletal muscle are TIMP-1 and TIMP2 (2,26,75,139). In animals, exercise has been shown to increase the expression level and
activity level of MMP (96). Intensity of the exercise has been shown in animals to affect the
expression and activity level of MMPs (26). Low-intensity exercise had no effect on
expression of MMP-2, but high-intensity exercise caused an increase in mRNA
expression of MMP-2 (1,139). The expression level and activity level of MMP-9 in the
exercised limb were not different from the control limb (26). In humans, MMP levels
have been shown to be altered after endurance exercise, immobilization, and eccentric
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exercise (106,138,161). These data suggest MMPs and consequently TIMPs are
important in the remodeling process of skeletal muscle. Therefore, it is expected that
eccentric exercise will result in an increase in the expression level and activation level of
MMPs and TIMPs within skeletal muscle ECM.
The lamina densa region contains the protein laminin and Type IV collagen;
laminin functions in the same manner as fibronectin, but laminin can also bind collagen
to the intermembrane protein integrin (140). Mice lacking laminin show growth
retardation and muscle dystrophy (93). Next to the basal lamina layer is the reticular layer,
which contains Types I and III fibrils of collagen and proteoglycans (e.g. fibromodulin,
decorin, biglycan, lumican, tenascin-C, proline, syndican, perlecan, agrin, laminin,
fibronectin, aggrecan, heparan sulfate, and chondroitin sulfate) (140). The proteoglycans
within the reticular layer assist in fibril fusion, fibril alignment, and spacing between
fibrils (93,140). Many of these proteoglycans (e.g. perlecan, heparan sulfate, biglycan,
laminin) have been shown in vitro to have increased expression in response to stretch
(3,96,137). After eccentric exercise in humans, tenascin-C showed increased mRNA and
protein expression compared to the control (31,49). The combination of the basal lamina
and the reticular layer make up the basement membrane of the sarcolemma.
Transmembrane Cytoskeletal System of Skeletal Muscle
The transmembrane system links and mediates interactions between the ECM and
the intracellular cytoskeleton (67) and consists of the dystrophin-associated protein
complex (DAPC), focal adhesion kinases (FAK), laminins, and integrins. Because the
ECM is sensitive to mechanical stress, increased or decreased stress to the ECM would
likely transfer to components that interact with the ECM (e.g. transmembrane system) and
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result in alteration in levels of the transmembrane system mRNA and their respective
protein products (61,81,97,161). The ECM is able to transfer the mechanical signals it
receives to the intermembrane system, which can then translate the mechanical signal
into a biochemical signal via the intermembrane or transmembrane proteins (4,57,89,).
Integrin is a transmembrane protein localized in the sarcolemma that links to the collagen
network of the ECM via laminin α-2. Integrins are a paired protein complex that consists of an α
integrin and a b integrin (137). The α7 and β1 integrins are the most abundant integrins found in the
skeletal muscle (53,89). In animals, mutations in integrins result in muscle dystrophy (46). In
addition to their link with the ECM, the integrins also associate with the cytosolic components of
skeletal muscle. They are connected to the cytoskeletal and contractile proteins via the DAPC,
and they also interact with cytosolic-signaling cascades via FAKs. Integrins have been
shown to convert the mechanical signals (strain and stress) from the ECM to an adaptive
response (e.g. hypertrophy) within the cell (61). This action is possible because integrins
are transmembrane proteins. They bind to collagen and some proteoglycans (e.g.
fibronectin, tenascin-C, and laminin) of the ECM and the DAPC of the muscle cytosol.
DAPC and FAKs are localized at the cytosolic domain of the α7-β1 integrins
and the localization of these protein groups are termed a focal adhesion complex
(FAC) (57,81). It has been suggested that the α7-β1 integrins transmit the mechanical
strain or lack of mechanical strain from laminin α -2 a protein, which interacts with the
collagen fiber network of the ECM (16,61,81,143). Boppart et al. (16) showed increased
protein levels of α7-β1 integrins and greater phosphorylation of the AKT1 protein in
mice post-downhill running compared to pre-downhill running. Additionally,
dystrophin-deficient mice overexpressing α7-β1 integrins have a reduction in muscle
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dystrophy symptoms (e.g. elevated creatine kinase and muscle damage) (16). It is
possible that the increased load and contraction that occur during eccentric exercise will
result in increased levels of laminin a-2 and integrin α7-β1 mRNA and protein. The
FAK will show increased tyrosine phosphorylation because of the increased protein levels
of the α7-β1 integrins. These alterations to the ECM may serve as a signal to initiate
sarcomerogenesis and skeletal muscle remodeling (151).
Recently, an animal model in dystrophin-lacking mice (mdx mice) showed that
an inducible activated (phosphorylated) AKT1 prevented the strength loss produced by
eccentric exercise (14). The lack of strength loss was attributed to the activated Akt
promoting up-regulation of genes whose protein products are part of the cytoskeletal
filaments (e.g. desmin) and the intermembrane system (e.g. integrins).
Repeated Bout of Eccentric Exercise and Muscle Function
Eccentric exercise is well known to produce muscle damage that is manifested by
DOMS and prolonged losses in strength and range of motion (36,49,58,124). These
temporary alterations in muscle function have been shown to be reduced after a repeated
bout of exercise. A single bout of novel eccentric exercise initiates a remodeling process
that facilitates muscle adaptation (23,44,119). The adaptation confers protection to future
bouts of similar exercise, such that a subsequent exercise bout results in decreased
strength loss and reduced soreness response compared to the initial bout of exercise
(44,80) This adaptation between the first and second bout, is called the “repeated bout
effect” (RBE) (39). The mechanisms underlying the RBE are unknown, but processes
involved in protein synthesis, inflammation, and motor control have been proposed to

44

play a role (20,149,150). The RBE has been shown to last for up to six months and is no
longer apparent between nine to 12 months after the initial bout of exercise (123,124).
Repeated Bout of Eccentric Exercise and the Extracellular Matrix
Few investigators have examined the ECM after a single much less a
repeated bout of eccentric exercise. However, Mackey et al. (105) had subjects
undergo two electrically stimulated exercise bouts (i.e. eSTIM1 and eSTIM2) and
found that changes in laminin-β1, collagen 1 and collagen 3 were significantly
different at 30 d after a single bout of eccentric exercise compared to a repeated
bout performed 1 mo after a single bout. In addition, Mackey et al. (105) found that
heat shock proteins 27 (HSP 27) and 70 (HSP 70), chemokine ligand 2 (CCL2),
connective tissue growth factor (CTGF), and tenascin-C (TNC) mRNA levels were
all attenuated at 48 h after a repeated bout of eccentric exercise compared to 48 h
after a single bout of exercise. Mackey et al. (105) proposed that the elevation of
HSP 27, HSP 70, CCL2, and TNC after a single bout of eccentric exercise was
because these molecules were involved in de-adhesive and disassembly processes in
the ECM in order to reorganize it. These results suggest that the attenuation of gene
expression for these molecules after a repeated bout of eccentric exercise was due to
a reorganized matrix after the first bout and thus the matrix was able to manage the
strain of the second bout. The recent focus in the last five years by investigators on
the ECM has begun to shed light on the importance of ECM components to skeletal
muscle repair, adaptation, and hypertrophy (16). Mackey et al. (105) were the first to
investigate alterations to ECM-related proteins after a repeated bout of exercise.

45

While Mackey et al. (105) have investigated changes in the ECM molecules after
a repeated bout, these results must be viewed with caution because the eccentric exercise
model used was eSTIM and not voluntary. Malm et al. (109) and Crameri et al. (49) have
shown that voluntary eccentric exercise does not display the extensive amount of Z-line
streaming or inflammation that is found after eSTIM. Furthermore, one of the hallmarks
of the “repeated bout effect” is the reduction in DOMS, and Mackey et al. (105) did not
find a reduction in DOMS after a second bout of eSTIM eccentric exercise.
Summary
Eccentric exercise is known to produce muscle damage by imposing muscle strain
(36,60,63). Indirect markers of muscle damage include prolonged muscle strength loss,
DOMS, and the appearance of muscle and connective tissue proteins in the blood. Direct
evidence of muscle damage has been provided using light and electron microscopy
techniques on muscle biopsy samples taken post-exercise. There is much evidence for
damage to the myofibrillar structure post-exercise. However, there is also some evidence
that structural and cellular components of the ECM are affected; the ECM responds to
strain by promoting transcription and translation of many of its structural components.
Given the paucity of information on ECM changes after voluntary eccentric exercise and
the important function that the ECM plays in muscle, more work is needed to elucidate
the role of the ECM in the muscle damage and repair processes.
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CHAPTER 3
MUSCLE SORENESS: COMPARING MUSCLE BIOPSIES
TO ECCENTRIC EXERCISE (Study 1)
Abstract
We examined the effect of a single muscle biopsy (baseline muscle biopsy, MB1)
and repeated biopsies on skeletal muscle soreness between a control group (biopsies only;
n=2 men and n=2 women) compared to an exercise group who performed eccentric
exercise and had muscle biopsies (n=4 men and n=4 women). We used three different
tests to measure muscle soreness: the Brief Pain Inventory Short Form (BPISF;
Apppendix B) the McGill Pain Questionnaire (MGPQ; Appendix C), questionnaire, and
two task-related measures of muscle soreness using a visual analog scale (VAS). All
three tests showed that peak muscle soreness was elevated at 24 h after a single and
repeated biopsies (~25 mm in VAS) and that this soreness was resolved by 96 h after
single or repeated biopsies. This peak soreness was significantly less than that found after
combined eccentric exercise and a muscle biopsy (~40 mm in VAS). Muscle soreness
after eccentric exercise and a muscle biopsy did not resolve until 120 h. Baseline biopsies
should be performed at least 96 h before exercise to ensure resolution of soreness from
the biopsy in studies examining exercise-induced muscle soreness.
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Introduction
Despite the widespread use of the muscle biopsy procedure in kinesiology
research, little information is known regarding the effects of a single or repeated biopsies
on muscle soreness and daily physical activity, both of which could confound
interpretation of study results. In 1902, Hough (14) documented soreness of skeletal
muscle that appeared 8–10 h and peaked 12–24 h after a strenuous eccentric exercise.
Hough (14) attributed the delayed soreness to a rupture within the muscle fibers. Almost
80 years later, Friden et al. (11) confirmed damage to muscle fibers by ultrastructural
analysis of skeletal muscle biopsies after eccentric exercise and associated this damage
with soreness development (12). Yu and colleagues (28,29) showed that the
ultrastructural damage, which peaked at 4–7 d post-exercise, was not related to the peak
of delayed onset muscle soreness (2–3 d post-exercise). Numerous studies have used
skeletal muscle biopsies as a useful tool to investigate the underlying mechanisms of
exertional muscle damage and its sequelae. (2,8,16,21,22) However, only one of these
studies (21) measured biopsy-related soreness development and found that the muscle
biopsy did not cause a significant elevation in muscle soreness.
Recently, Tarnopolsky et al. (25) examined the safety and size of muscle biopsy
samples from 13,500 biopsies performed at McMaster University by one neuromuscular
clinician. Using a Bergstrom needle with suction, they collected three biopsy samples
from one insertion of the biopsy needle, resulting in an overall sample size of 150–200
mg (25). Complications arose in one out of 519 biopsies, and the most common
complication was a local skin infection (25). These results indicate that relatively large
samples can be obtained with few and minor complications, supporting biopsy as a
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relatively safe research technique. To test that multiple biopsies did not affect results,
Malm et al. (21) performed repeated biopsies at the same incision site on exercised and
non-exercised (control) individuals. Immunological changes (e.g. an increase of
macrophages near the edge of the biopsy-incision site) were found with repeated muscle
biopsies in both groups; however, the changes in the non-exercised (control) muscle were
equal to or greater than those in the exercised muscle. In addition, Friedmann-Bette
examined gene expression among multiple biopsies (four muscle biopsies) and found no
difference from the baseline biopsy for the following genes of interest: interleukin-6 (IL6), IL-6 receptor, insulin-like growth factor 1, p21, phosphofructokinase, and glucose
transporter. The results from Malm et al. (21) and Friedmann-Bette et al. (13) suggest
that inflammatory processes can be affected if the multiple biopsies are taken from the
same site and that multiple biopsies do not affect the muscle growth signaling processes.
Therefore, we can examine the vastus lateralis muscle as it is easier to take multiple
biopsies that are more than 2 cm apart. This will ensure that any muscle soreness
identified after the biopsy and future analysis of gene and protein expression is not
attributed to the inflammatory processes identified by Malm et al. (21) and FriedmannBette and colleagues (13).
The purpose of this study was to compare muscle soreness and daily physical
activity levels between two groups of healthy subjects after muscle biopsies of the vastus
lateralis: 1) a control group (n=4) who had a baseline plus two additional muscle
biopsies; and 2) an exercise group (n=8) who had a baseline biopsy, performed two bouts
of eccentric exercise, and then had a muscle biopsy within 24 h of each exercise bout. We
assessed the effect of the biopsy (e.g. control group muscle biopsy 1, 2, and 3 [MB1,
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MB2, MB3] and exercise group MB1) and the eccentric exercise+biopsy (exercise group
muscle biopsy 2, and 3 [MB2 and MB3]) on muscle soreness and daily living using two
questionnaires (the BPISF and MGPQ; see Appendices B and C). We also used the VAS
of 100 mm and two tasks (e.g. walking down a flight of stairs and two single-legged
squats) to assess muscle soreness. For the stair task, subjects descended the flight of stairs
and then recorded the peak soreness for each leg (e.g. exercised leg without a muscle
biopsy [EXNB] compared to the exercised leg with a muscle biopsy [EXB]). The
soreness task of two single-legged squats allowed us to differentiate the muscle soreness
of the EXNB leg compared to the EXB leg and the control group’s biopsy leg (CON)
soreness at Bout 0 (muscle biopsy 1, MB1-baseline muscle biopsy), Bout 1 (muscle
biopsy 2, MB2), and Bout 2 (muscle biopsy 3, MB3). In addition to the measures of
muscle soreness, we also used an activity monitor to assess the effect of a muscle biopsy
(MB1) on daily physical activity.
Methods
Study Design
The study protocol and informed consent document were approved by the
University of Massachusetts Amherst Institutional Review Board for human subjects. All
subjects provided written consent. Subjects were randomized to have either their
dominant or non-dominant leg biopsied at baseline (muscle biopsy 1, MB1). Baseline
measures (before the biopsy) of muscle soreness of the quadriceps were assessed on two
separate visits, with at least 2 d but not more than 5 d between the baseline visits. The
post-biopsy muscle soreness measures were assessed daily for 7 d. The three measures of
muscle soreness were used at every visit where soreness was assessed: (100 mm VAS,
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BPISF, and MGPQ). Maximal isometric strength was assessed at the baseline visits and
at 7 d post-MB1 and 14 d post-MB2. MB1 (Bout 0 muscle biopsy) was taken 3–5 d after
subjects completed the baseline measures of muscle soreness and isometric strength
testing. The MB2 was taken 24 h after the first exercise or no-exercise bout (Bout 1), and
MB3 was taken 24 h after the repeated exercise or no-exercise bout (Bout 2). Bout 1, the
first bout of exercise or no-exercise (control group), occurred one week after the baseline
muscle biopsy (Bout 0, MB1). Bout 2, the repeated bout of exercise or no-exercise,
occurred two weeks after Bout 1. The control group completed the study in the same
timeline as the exercise group. The study timeline is shown in Figure 3.1.

*

Figure 3.1: Study timeline.
Subjects
Twelve healthy male and female subjects (n=6 male, 6 female) enrolled and
completed the study. Of the 12 subjects, eight were randomized into the exercise group
and four were randomized into the no-exercise control group. The exercise and control
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groups were balanced for sex. Subjects were also randomized as to which leg was
biopsied first (MB1); the contralateral leg was biopsied for the second (MB2) and third
(MB3) biopsy time points.
All subjects were recruited from the University of Massachusetts Amherst and
surrounding area. Individuals were eliminated from the study if they 1) had an occupation
requiring heavy weight lifting or had participated in a weight-training activity of the
lower body within the past six months; 2) were a smoker; 3) had undergone orthopedic
surgery in the leg (unless cleared by a physician) or had any skeletal, muscular, or
neuromuscular dysfunction; 4) had participated in a leg muscle soreness trial within the
previous six months; 5) were currently participating in or planning on participating in a
research study involving an investigational drug, supplement, medical device, or exercise
protocol; 6) were currently taking any medication that would interfere with the study
results such as products with analgesic properties as labeled; 7) were taking dietary
supplements during the course of the study except the study treatment; 8) had consumed
any narcotic preparation (e.g. codeine) or illicit drugs (such as marijuana, etc.) within the
previous seven days; or 9) had any serious medical condition, including but not limited to
diabetes, hypertension, kidney, cardiovascular, or pulmonary disease. In addition, biopsy
care instructions were reviewed verbally with all subjects. If subjects were not willing to
follow the biopsy care instructions, they would have been excluded from the study;
however, none were excluded for this reason.
Individuals who met the inclusion criteria, agreed to follow the biopsy care
instructions, and completed the baseline muscle function measures were randomized for
baseline leg biopsy (dominant leg or non-dominant leg to be biopsied first) and reported
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to the lab for the muscle biopsy. All subjects were provided with a standardized snack
(Oscar Myers Lunchable® with 8 oz. of water) 4 h prior to the skeletal muscle biopsy.
They were not allowed to eat after this snack until the biopsy was completed. The caloric
content of the standardized snack was 360–370 calories (8–12 g total fat, 51–63 g total
carbohydrate, and 10–12 g protein).
Muscle Biopsy Procedure
Subjects were transported to and from Hartford Hospital where the biopsy
procedure was performed. A licensed physician performed the needle biopsy procedure
under local anesthesia using a Bergstrom needle with suction. A small incision (about 0.5
–2.0 cm) was made into the skin and fascia of the vastus lateralis. The Bergstrom 5–6
mm biopsy needle was then inserted into the muscle, and suction was used to allow a
specimen of muscle tissue to be “clipped” with the needle. The biopsy needle was rotated
90° to the right, suction was applied, and another sample was collected; this was repeated
to collect a third sample. When the needle was removed from the muscle, by using this
three-“clip” method, the overall specimen size was about 150–200 mg. For four of the 12
subjects, the biopsy needle was reinserted and the three “clips” were performed a second
time because at the first collection the specimen size yielded less than 100 mg of tissue.
To reduce the risk of bleeding post-biopsy, subjects were instructed not to consume any
anti-inflammatory drugs (i.e. non-steroidal anti-inflammatories (NSAIDS) like Ibuprofen
or aspirin) or any aspirin-containing drugs such as Alka-Seltzer, Pepto-Bismol, or certain
decongestants (i.e. Dristan) within 4 d of the muscle biopsy.
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Physical Activity Assessment
At the beginning of the study, the subjects completed the 7-day short form
International Physical Activity Questionnaire (IPAQ). They were asked to maintain the
same level of physical activity until the muscle biopsy procedure and were given an
Actical physical activity monitor (Mini Mitter Co., Inc., Bend, OR) to wear for 48 h prior
to the baseline muscle biopsy. The activity monitor was set to collect activity data in 15sec epochs and the data were downloaded to a computer. Subjects continued to wear the
monitors for all waking hours during the 48 h after the baseline muscle biopsy procedure,
and they were instructed to not wear the monitor while showering or sleeping.
Timeline
Subjects completed two baseline strength-measure visits that were separated by at
least 2 d, but not more than 5 d, as shown in Figure 3.1. Subjects were given a physical
activity monitor to wear between these baseline visits and asked to complete an activity
log. Muscle soreness was measured prior to the baseline muscle biopsy (MB1) and at 24
h intervals up to 120 h post-MB1. At 120 h after MB1, all subjects returned for the
exercise or no-exercise session (Bout 1): the exercise group performed an eccentric
exercise that used both legs (descending stairs) and had a strength measure (e.g. maximal
isometric strength at 70°) before and after the exercise bout. The control group did not
exercise, but they completed the same strength measure. The following day (24 h postBout 1) all subjects completed the muscle soreness measures before the muscle biopsy
(MB2). This biopsy was collected from the leg contralateral to that biopsied at MB1.
Muscle soreness was measured at 24 h intervals up to 120 h post-MB2. Two weeks after
exercise or no-exercise Bout 1, subjects returned to the lab for exercise or no-exercise
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Bout 2. The following day (24 h post-Bout 2) all subjects completed muscle soreness
measures before the muscle biopsy (MB3). This biopsy was collected from the same leg
that was biopsied at MB2. Muscle soreness was measured at 24 h intervals up to 120 h
post-MB3.
Eccentric Exercise Protocol and No-Exercise Protocol
Subjects in the exercise group performed eccentric actions of the knee-flexors.
They ran down 10 flights of stairs (e.g. 11th floor to the first floor) 15 times (15 “sets” of
stairs) and used the elevator to return to the top of the flight of stairs. Each flight of stairs
consisted of two sets of 12 steps, so subjects ran down 24 steps between each floor. Each
step rise was 17.78 cm, the run was 29.21 cm, and the tread width was 154.94 cm. The
average amount of work done was -31.53 kJ ± -4.10 kJ (mean ± SEM). The subjects
were monitored by an investigator at the top and the bottom of the stairs and were
encouraged to maintain a rate between 2.09 and 2.87 steps/sec down the stairs. This rate
of descending the steps resulted in the subjects completing the 10 flights of stairs between
90 and 115 sec and an overall 22–26 min bout of eccentric exercise (including time
waiting for the elevator between “sets”). This protocol was used previously by others and
has been shown to result in muscle damage (11,28,29). Subjects in the control group did
not perform the stair exercise, but they reported to the Muscle Biology and Imaging
Laboratory and performed the muscle strength tests. Both groups were instructed to
maintain their regular activity level throughout the duration of the study.
Muscle Soreness Measures
Subjects were asked to perform two tasks with the quadriceps and then record
their soreness using a VAS. The VAS is a 100 mm horizontal line: One end of the line (0
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mm) indicates no soreness and the other end (100 mm) indicates severe soreness (great
pain and difficulty while completing the task). For the first task-related VAS muscle
soreness rating, subjects performed two stand-to-sit (STS-VAS) motions using only a
single leg (the biopsied leg). For the second task-related muscle soreness rating, subjects
were asked to descend a flight (10 steps) of stairs (Stair-VAS). The stair descent began
with the left leg, and subjects were allowed to use the handrail to regain their balance but
were monitored to ensure they did not use the handrail to support their weight. After each
task, subjects were then asked to record the peak soreness of their quadriceps muscle by
placing a vertical line on the VAS. In addition, the time to descend the stairs at their
preferred walking pace was recorded to examine if the muscle biopsy or the biopsy and
exercise session had changed the preferred walking pace for a task that they would
perform on a daily basis. After completing the soreness tasks, subjects completed the
BPISF and the MGPQ.
Muscle Strength Measures
Following the pre-biopsy soreness evaluations, the subjects performed a maximal
isometric strength test. They sat on the Biodex machine (Biodex System 4 Pro, Biodex
Medical Systems, Shirley, NY), with their legs relaxed and knees flexed in a 90o angle.
The chair, back support, and lever arm of the Biodex were positioned so that the axis of
rotation of the Biodex lever arm was in line with the lateral condyle of the femur. For the
isometric strength test, the lower leg was then secured in the knee attachment with the
foot in a flexed position. Knee extension range of motion (ROM) was set from the knee
in a flexed position at 90o until the knee was extended to 0o of knee flexion (straight leg).
The Biodex lever arm moved the leg to a 70° position, and subjects were asked to first
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attempt to extend their leg for 3 sec with maximal effort and then attempt to flex their leg
for 3 sec, also at maximal effort; they repeated this action three times for one set. Because
the test was isometric, the lever arm did not move while the subjects contracted with full
effort. The isometric strength test was repeated until three trials were within 10% of each
other. After each maximal isometric set, 1-min rest was given.
Data Analysis
All statistical analyses were performed using SigmaPlot 11.0. Baseline
characteristics for men and women are shown in Table 3.1 (e.g. age, height, weight, leg
dominance, and maximal isometric strength). All baseline measures were analyzed for
validity and reliability using a repeated measures ANOVA (rmANOVA) and an
interclass correlation (Pearson product moment) between the two baseline visits. The
rmANOVA provided the main effect of time (day) and group (sex was used as a grouping
factor).
The change in isometric strength pre- to post-biopsy was analyzed with an
rmANOVA with the main effect of time (e.g. pre- vs. post-biopsy), group (control vs.
exercise) and leg (biopsied vs. non-biopsied). All measures (isometric strength, soreness,
and physical activity) were analyzed for a normal distribution and equal variance. If the
measure failed the normality or variance test, the appropriate non-parametric test was
used to analyze the measure. Changes in task-related muscle soreness (e.g. STS-VAS,
Stair-VAS) were analyzed with rmANOVA for the main effect of time (baseline and days
post-biopsy), bout (e.g. muscle biopsy 1 (MB1)=Bout 0, MB2=Bout 1, and MB3=Bout
2), group (e.g. control vs. exercise), leg (biopsied vs. non-biopsied leg) and their
interactions. The muscle soreness assessed via questionnaires (e.g. BPISF, and MGPQ)
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was analyzed with a Kruskal Wallis test for the main effects analyzed in the task-assessed
muscle soreness measures (e.g. time, bout, group, and leg). Percent of time spent in
sedentary, light, moderate, and vigorous physical activity for one day was analyzed with
an rmANOVA for the main effect of time (pre- vs. post-biopsy) and group (sex). We also
examined the total activity counts and the amount of steps pre- and post-biopsy using a
Students t-test. The percent difference between the average isometric strength at baseline
and the assessment at 7 d post-biopsy was analyzed with an rmANOVA for the main
effects of visit, group, sex, and leg.
Results
Fifteen individuals completed the interview and read the informed consent for this
study; 12 signed the informed consent, enrolled, and completed the study. The 12
individuals enrolled in the study were six men and six women. The physical
characteristics of the 12 subjects are (mean ± SEM): age 23.0 ± 1.6 yr, height 174.1 ±
2.78 cm, and weight 85.68 ± 9.48 kg. Of the 12 subjects, eight were randomized into the
exercise group and four were randomized into the control (non-exercise) group. The
physical characteristics for the two groups are shown in Table 3.1. There was no
significant difference between the groups for age (p=0.335), height (p=0.903), or weight
(p=0.261). The exercise and control (non-exercise) groups were balanced for sex.
Table 3.1: Characteristics for exercise and control groups.
Exercise

Control

Age (y)

22.13 ± 1.10

24.75 ± 2.20

Height (cm)

173.83 ± 2.91

174.63 ± 5.43

Weight (kg)

91.39 ± 11.76

74.26 ± 8.27

Values are mean ± sem.
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Subjects received a standardized snack that was consumed 3–5 h before the
biopsy. After the biopsy, an ice pack was kept on the incision site for 30 m, and during
this time all subjects were given Tylenol (500mg), a snack (juice box and a granola bar),
and a physical activity monitor to wear. All subjects consumed the entire biopsy snack
prior to each biopsy and had the same snack prior to each biopsy. One of the subjects
declined taking the Tylenol after the biopsy and was instead given an extra packet of
Tylenol to take away in case it was needed later. At the end of the biopsy visit, subjects
were given the biopsy care instruction sheet, icepacks, and individual Tylenol packets to
take home.
On subsequent visits the biopsy site was inspected for redness, swelling, bleeding,
elevated temperature, and/or tenderness. The biopsy dressing was then changed and
subjects were provided with additional Tylenol packets. During this study none of the
subjects presented with an infection or irritation at the biopsy incision site. However,
three subjects did present with blisters by 72 h post-biopsy at the terminal points of the
steri-strips that were used to close the biopsy incision. It is likely that the steri-strips
pulled on the skin and caused this irritation. All subjects were contacted via telephone at
48 h and 96 h post-biopsy, and none reported changes at the biopsy incision site since
their previous visit to the laboratory.
Physical Activity Assessment
All subjects wore the Actical for 48 h before and after the baseline muscle biopsy.
The percent of time the person spent in sedentary, light, moderate, and vigorous activity
during the 48 h blocks were compared using a 1-way repeated measures ANOVA to
examine the main factor of time (pre- vs. post-biopsy). All measures of physical activity
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are shown in Table 3.2 and Figure 3.2. There was no significant difference pre- to postbiopsy for time spent in sedentary activity p=0.078, for light activity p=0.201, for
moderate activity p=0.119, or for vigorous activity p=0.200. These results indicate that
within the first 48 h after a muscle biopsy the physical activity levels were similar to their
pre-biopsy levels. As shown in Figure 3.3, the daily average for total activity count
between time points suggests that the biopsy affected their physical activity level, but it
did not reach significance (p=0.061); pre-biopsy average daily activity count was
176,216.25 ± 39,256.42, and post-biopsy was 79,938.9 ± 9,456.75. However, we did find
a significant decrease in total daily steps (p=0.047) after the biopsy compared to before;
pre-biopsy steps were 7,561.78 ± 1,278.85, and post-biopsy were 4,549.4 ± 813.8. These
results indicate that subjects were following the biopsy protocol and resting their leg in
the days after the muscle biopsy.
Table 3.2: Percent of time spent in different levels of physical activity after a single
muscle biopsy.
Sedentary
Light
Moderate
Vigorous

Baseline

Post-Biopsy

% Change from Baseline

80.0 ± 2.4
12.0 ± 1.4
7.0 ± 1.2
0.3 ± 0.2

84.2 ± 1.4
10.2 ± 0.9
4.6 ± 0.6
0.0 ± 0.0

5.25%
-15%
-34.4%
100%

Values are mean ± sem.
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Figure 3.2: Percent time spent in different levels of physical activity pre- and post-biopsy.
Values are mean ± sem.
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Figure 3.3: Total daily average for A) steps and B) activity counts pre- and post-baseline
muscle biopsy. Values are mean ± sem. *p <0.05 from pre-biopsy.
Muscle Soreness Measures
Eccentric exercise causes delayed onset muscle soreness, which peaks between 24
h and 48 h post-exercise (5). In the present study, we investigated muscle soreness using
three different measures. The first measure, task-related VAS, has commonly been used
in our lab to assess muscle soreness post-exercise (10). The second and third measures
used questionnaires to assess pain. All muscle soreness measures indicated that peak
soreness occurred at 24 h for Bout 0 and at 48 h for Bout 1 and Bout 2 (p < 0.05). These
results are shown in Table 3.3 and Figure 3.4 for the Stair-VAS and STS-VAS, in Table
3.4 and Figure 3.5 for the MGPQ, and in Table 3.5 and Figure 3.6 for the BPISF
questionnaire.
Task-Related Visual Analog Scale
The stair descent exercise required both legs to undergo eccentric actions, and
because the muscle biopsy was performed on the same leg 24 h after Bout 1 and Bout 2
we were able to measure 1) the effect of the exercise on muscle soreness, and 2) the
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effects of the exercise and muscle biopsy on muscle soreness. The control group did not
perform the exercise, but still had a muscle biopsy and we measured the soreness of a
single (Bout 1) and repeated muscle biopsy (Bout 2) on the same leg—the baseline
muscle biopsy was on the contralateral leg. Traditionally, a single-legged stand-to-sit-tostand task (STS-VAS) has been used in our lab to measure muscle soreness of the
exercised knee extensors, but our exercise model was stair descent so we also measured
muscle soreness after stair descent (Stair-VAS). The task-related Stair-VAS was
performed in the laboratory. Because subjects did not report to the laboratory for the 72 h
and 120 h visit, the Stair-VAS was not measured at these time points as not all subjects
had access to stairs. Subjects were able to perform the STS-VAS at home for the 48 h and
96 h visit.
Table 3.3: Task-related visual analog scale (VAS) soreness levels hours after a muscle
biopsy.
0h
24 h
48 h
72 h
96 h
120 h
168 h

STS (mm)

Stair (mm)

0.96 ± 0.55
25.46 ± 4.89*
15.75 ± 3.55*
8.33 ± 3.49*
3.58 ± 2.33
1.83 ± 1.14
0.75± 0.59

0.38 ± 0.27
24.96 ± 4.33*
4.64 ± 3.36
1.25 ± 0.99
0.38 ± 0.38

Stair Descent (sec)

Note: STS, stand-to-sit-to-stand motions. Values are mean ± sem.
*Indicates (P < 0.05) from 0 hour (baseline).
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6.25 ± 0.24
6.25 ± 0.37
8.09 ± 1.41*
6.17 ± 0.41
6.20 ± 0.37

Figure 3.4: Visual analog scale (VAS, 100 mm) results for muscle soreness task activities
(e.g. stand-to-sit-to-stand (VAS-STS) and stair descent (VAS-Stair) for the exercise
group (A1–A4) and the control group (B1–B4). *p >0.05 between hours post-bout, φ p >
0.05 between bouts, τ p >0.05 between exercise vs. control.
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Using the STS-VAS, we detected a difference in soreness between the biopsied
(Figure 3.4.A1) and non-biopsied (Figure 3.4.A3) leg after Bout 0, Bout 1, and Bout 2
(p=0.039); however, using the Stair-VAS measure, we found no difference between
biopsied (Figure 3.4.A2) and non-biopsied (Figure 3.4.A4) legs (p=0.1018). The taskrelated muscle soreness measures showed that muscle soreness increased to a greater
extent in the exercise group despite leg biopsied or bout compared to the control group (p
<0.0001) at all time points. The exercise group had significantly higher task-related
soreness levels for both legs after Bout 1 compared to the control group biopsied leg at
Bout 1 (p <0.05) as assessed with both task-related VAS measures. The exercise group
also had significantly lower task-related soreness levels after Bout 2 compared to Bout 1
(p <0.05) for both legs. In addition, the soreness levels of the biopsied and non-biopsied
leg in Bout 2 for the exercise group were not significantly different from the biopsied leg
for the control group at Bout 0 and Bout 1.
McGill Pain Questionnaire
Sensory and Affective Measures of Pain
The MGPQ assessed four aspects related to pain: sensory, affective, non-taskrelated VAS, and current pain index; these results are shown in Table 3.4 and Figure
3.5.A1–A4 and 3.5.B1–B4. Subjects did not fill out a different MGPQ for the biopsied
and non-biopsied leg; therefore, the four pain aspects measured with the MGPQ
encompass both legs for the exercise group and the biopsied leg, only, for the control
group. The McGill Pain Sensory score assessed pain intensity by tabulating 11 pain
quality items (e.g. throbbing, stabbing, sharp) with a potential of three points per item (0
point=none, 1 point=mild, 2 points=moderate, 3 points=severe). Muscle pain intensity
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(e.g. sensory score) was significantly elevated (p >0.05) for the exercise group compared
to the control group at 48 h and 72 h post-Bout 1 compared to 0 h post-Bout 1 and to 48 h
and 72 h post-Bout 0 (Figure 3.5.A1 and 3.5.B1). The second aspect of the MGPQ
assessed the affective component of pain and measured the unpleasantness caused by the
pain using four pain quality items (e.g. fearful, tiring-exhaustive, sickening, punishing
cruel) with the same three-point scale used for the sensory score. The exercise group
compared to the control group had a significantly (p <0.05) higher affective score at 48 h
post-Bout 1 compared to 0 h post-Bout 1 and to 48 h post-Bout 0. The exercise group
also reported a significantly lower affective score after Bout 2 compared to Bout 1 and
Bout 0 at 48 h. The control group did not report a significant increase in unpleasantness
after the muscle biopsy at any time point (p=0.451) or among bouts (p=0.422).
Table 3.4: McGill Pain Questionnaire (MGPQ) scores hours after a muscle biopsy, n=12.
0h
24 h
48 h
72 h
96 h
120 h
168 h

Sensory

Affective

VAS Non-Task

Current Pain

0.08 ± 0.08
6.75 ± 1.00*
2.17 ± 0.47*
1.25 ± 0.45
0.50 ± 0.19
0.08 ± 0.08
0.08 ± 0.08

0.00 ± 0.00
0.33 ± 0.19
0.00 ± 0.00
0.00 ± 0.00
0.00 ± 0.00
0.00 ± 0.00
0.00 ± 0.00

1.06 ± 0.63
27.75 ± 5.35*
10.25 ± 2.28*
4.81 ± 1.18
2.63 ± 1.17
3.13 ± 2.37
0.00 ± 0.00

0.00 ± 0.00
1.13 ± 0.23*
0.38 ± 0.18
0.25 ± 0.16
0.13 ± 0.13
0.25 ± 0.16
0.00 ± 0.00

Values are mean ± sem.
*Indicates (P <0.05) from 0 hour (baseline).
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Figure 3.5: McGill Pain Questionnaire (MGPQ) results for the exercise group (A1–A4)
and the control group (B1–B4). Included plots are the averaged scores for the following
parameters: 1) sensory score, 2) affective score, 3) non-task VAS, and D) current pain
index. Results are mean ± SEM. *p >0.05 between hours post-bout, φ p > 0.05 between
bouts, τ p >0.05 between exercise vs. control.
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Non-task Visual Analog Scale and Current Pain Index
The MGPQ contains a VAS, but this scale does not use a task (VAS-non-task),
and the results are shown in Figure 3.5.A3 and Figure 3.5.B3 for the exercise and control
group. The non-task VAS measured muscle soreness due to the muscle biopsy in the
control group but, because subjects filled out a single questionnaire, the exercise group
reported their maximal soreness indifferent to the leg biopsied. There was a significant
difference between the exercise and control group (p=0.0049), hours post-bout (p
>0.0001), and among bouts (p >0.0001). At 24 h after Bout 0 the exercise and control
group had a significantly (p > 0.05) higher level of non-task VAS soreness (27.75 mm ±
5.34 mm and 37.38 mm ± 18.69 mm, exercise and control group, respectively) compared
to 0 h (0 mm ± 0mm for both legs). At 48 h after Bout 1, the exercise and control group
had a significantly (>0.05) higher level of non-task VAS soreness (60.88 mm ± 9.84 mm
and 40.13 mm ± 10.62 mm, exercise and control group, respectively) compared to 0 h (0
mm ± 0mm for both legs) and 24 h (39.81mm ± 8.74 and 36.38 mm ± 9.94 mm, biopsied
and non-biopsied legs, respectively). The exercise group also had a significantly higher
level of non-task VAS soreness in Bout 1 at 72 h and 96 h compared to baseline. After
Bout 2, the exercise and control group had a significantly (p >0.05) lower level of nontask VAS soreness at 48 h compared to Bout 1 (18.63 mm ± 4.04mm and 13.25 mm ±
6.40 mm, exercise and control group, respectively). The final pain-measuring aspect of
the MGPQ was the Current Pain Index (CPI), which required the subjects to rate their
pain based on a 6-point scale (0=no pain and 5=excruciating pain). The results of the CPI
are shown in Figure 3.4.A4 and 3.4.B4 for the exercise and control group, respectively.
There was no significant difference in Bout 0 for time or group. In Bout 1, the exercise
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group had a significantly higher CPI at 48 h (p >0.001) and 72 h (p=0.002) compared to 0
h, while the control group in Bout 1 had a significantly higher CPI level at 48 h post-Bout
1 (p=0.001) compared to 0 h. In addition, at 48 h the exercise group had a significantly
higher CPI level in Bout 1 compared to Bout 0 (p >0.05) and Bout 2 (p >0.001), a
difference that was also evident at 72 h (p=0.016). There was no significant difference in
CPI level for the control group among bouts (p=0.422).
Using the sensory and affective pain assessments of the MGPQ, we detected a
repeated bout effect in the exercise group. In the control group the MGPQ non-task VAS
indicated that a second biopsy (e.g. MB3, Bout 2) from the same leg as biopsied in Bout
1 (MB2) resulted in less soreness than the second biopsy (Bout 1, MB1). However, when
the muscle biopsy was performed in the contralateral leg (e.g. Bout 0, MB1 compared to
Bout 1, MB2) the muscle soreness level was not significantly lower. These results
demonstrate that each of the four pain aspects assessed by the MGPQ can detect the
repeated bout effect after eccentric exercise and indicate that a second biopsy in the same
leg results in less soreness.
Brief Pain Inventory Short Form
Severity and Interference Measures of Pain
The BPISF, similar to the MGPQ, measured the sensory aspect of pain, but
instead of measuring items of pain intensity, the BPISF measures items of pain severity
as shown in Figure 3.6.A1–A4 and 3.6.B1–B4 (exercise and control groups,
respectively). The exercise group reported a significant (p <0.05) increase in pain severity
at 24 h and 48 h for all three bouts compared to 0 h, as shown in Figure 3.6.A1. The
increase in pain severity reported by the exercise group a day after the exercise in Bout 1
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(24 h post-Bout 1) was significantly (p >0.001) greater than the pain severity reported by
the control group, which did not exercise. The day after the muscle biopsy (24 h postBout 0 and 48 h post-Bout 1), the control group reported a significant (p <0.001)
elevation of pain severity as shown in Figure 3.6.B1. However, there was no significant
difference between the pain severity of the control and exercise groups at 48 h despite
bout. The BPISF also measured how the exercise and/or muscle biopsy affected the
subjects’ daily life by measuring the level of interference resulting from the pain/soreness
based on nine pain interference items using an 11-point Likert Scale (0=does not interfere
and 10=completely interferes). The tabulated interference pain score showed that the
exercise produced pain that significantly interfered with their daily life (p=0.0001). In
Bout 1, the exercise group reported greater interference with daily tasks at 24 h (1.68 ±
0.61) and 48 h (3.79 ± 0.44) compared to the control group (0 ± 0 and 1.04 ± 0.58 for 24
h and 48 h, respectively) as shown in Figure 3.6.A2 and 3.6.B2. The exercise group also
reported a significantly (p=0.002) lower level of pain interference in Bout 2 at 48 h and
72 h compared to Bout 1 and Bout 0 at these time points. The exercise resulted in a
significant increase in pain severity and pain that interfered with activities of daily living,
but both of these measures indicated the repeated bout effect, as they were reduced
significantly in Bout 2 compared to Bout 1.
Table 3.5: Brief Pain Inventory Short Form (BPISF) scores hours after a muscle biopsy.
Severity

Interference

Tylenol Tylenol dose (mg)
users
0h
2.3 ± 1.8
2.0 ± 1.7
0
0.0 ± 0.0
24 h
8.8 ± 1.0*
15.5 ± 2.7*
11
1458.3 ± 242.0*
48 h
3.8 ± 0.7*
5.3 ± 2.0
8
1250.0 ± 295.2*
72 h
2.0 ± 0.8
0.8 ± 0.4
4
1000 ± 246.2*
96 h
1.8 ± 0.9
0.6 ± 0.5
0
0.0 ± 0.0
120 h
1.2 ± 0.6
0.2 ± 0.2
0
0.0 ± 0.0
168 h
0.2 ± 0.1
0.0 ± 0.0
0
0.0 ± 0.0
Values are mean ± sem. * Indicates (P < 0.05) from 0 hour (baseline).
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% Relief
0.0% ± 0.0%
49.2% ± 6.6%*
33.3% ± 11.0%
21.0% ± 10.4%
0.0% ± 0.0%
0.8% ± 0.8%
0.0% ± 0.0%

Figure 3.6: Brief Pain Inventory Short Form (BPISF) questionnaire results for the
exercise group (A1–A4) and the control group (B1–B4). Included plots are the averaged
scores for the following parameters: 1) severity, 2) interference, 3) Tylenol use, and D)
Tylenol % relief. Results are mean ± SEM. *p >0.05 between hours post-bout, φ p >0.05
between bouts, τ p >0.05 between exercise vs. control.
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Tylenol Use and Percent Relief from Tylenol
One of the subjects from the exercise group declined taking the Tylenol after the
baseline biopsy or the biopsies after Bout 1 and Bout 2 and was instead given an extra
packet of Tylenol to take away in case it was needed later. This subject reported never
taking Tylenol after the baseline biopsy or the biopsy in Bout 1 and Bout 2. Therefore,
this subject was removed from the analysis of Tylenol use and percent relief from
Tylenol. The seven exercise subjects who took the Tylenol used 1500 mg the day of the
biopsy and the day after in Bout 0, 1, and 2 and reported a 42.50 % ± 8.40 % relief of
their pain for Bout 0 (biopsy only), a 27.50 % ± 9.01 % relief of their pain for Bout 1
(eccentric exercise Bout 1 and biopsy), and a 31.25 % ± 9.93 % for Bout 2 (eccentric
exercise Bout 2 and biopsy) as shown in Figure 3.5.A4. The control group reported a 62.5
% ± 7.5 % relief of pain for Bout 0 (biopsy, e.g. right leg), an 80.00 % ± 4.1 % relief of
pain for Bout 1 (biopsy, e.g. left leg), and a 75.01 % ± 10.4 % relief of pain for Bout 2
(biopsy, e.g. left leg) for the same dose of Tylenol as the exercise group at one day after
the biopsy, as shown in Figure 3.6.B4. The control and exercise group used Tylenol until
96 h in Bout 0. In Bouts 1 and 2, the control group only used the Tylenol until 48 h, while
the exercise group continued to use Tylenol until 120 h in Bout 1 and until 96 h in Bout
2, as shown in Figure 3.6.A3 and 3.6.B3.
Similar to the results from the MGPQ, the BPISF questionnaire also indicated a
repeated bout effect after eccentric exercise for the sensory and affective measures of
muscle pain (e.g. pain severity and pain interference). In addition, only the pain severity
measure was significantly elevated after a muscle biopsy and neither pain severity nor
pain interference was significantly different for the control group among bouts. The
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Tylenol use and percent relief due to the Tylenol data indicates that pain resulting from a
muscle biopsy required the use of Tylenol the first few days after the first muscle biopsy
and only for the first day after a repeated biopsy—despite the biopsy being collected from
the ipsilateral or contralateral leg. Unlike the non-task VAS of the MGPQ, which
indicated less soreness after the muscle biopsy in Bout 2 compared to Bout 1 and Bout 0,
there was no reported difference in Tylenol use between bouts after a muscle biopsy.
Muscle Strength Measures
Baseline maximal isometric strength was measured at two visits separated by 2–5
d before Bout 0. There was no significant difference between the two baseline 70°
isometric strength measures (p=0.372). The baseline measures of muscle strength were
not different between the exercise and control group. Because there was no significant
difference between the baseline strength visits, the baseline strength assessments were
averaged. The measure of maximal isometric strength was used to assess if the exercise
protocol produced muscle damage, and therefore it was only measured at baseline and
pre- and post-Bout 1 and Bout 2 because Bout 0 did not have any exercise.
All subjects had a muscle biopsy (MB1, baseline biopsy) between the baseline
and pre-bout strength measure, and therefore the averaged baseline strength measures
were compared to the pre-bout strength measure using a Student’s t-Test. There was no
significant difference in the strength measure between the averaged baseline visits
compared to pre-bout strength (p >0.700, isometric strength; p=0.074). The control group
did not perform the exercise and therefore they did not complete the post-bout strength
measure. As expected, the exercise group had a significant (p=0.018) decrease in strength
after the eccentric exercise, as shown in Table 3.6 and Figure 3.7. In addition, the
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exercise group did not have a significant (p >0.290) decrease in strength post-Bout 2
compared to pre-Bout 2. Maximal isometric strength data indicate that the exercise group
experienced the repeated bout effect. For the control group there was no difference
between baseline, pre-Bout 1, and pre-Bout 2 for strength (p=0.744), as shown in Table
3.6 and Figure 3.7. Overall, these results indicate that the eccentric exercise of stair
descent was sufficient to produce a repeated bout effect for strength. Isometric strength
was not significantly different from baseline at 6 d post-muscle biopsy, and multiple
biopsies (e.g. control group) did not significantly affect strength.
Table 3.6: Isometric and passive torque hours after a muscle biopsy.
Isometric Extension
Peak Torque (N-m)
70°
Baseline 1
Baseline 2
Average of Baseline Visits
168 h Post-Biopsy

251.3 + 28.6
258.6 + 31.0
253.77 ± 31.1
252.2 ± 31.8

Values are mean ± sem.

Figure 3.7: Maximal isometric strength 70° (N-m) of the exercise (A) and
control (B) groups. Values are mean ± sem. *Indicates p <0.05 from Pre-Bout.
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Discussion
Skeletal muscle soreness has been used by researchers to document the recovery
of muscle from damaging exercise (3,14,21). However, many researchers also use muscle
biopsies to examine the molecular changes to muscle after a damaging exercise. Here we
show that the muscle biopsy alone produces a significant amount of muscle soreness. We
have also shown the effects a muscle biopsy has on physical function (e.g. a decrease in
total daily steps and likely in total activity counts). The results from this study can help
inform institutional review boards and other researchers on how a muscle biopsy affects
an individual (e.g. peak sensory and affective aspects), how long the effects are present
after the muscle biopsy procedure, and if the biopsy confounded measures of muscle
soreness and strength.
We used a three-pronged approach in this study to examine muscle soreness and
how this soreness affected the subject’s daily life after a muscle biopsy. The first
approach to examine muscle soreness used a typical laboratory measurement—a visual
analog scale (VAS, 0–100 mm). In our lab, subjects perform a task that requires them to
use the affected muscle group and then record their level of soreness on the scale. For this
study we used two tasks: the first task was to perform stand-sit-stand (STS-VAS) action
using just the affected leg, and the second task was to walk down stairs (Stair-VAS). We
found the muscle biopsy elicited a significant increase in muscle soreness with both
soreness tasks. The second approach entailed the use of two questionnaires. Both the
MGPQ and the BPISF have a sensory component and an affective component.
Therefore, we were able to measure the unpleasantness of the biopsy procedure and to
what degree the soreness affected the subjects. The third approach was the use of
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physical activity monitors because they provide an objective measure of physical activity
levels. This is in contrast to the task-specific VAS and the questionnaires, which are
subjective measures of muscle soreness.
VAS Task-Specific Soreness
The increase in muscle soreness at 24 h after a biopsy only was ~25 mm for both
tasks, STS-VAS and Stair-VAS. The soreness elevation of ~25 mm is approximately
40% less than the soreness level commonly reported in studies using a leg eccentric
exercise model without a biopsy procedure (5). In addition, by 96 h post-biopsy all
subjects reported a soreness level of ~3 mm and that level was not significantly different
from their baseline soreness level (~1 mm). After a bout of eccentric exercise, muscle
soreness does not generally return to baseline until 120 h (5); high-responders have a
more prolonged return to baseline levels (~14 d) (4,6). These results indicate that both
peak soreness and duration of soreness after a biopsy is significantly less than after a bout
of eccentric exercise. The VAS soreness tasks allowed us to measure the sensory
components of soreness (e.g. severity of soreness) felt after a muscle biopsy procedure,
but the VAS measures do not allow us to understand how this soreness affects the
subjects’ daily life (e.g. sickening, tiring-exhaustion, fear causing, walking ability,
relations with other people, work, and sleep).
Overall, the task-related VAS measures indicate that muscle soreness from
eccentric exercise and/or a muscle biopsy returns to baseline by 96 h despite bout. And
that in the exercise group, the repeated bout effect was achieved with the stair descent
exercise as shown by the significantly lower levels of muscle soreness in Bout 2
compared to Bout 1 at all time points after the exercise.
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Pain Questionnaires: Sensory Component
We found that the sensory component of the BPSIF, the MGPQ, and the non-task
VAS from the MGPQ indicated a significant elevation of muscle soreness at 24 h after
biopsy, but the level of muscle soreness was smaller than the task-specific muscle
soreness measurement (e.g. VAS-Stair and VAS-STS). Of interest, the STS-VAS muscle
soreness levels in Bout 1 at 72 h of 41.07 mm ± 10.88 mm and 33.71 mm ± 12.76 mm
(biopsied and non-biopsied leg, respectively) were similar to the non-task VAS muscle
soreness level of 38.33 mm ± 9.52 mm; however, unlike the non-task VAS measure, the
STS-VAS measures of muscle soreness were not found to be significantly greater at 72 h
compared to baseline. At 96 h after Bout 1 the task-related muscle soreness measures
were again not different from baseline, while the non-task VAS found muscle soreness
was still significantly elevated despite similar amount (mm) of soreness between the two
non-task and task-related VAS measures. These results suggest that non-task and taskrelated VAS muscle soreness measures detect muscle soreness similarly, but that the nontask VAS may assess muscle soreness at later time points (e.g. 72 h and 96 h post-bout)
better than the task-related VAS.
Based on the BPISF, soreness was significantly elevated at 48 h post-biopsy, and
the sensory component of the MGPQ also showed that at 72 h post-biopsy, soreness was
not significantly different from baseline, indicating that the individuals were no longer
sore from the biopsy procedure. Because the task-specific VAS found that individuals
still had soreness at 96 h post-biopsy and the MGPQ reported that individuals had
returned to baseline 24 h prior, we believe that the MGPQ underestimates the intensity
and duration of muscle soreness after a muscle biopsy because the subjects were not
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performing a task to measure their muscle soreness. It is likely that when the subjects
recalled their peak level of soreness as they filled out the BPISF and the MGPQ, they had
difficulty ascribing a score to their peak soreness because the soreness was not as
noticeable throughout the day. The muscle soreness from the biopsy may have only been
noticeable when the subject performed an activity or contracted the muscle. These results
suggest that using an activity or task to measure muscle soreness may be more
appropriate to measure peak soreness. These findings illustrate the need for muscle
soreness researchers to use a common tool or a standard set of tools to evaluate muscle
soreness after a biopsy or eccentric exercise so that studies examining modalities to treat
muscle soreness can be compared.
Pain Questionnaires: Affective Component
Because soreness after a biopsy had not been previously investigated, we
expected that the affective component of the questionnaires would be significantly
elevated in the days after the muscle biopsy. However, we found that the affective
component of the MGPQ was not significantly different from baseline at any time point
and the BPISF was only elevated at 24 h post-biopsy. It is likely that the BPISF was able
to measure the affective component better than the MGPQ in the present study because
the BPISF had an ordinal scale that ranged from 0–10 (0=does not interfere, to
10=completely interferes) instead of the 0–3 (0=none, to 3=severe) used in the MGPQ.
For the MGPQ, individuals rated the quality of their pain with these characteristics: fear
causing, punishing-cruel, sickening, and tiring-exhaustive. For the BPISF, individuals
rated their amount of interference with these characteristics: quality of life, daily
activities, walking ability, sleeping, mood, and relations with people. While the biopsy
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procedure itself may have elicited severe pain ratings for being fear causing, sickening,
punishing-cruel, and tiring-exhaustive, on the MGPQ none of these characteristics were
selected at 24 h post-biopsy and none of these characteristics were found to be
significantly elevated 24 h after a single or repeated bout of eccentric exercise.
Since the control group did not exercise they were not expected to report
interference of their daily tasks from pain at 24 h, but it was expected that the pain of the
muscle biopsy would interfere with their daily life. Of note, the MGPQ also found that
the muscle biopsy did not affect their daily lives. These results suggest that in young,
healthy individuals, a muscle biopsy does not affect or interfere significantly with
activities of daily living.
The difference in the duration of Tylenol use between Bout 1 and Bout 2 (e.g.
taking Tylenol for 120 h vs. 96 h) for the exercise group may be related to the repeated
bout effect for DOMS. Incidentally, the percent relief from Tylenol in Bout 1 and Bout 2
for the exercise group was significantly less than the control group at 48 h (p >0.05).
Within the first 24 h post-biopsy, over 70% relief was provided by the Tylenol for the
control group; this, combined with the fact that the control group did not report taking
Tylenol after 48 h in Bout 1 and Bout 2, indicates that any pain remaining after 48 h postmuscle biopsy did not require Tylenol for management. However, the exercise group
found less relief from pain, and four of the seven individuals in that group continued to
manage their pain until 72 h post-bout, one individual requiring Tylenol to manage the
pain from the muscle biopsy at 120 h. This indicates that the exercise likely affected pain
to a greater extent than the biopsy alone, and that Tylenol use can indicate soreness.
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Physical Activity Monitor
Physical activity monitors have been commonly used to assess physical activity
and to measure changes in physical activity (9,19,24). In addition, physical activity
monitors have been used to assess one’s recovery from surgery (17,23,27). However,
these studies have examined individuals who underwent a surgery requiring a hospital
stay. The muscle biopsy procedure used in this study was similar to protocols used in
other studies and does not require a hospital stay (13,15,16,18,20,21,25,26). A muscle
biopsy is a minor surgery, such that a local anesthesia is used and often the incision does
not require stiches (25). Many researchers have had the subjects perform strenuous
activity after a muscle biopsy (1,7). After the biopsy in this study, our subjects were
encouraged to maintain their regular activities (e.g. laundry, grocery shopping, etc.) but
were instructed to refrain from vigorous activity for the first 48 h after the biopsy. The
decrease in vigorous physical activity pre- and post-biopsy was therefore not a result of
the biopsy affecting the subjects, but instead was because the subjects were instructed to
not perform vigorous activity for the first 48 h after the biopsy. These instructions
account for the decrease in vigorous activity from 0.3% to 0.0% after the muscle
biopsy—a 100% difference between pre- and post-biopsy. Interestingly, both the light
and moderate activity decreased by 15% and 34%, respectively, after the muscle biopsy
compared to baseline. Light and moderate activity were both strongly negatively
correlated to the increase in sedentary activity. However, we did not find a correlation
between any activity level and the task-related VAS soreness levels. It is possible that our
inability to detect a significant difference between activity levels before and after the
biopsy was due to small sample size or using a monitor that is best at measuring total
activity and not time in specific activity levels (19). When we analyzed total activity
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counts we did not find a significant decrease after the biopsy compared to before. But, we
did find that subjects took fewer steps after a muscle biopsy compared to before a biopsy.
Activity monitors may underestimate activity at vigorous levels and overestimate activity
at light levels (9). The negative correlation found between sedentary activity and light
and moderate activity suggest that the muscle biopsy did affect physical activity levels. In
addition, the decrease in steps after as compared to before a muscle biopsy indicates that
the muscle biopsy did affect the subject’s physical activity. Using a monitor that can
distinguish between sitting and standing, such as an activPal™, may be more sensitive
and indicate a significant difference between pre- and post-biopsy.
Conclusion
We found that a muscle biopsy does not affect muscle soreness more than a
moderate eccentric exercise protocol, either in peak soreness or duration (5,11,16).
However, we cannot say how a muscle biopsy performed at later time points (e.g. 48 h,
72 h, 96 h, or 120 h) post-eccentric exercise would affect muscle soreness. We had
expected that the muscle biopsy would produce a significant and potentially prolonged
affective soreness; however, this was only true 24 h post-biopsy. Finally, we had
expected that the use of a physical activity monitor would provide us with a better
understanding of how the recorded levels of muscle soreness may affect one’s daily
activity. Rather, we found no correlation between these measures when using an Actical
to measure physical activity levels. It is important to note that the muscle biopsy
procedure only resulted in a minimal elevation of affective measures of soreness at 24 h,
that the modest increase in the task-related VAS measure of soreness returned to baseline
by 72 h, and that there was no effect on physical activity levels. These results indicate
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that researchers examining treatments for muscle soreness can feel confident that a
baseline biopsy scheduled 2–3 d prior to an exercise will not confound their results.
Finally, while the muscle biopsy did result in a decrease of average daily steps after the
biopsy, the peak soreness level and the duration of muscle soreness indicate that a muscle
biopsy is less “damaging” to the skeletal muscle than a bout of eccentric exercise.

93

References
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.

17.

Apple F, Rogers M, Sherman W, Costill D, Hagerman F, Ivy J. Profile of creatine
kinase isoenzymes in skeletal muscles of marathon runners. Clin Chem
1984;30(3):413–6.
Chen YW, Hubal MJ, Hoffman EP, Thompson PD, Clarkson PM. Molecular
responses of human muscle to eccentric exercise. J Appl Physiol.
2003;95(6):2485–94.
Clarkson PM, Byrnes WC, McCormick KM, Turcotte LP, White JS. Muscle
soreness and serum creatine kinase activity following isometric, eccentric, and
concentric exercise. Int J Sports Med. 1986;7(3):152–5.
Clarkson PM, Newham DJ. Associations between muscle soreness, damage, and
fatigue. Adv Exp Med Biol. 1995;384:457–69.
Clarkson PM, Nosaka K, Braun B. Muscle function after exercise-induced muscle
damage and rapid adaptation. Med Sci Sports Exerc. 1992;24(5):512–20.
Clarkson PM, Sayers SP. Etiology of exercise-induced muscle damage. Can J
Appl Physiol. 1999;24(3):234–48.
Costill DL, Bowers R, Branam G, Sparks K. Muscle glycogen utilization during
prolonged exercise on successive days. J Appl Physiol. 1971;31(6):834–8.
Crameri RM, Langberg H, Teisner B, et al. Enhanced procollagen processing in
skeletal muscle after a single bout of eccentric loading in humans. Matrix Biol.
2004;23(4):259–64.
Crouter SE, Bassett DR, Jr. A new 2-regression model for the Actical
accelerometer. Br. J. Sports Med. 2008;42(3):217–24.
Ebbeling CB, Clarkson PM. Muscle adaptation prior to recovery following
eccentric exercise. Eur J Appl Physiol Occup Physiol. 1990;60(1):26–31.
Friden J, Sjostrom M, Ekblom B. A morphological study of delayed muscle
soreness. Experientia. 1981;37(5):506–7.
Friden J, Sjostrom M, Ekblom B. Myofibrillar damage following intense eccentric
exercise in man. Int J Sports Med. 1983;4(3):170–6.
Friedmann-Bette B, Schwartz FR, Eckhardt H, Billeter R, Bonaterra G, Kinscherf
R. Similar changes of gene expression in human skeletal muscle after resistance
exercise and multiple fine needle biopsies. J Appl Physiol. 2012;112(2):289–95.
Hough T. Ergographic studies in muscular soreness. Am J Physiol—Legacy
Content. 1902;7(1):76–92.
Hubal MJ, Chen TC, Thompson PD, Clarkson PM. Inflammatory gene changes
associated with the repeated-bout effect. Am J Physiol Regul Integr Comp
Physiol. 2008;294(5):R1628–37.
Hyldahl RD, Xin L, Hubal MJ, Moeckel-Cole S, Chipkin S, Clarkson PM.
Activation of nuclear factor-{kappa}B following muscle eccentric contractions in
humans is localized primarily to skeletal muscle-residing pericytes. FASEB J.
2011;25(9):2956–66.
King W, Hsu J, Belle S, et al. Pre- to postoperative changes in physical activity:
report from the longitudinal assessment of bariatric surgery-2 (LABS-2). Surg
Obes Relat Dis. 2012;8(5):522–32.

94

18.
19.
20.
21.
22.
23.

24.
25.
26.

27.

28.
29.

Kostek MC, Chen Y-W, Cuthbertson DJ, et al. Gene expression responses over 24
h to lengthening and shortening contractions in human muscle: major changes in
CSRP3, MUSTN1, SIX1, and FBXO32. Physiol Genomics. 2007;31(1):42–52.
Lyden K, Kozey Keadle S, Staudenmayer J, Freedson P. Validity of two wearable
monitors to estimate breaks from sedentary time. Med Sci Sports Exerc.
2012;44(11):2243–52.
Mahoney DJ, Safdar A, Parise G, et al. Gene expression profiling in human
skeletal muscle during recovery from eccentric exercise. Am J Physiol Regulatory
Integrative Comp Physiol. 2008;294(6):R1901–10.
Malm C, Nyberg P, Engstrom M, et al. Immunological changes in human skeletal
muscle and blood after eccentric exercise and multiple biopsies. J Physiol.
2000;529(Pt 1):243–62.
Malm C, Yu J. Exercise-induced muscle damage and inflammation: re-evaluation
by proteomics. Histochem Cell Biol. 2012;138(1):89–99.
Papaspyros S, Uppal S, Khan SA, Paul S, O'Regan DJ. Analysis of bedside
entertainment services' effect on post cardiac surgery physical activity: a
prospective, randomised clinical trial. Eur J Cardiothorac Surg.
2008;34(5):1022–6.
Pober DM, Staudenmayer J, Raphael C, Freedson PS. Development of novel
techniques to classify physical activity mode using accelerometers. Med Sci
Sports Exerc. 2006;38(9):1626–34.
Tarnopolsky M, Pearce E, Smith K, Lach B. Suction-modified Bergstrom muscle
biopsy technique: experience with 13,500 procedures. Muscle Nerve.
2011;43(5):717–25.
Urso ML, Scrimgeour AG, Chen Y-W, Thompson PD, Clarkson PM. Analysis of
human skeletal muscle after 48 h immobilization reveals alterations in mRNA and
protein for extracellular matrix components. J Appl Physiol. 2006;101(4):1136–
48.
van Dam MS, Kok GJ, Munneke M, Vogelaar FJ, Vlieland TPMV, Taminiau
AHM. Measuring physical activity in patients after surgery for a malignant
tumour in the leg: the reliability and validity of a continuous ambulatory activity
monitor. J Bone Joint Surg Br. 2001;83-B(7):1015–9.
Yu JG, Carlsson L, Thornell LE. Evidence for myofibril remodeling as opposed
to myofibril damage in human muscles with DOMS: an ultrastructural and
immunoelectron microscopic study. Histochem Cell Biol. 2004;121(3):219–27.
Yu JG, Furst DO, Thornell LE. The mode of myofibril remodelling in human
skeletal muscle affected by DOMS induced by eccentric contractions. Histochem
Cell Biol. 2003;119(5):383–93.

95

CHAPTER 4
DELAYED ONSET MUSCLE SORENESS & MOLECULAR CHANGES IN
SKELETAL MUSCLE EXTRACELLULAR MATRIX AFTER ECCENTRIC
EXERCISE (Study 2)
Abstract
We sought to examine the relationship between delayed onset muscle soreness
(DOMS) and the molecular response of the extracellular matrix (ECM) remodeling
molecules (MMP9, MMP2, TIMP1, TIMP2, and TNC) and mechanotransduction
molecules (ITGA7, ITGB1, COL3, COL4, and LAMA2). We wanted to identify which
genes and their protein products may provide protection from a future bout of exercise
and be related to the reduction in DOMS found after a second bout of exercise. These
molecules were examined at baseline (MB1), 7 d after MB1 (MB2), and 14 d after MB2
(MB3); the exercise group completed the exercise bout 24 h prior to MB2 (Bout 1) and
MB3 (Bout 2). Our model induced muscle soreness after eccentric exercise (Bout 1 and
Bout 2) (p <0.05). TNC mRNA levels increased (p=0.016) after Bout 1 of eccentric
exercise compared to baseline and decreased (p <0.016) after Bout 2 compared to Bout 1.
The TNC mRNA results were correlated with DOMS at 48 h post-exercise in Bout 1
(r=0.621, p=0.031) and Bout 2 (r=0.935, p=0.036), but none of the other ECM
remodeling genes or mechanotransduction genes were correlated with DOMS. mRNA
expression levels for MMP9 (p >0.03) in the control and exercise groups was greater
after Bout 1 compared to baseline, and COL3 mRNA levels increased (p=0.018) after
Bout 1 and Bout 2 compared to baseline. ITGA7 (p=0.012) mRNA levels increased after
Bout 2 compared to baseline. Additionally, the mRNA expression levels for ITGA7
(p=0.012) in the control and exercise groups were greater in the left leg compared to the
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right leg for Bout 1 and Bout 2 compared to baseline. The respective protein products for
TNC, MMP9, and COL3 were unaltered 24 h after a single or repeated bout of eccentric
exercise. However, we found three isoforms for ITGA7 protein (7X12X2B, 7X1B, and
7X2B) expressed in the control and exercise group. The protein levels of the 7X2B
isoform were decreased in Bout 1 for the control and exercise group compared to baseline
and returned to baseline in Bout 2. Overall, these results demonstrate that only the mRNA
of TNC, an ECM remodeling molecule, is associated with DOMS and that the remaining
ECM and mechanotransduction molecules investigated in this study are not associated
with DOMS or the repeated bout effect. While the TNC and COL3 results are not novel,
they do confirm the changes in mRNA expression levels after exercise compared to
baseline reported by previous studies. The effect of a single and repeated bout of
eccentric exercise on expression levels of MMP9 mRNA and the three isoforms of
ITGA7 protein are a new contribution to the DOMS literature.
Introduction
Delayed onset muscle soreness (DOMS) has been thought to have an origin in the
connective tissue of skeletal muscle since 1902 (25). DOMS was discovered by Hough
(25) in 1902 after subjects performed an unaccustomed exercise and in 1973 Talag et al.
(74) determined that it was the muscle-lengthening versus muscle-shortening exercises
that produced DOMS. Currently, we understand which activities (e.g. eccentric exercise,
downhill walking, negatives) produce DOMS but we do not have a clear understanding of
what causes DOMS. The origins of DOMS have been suggested to be a result of
inflammation processes due to chemotaxis (12,13,43) in the connective tissue, or
activation of connective tissue resident cells (83) and molecules (65) (e.g. MMPs and
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tenascin-C) from the strain of eccentric exercise (19,33,48). Only recently, has a
connection between a connective tissue molecule called tenascin-C and DOMS been
found (12 44). Crameri et al. (12) found that skeletal muscle soreness was correlated to
tenascin-C levels. Malm et al. (49) has also shown that proteins altered after eccentric
exercise are associated with molecules within the connective tissue of skeletal muscle and
not the inflammation processes due to chemotaxis.
While the genes and proteins involved in these remodeling processes are known,
the genes and proteins that are related to DOMS are not well defined. It is possible that
genes and proteins that initiate muscle adaptation to eccentric exercise are likely involved
in the development of DOMS and are sensitive to the load that is placed on the muscle
and act as mechanosensors. The mechanosensors in skeletal muscle would sense the load
placed on the muscle and then initiate the proper remodeling response. In order to initiate
remodeling processes, the mechanosensors would need to be located in an area that
conducts the force from the myofilaments in the muscle cell to the tendon that attaches to
the bone (35). The organization of skeletal muscle allows for force to be easily
transmitted from the myofilaments to the tendon attached to the bone.
Skeletal muscle cells (muscle fibers) are arranged in parallel and are connected to
each other through the cytoskeleton (16). The cytoskeleton also connects the muscle
fibers to a layer of connective tissue called the extracellular matrix (ECM) that surrounds
the muscle cell (35,58). Together, the cytoskeleton and the ECM allow for the
transmission of force from the myofilaments to the tendon of the bone (35,58).
Coincidentally, the organization of the ECM and the cytoskeleton allows for the
transmission of an external force (e.g. eccentric exercise) to be transmitted to the muscle
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cell. Stauber et al. (68) showed that in cross sections from skeletal muscle biopsy
samples, the tight packing of the muscle fibers were shown to be widened, and the ECM
appeared to be disrupted after eccentric exercise. However, the Stauber et al. (68) study
did not investigate components of the ECM involved in connecting the ECM to the
cytoskeleton or remodeling enzymes such as tenascin-C, matrix metalloproteinases
(MMPs), and tissue-inhibitor of metalloproteinases (TIMPs) or their relationship to
DOMS. When Stauber et al. (68) investigated the ECM after eccentric exercise, tenascinC, MMPs, and TIMPs had not yet been well characterized and their potential role in
DOMS and skeletal muscle remodeling was not explored. It is important to understand
how these remodeling proteins are regulated before and after a repeated bout of eccentric
exercise because they may act as mechanosensors and be involved in DOMS. If their
activation is suppressed following a repeated bout of eccentric exercise, they may be the
molecules responsible for rendering a muscle “adapted” to a previous load and having
less soreness.
The activity and protein levels of MMPs in human skeletal muscles have been
shown to be responsive to endurance exercise (24,62,64). MMPs may play an important
role in the repair and remodeling process after eccentric exercise because they cleave cell
surface receptors (55), cleave collagens (MMP2 and MMP9 cleave collagen 4) (37), and
initiate and control inflammatory processes (51). It is likely that the expression and
activity of MMPs would also increase in skeletal muscle after an acute bout of eccentric
exercise because the remodeling process in skeletal muscle requires cleavage of cell
surface receptors and collagen in order to reorganize the ECM. The inflammatory process
activates macrophages to phagocytize cellular debris (53,54) and promote activation of
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myogenic precursor cells to assist in the repair and remodeling process. Macrophages are
a known source of MMPs (7,27,59).
In a repeated bout of eccentric exercise the muscle has adapted to the strain and
thus the activation of MMPs, and their expression is expected to be blunted because the
muscle and the ECM are stronger and more resilient (14). In mice that did not produce
MMP-9, skeletal muscle remodeling occurred sooner compared to the wild-type mice
(14). Ablation of MMP9 in this model after muscle damage delayed the remodeling
process when compared to wild-type, supporting the role of MMP-9 in promoting
remodeling processes (14). Dhaiya et al. (14) also found an increase in AKT1
phosphorylation and its downstream products (FOXO and mTOR) as well as a decrease
in protein levels of collagen I and collagen IV in animals with elevated MMP9 levels.
These results suggest that MMP9 plays a role in activation of protein synthesis necessary
for growth via AKT1 and that MMP9’s effect on collagens allows for the expansion of
the muscle fiber within the ECM matrix (37,87).
In addition to MMPs and collagens being altered after exercise, the ECM
molecules tenascin-C, integrins, and laminin are also altered after stretching or exercise
and may therefore play a role in DOMS (2,13,42,45,50). Of these ECM molecules,
collagen, integrin and laminin are intimately connected to form the 3-dimensional ECM
and therefore these molecules play an important role in transmitting force to and from the
muscle fiber (35). The integrins are a key component to the 3-dimensional meshwork of
the ECM because they are a membrane protein that has both cytosolic and extracellular
domains (35,73). The location of integrins suggests that they may act as mechanosensors
for skeletal muscle. For example, the cytosolic domain of integrins interact with focal
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adhesion molecules (e.g. focal adhesion kinase [FAK]) and after injury, integrins have
been shown to cluster and then phosphorylate the tyrosine residues of FAK (73). FAK
tyrosine phosphorylation (FAKTyr) has been shown to increase after eccentric exercise in
humans (82), and because FAK is upstream of AKT1, it also increases AKT1
phosphorylation and can promote protein synthesis. Mice with an increase in integrin α7
expression compared to wild-type are protected from muscle damage after eccentric
exercise (2,91) and have muscle hypertrophy (42,91). These data from animal and cell
culture work demonstrate that integrins play an important role in the repair and
remodeling process after damage.
There are no data at this time to support that integrins play a role in the
remodeling process after eccentric muscle damage in humans. Therefore, it is important
to determine if integrins play a similar role in human skeletal muscle after eccentric
exercise as what has been demonstrated in animals (2,91). An increase in integrin protein
and gene expression after an initial and repeated bout of exercise would suggest that the
up-regulation is to render the muscle more resilient to the strain resulting in less soreness.
Splicing of the integrin RNA transcript creates isoforms of integrin that have different
cytoplasmic (e.g. α7A and α7B) and extracellular domains (e.g. Alpha 7X12X2B, Alpha
7X1B, and Alpha 7X2B). These different domains affect the function of integrins
(1,5,67). After a muscle injury in animals (e.g. transection or crush) variants of integrin
were expressed at different levels and time points (3,34). For example, α7x1 and α7x2
are found in animals during myogenesis (34), but in developed healthy adult animal
muscle, only α7x2 (34) is observed and overexpression of α7BX2 has been found to
protect animals from injury (3). Because of their various isoforms, integrins interact with
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many other ECM molecules (e.g. MMPs, laminin, tenascin-C, collagen, decorin, and
biglycan) and it is important to determine if there is a relationship with integrin and these
molecules after a single and repeated bout of exercise because these molecules may be
related to the variability found in functional indicators of muscle damage (e.g. DOMS
and strength loss). If this were the case, DOMS may be minimized by understanding
these cellular changes. In addition, we wanted to examine if humans express different
isoforms of integrin after skeletal muscle after injury and if these isoforms are related to
muscle soreness. For example, coordinated changes in the expression of ECM (e.g. TNC)
and mechanotransduction (e.g. integrins) molecules may indicate a molecular “footprint”
that signifies when a muscle has been stressed enough to reach a point of resilience
against another bout of exercise (i.e. protect against DOMS). An index such as this has
significant clinical importance because you could strain the muscle enough to initiate the
adaptation process without inducing strength loss and muscle soreness.
Therefore, we used a descending-stair model of eccentric exercise to identify the
relationship between DOMS after a single and repeated bout of exercise and changes in
the integrins and the co-signaling molecules, the MMPs and the collagens. The stair
descent exercise protocol was used previously by others and has been shown to cause
muscle damage to the triceps surae (84,85), but muscle damage to the vastus lateralis has
not been examined using this exercise protocol. However, the vastus lateralis, one of the
quadriceps muscles, does perform eccentric actions when descending stairs. Talag and
colleagues (74) showed that the quadriceps developed DOMS when walking at a decline
on a treadmill, and pilot data from our laboratory showed that DOMS developed in the
quadriceps after subjects performed the stair descent exercise protocol. Instead of the
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triceps surae, we examined the vastus lateralis because it is a larger muscle and it is easier
to collect a second biopsy from it that is more than 2 cm away from the initial biopsy.
Analysis of biopsies that were collected at less than 2 cm apart in non-exercised limbs
showed the same level of activated inflammatory cells as found in a single biopsy
collected after strenuous exercise. Biopsies collected at more than 2 cm apart showed no
increase in activated inflammatory cells. We hypothesized that the gene and protein
levels of the ECM molecules—integrins, MMPs, laminin, tenascin-C, collagens,
biglycan, and decorin—and a downstream target (FAKTyr) molecule would be upregulated after an initial bout of eccentric exercise and that their expression would be
positively correlated to DOMS. Since these molecules may be the signals rendering
muscle more resilient to a repeat bout of eccentric exercise, we hypothesized that there
would be decreased expression after a repeated bout and a decreased positive correlation
to DOMS.
Materials and Methods
Subjects
Twelve healthy male and female subjects (6 male and 6 female) enrolled and
completed the study. Of the 12 subjects, eight were randomized into the exercise group
and four were randomized into the no-exercise control group. The exercise and control
groups were balanced for sex. Subjects were also randomized as to which leg would be
biopsied first (MB1); the contralateral leg would be biopsied for the second (MB2) and
third (MB3) biopsy time points. The MB2 was taken 7 d after MB1, and the exercise
group completed Bout 1 of exercise 24 h prior to MB2. The MB3 was taken 14 d after
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MB2, and the exercise group completed Bout 2 of exercise 24 h prior to MB3. The
control group had biopsies taken at the same time as the exercise group.
All subjects signed a written informed consent document approved by the
University of Massachusetts Amherst Institutional Review Board. All study procedures
conformed to the standards outlined in the Declaration of Helsinki. All subjects had no
prior history of musculoskeletal injury of the lower extremity and were willing to refrain
from participating in new physical activities or taking oral or topical analgesics for the
duration of the study. Subjects were excluded if they had been involved in a strengthtraining program in the past six months or routinely lifted heavy objects or engaged in
activity with a heavy eccentric component.
Timeline
Subjects completed two baseline strength measure visits that were separated by at
least 2 d, but not more than 5 d as shown in Figure 4.1. Muscle soreness was measured
prior to the baseline muscle biopsy (MB1) and at 24 h intervals up to 120 h post-MB1.
120 h after MB1 all subjects returned for the exercise or no-exercise session (Bout 1); the
exercise group performed an eccentric exercise that used both legs (descending stairs)
and had strength measures (e.g. maximal isometric strength at 70°). The control group
did not exercise, but they completed all strength measures. The exercise group performed
strength measures before and after the exercise bout. The following day (24 h post-Bout
1) all subjects completed the muscle soreness measures before the muscle biopsy (MB2).
This biopsy was collected from the contralateral leg that was biopsied at MB1. Muscle
soreness was measured at 24 h intervals up to 120 h post-MB2. Two weeks after exercise
or no-exercise Bout 1, subjects returned to the lab for exercise or no-exercise Bout 2. The
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following day (24 h post-Bout 2) all subjects completed muscle soreness measures before
the muscle biopsy (MB3). MB3 biopsy was collected from the same leg that was biopsied
at MB2. Muscle soreness was measured at 24 h intervals up to 120 h post-MB3.

Figure 4.1: Study timeline.
Eccentric Exercise Protocol and No-Exercise Protocol
Subjects in the exercise group performed eccentric actions of the knee-extensors
(e.g. quadriceps muscles). Subjects ran down 10 flights of stairs (e.g. 11th floor to the first
floor) 15 times and they used the elevator to return to the top of the flight of stairs. Each
flight of stairs consisted of two sets of 12 steps, so subjects ran down 24 steps between
each floor. Each step rise was 17.78 cm, the run was 29.21 cm, and the tread width was
154.94 cm. The average amount of work done was -31.53 kJ ± -4.10 kJ (mean ± sem).
The subjects were given verbal instructions to maintain a rate between 2.09 steps/sec and
2.87 steps/sec down the stairs. The subjects completed the 10-flight stair descent between
90 and 115 sec. Overall, the entire bout of eccentric exercise took 22–26 min. However,
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between each descent subjects had to wait for the elevator and take the elevator to the
11th floor. They were monitored by an investigator at the top and the bottom of the stairs
to assist them in maintaining the rate between 2.09 and 2.87 steps/sec down the stairs.
Subjects in the control group did not perform the stair exercise, but they reported to the
Muscle Biology and Imaging Laboratory and performed the muscle strength tests. Both
groups were instructed to maintain their regular activity level throughout the duration of
the study.
Muscle Soreness
We measured muscle soreness in response to performing a task (e.g. single-legged
stand-sit-stand) to assess soreness of the quadriceps muscles (vastus lateralis, vastus
medialis, vastus intermedius, and biceps femoris). We measured the soreness from the
stand-sit-stand task with a visual analog scale (VAS). Muscle soreness was examined at
baseline and at 24 h increments up to 120 h after the exercise or no-exercise bouts (Bout
1 and Bout 2).
Muscle Strength
We examined maximal isometric strength and passive muscle strength using a
Biodex machine (Biodex System 4 Pro, Biodex Medical Systems, Shirley, NY).
Maximal isometric strength measurements allowed us to demonstrate that the eccentric
exercise resulted in damage after a single and repeated bout of eccentric exercise. For the
strength tests, subjects were seated upright on the Biodex machine with their legs relaxed
and the knee flexed in a 90o angle. The chair, back support, and lever arm of the Biodex
were positioned so that the axis of rotation of the lever arm was in line with the lateral
condyle of the femur. The leg was then secured in the knee attachment with the foot in a
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flexed position. Knee extension range of motion (ROM) was set from the knee in a flexed
position at 90o until the knee was extended to 0o of knee flexion.
For the maximal isometric test, the Biodex lever arm moved the leg to a 70°
position and subjects were asked to first maximally extend their leg for 3 sec and then
maximally flex their leg for 3 sec; they repeated this action three times for one set. The
isometric strength test was repeated until three trials were within 10% of each other. A 1minute rest was given after each maximal isometric set. A pre-exercise and post-exercise
maximal isometric strength test was performed in the same manner as described above
after each eccentric exercise protocol for the exercised group. The control group
performed the maximal isometric test only once.
Muscle Biopsy Procedure
A licensed physician performed the muscle biopsy procedure. All subjects were
transported to and from the biopsy visit. The needle biopsy procedure was performed
under local anesthesia (approximately 4 ml of 2% lidocaine hydrochloride solution) using
a 5 mm Bergstrom needle with suction (Depuy, Warsaw, IN). A small incision (about
0.5–2 cm) was made into the skin and fascia of the vastus lateralis. The Bergstrom 5 mm
biopsy needle was then inserted into the muscle, and suction was used to obtain a small
"plug" of tissue before the needle was removed from the muscle. Approximately 150–200
mg of muscle tissue was collected from each subject. The tissue was divided up into at
least two 75 mg aliquots and each muscle sample was rinsed with sterile saline solution
to remove excess blood before the samples were flash frozen in liquid nitrogen. Muscle
biopsy samples were stored at -80° C until analysis. Subjects were given an Actical
physical activity monitor (Mini Mitter Co., Inc., Bend, OR) to ensure they did not
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perform any vigorous activity after the muscle biopsy.
Subjects received a standardized snack that was consumed 3–5 h before the
biopsy and consisted of an Oscar Myers Lunchable® with water. The calorie content of
these snacks was 360–370 (8–12 g total fat, 51–63 g total carbohydrate, and 10–12 g
protein). After the biopsy, an ice pack was kept on the incision site for 30 minutes, and
during this time all subjects were given Tylenol (500mg/packet), a snack (juice box and a
granola bar), and a physical activity monitor to wear. One of the subjects declined taking
the Tylenol after the biopsy and was instead given an extra packet of Tylenol to take
away in case it was needed later. At the end of the biopsy visit, subjects were given a
biopsy care instruction sheet, icepacks, and individual Tylenol packets to take home with
them. After each visit to the lab for measures of muscle soreness, Tylenol was provided
to the subjects. Tylenol use for each subject was recorded with the Brief Pain Inventory
Short Form (BPISF) questionnaire. Subjects were instructed to use the Tylenol as needed
for pain relief from the muscle biopsy.
Total RNA Isolation and qRT-PCR
Total RNA from all muscle biopsies was extracted using the standard TRIzol
(Invitrogen, Carlsbad, CA, USA) method. Double-stranded cDNA was created using the
First-Strand cDNA Synthesis kit (Fermentas, Hanover, MD). For all PCR protocols, an
RT2 Fast SYBR Green/Fluorescein qPCR Master Mix (Catalog PA-012, SABiosciences
Corporation, Frederick,MD) was used as the reaction buffer. Forward and reverse primers
specific for the genes of interest were designed by SABiosciences (SABiosciences
Corporation, Frederick, MD). Integrin Alpha 7 (ITGA7, SABiosciences catalog
PPH00665A), Collagen 4A2 (COL4A2, SABiosciences catalog PPH002474A), Collagen
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3 A1 (COL3A1, SABiosciences catalog PPH00439A), Integrin Beta 1 (ITGB1,
SABiosciences catalog PPH00650A), Laminin alpha 2 (LAMA2, SABiosciences catalog
PPH21264A), Matrix Metalloproteinase 9 (MMP9, SABiosciences catalog PPH00152A), Matrix Metalloproteinase 2 (MMP2, SABiosciences catalog PPH00151B),
Tissue inhibitor metallopeptidase 2 (TIMP2, SABiosciences catalog PPH00904A),
Tenascin-C (TNC, SABiosciences catalog PPH02442A). The candidate gene primers and
the housekeeping gene primers were optimized by SABiosciences to ensure similar
efficiency and amplification among primer pairs for the genes of interest and the primer
pair for the reference standard Beta-2-Microglobulin (B2M, SABiosciences catalog
PPH01094E).
qRT-PCR reactions were run in 96-well plates with cDNA samples from each
subject at baseline (MB1), 24 h after Bout 1 (MB2), and 24 h after Bout 2 (MB3) in
triplicate for each gene of interest. Thus, each plate allowed for analysis of one gene of
interest and one reference standard for two subjects at each time point. The average
comparative threshold (Ct) value was used for data analysis. Ct values were directly
related to the fluorescence of the respective SYBR-green probe after 40 cycles of
amplification using the CFX96 Real-Time PCR System (Bio-Rad, Hercules, CA, USA).
Thermal cycling conditions were as follows: one cycle at 95oC for 10 min for enzyme
activation, 40 cycles at 95oC for 15 sec for denaturation, and one cycle at 60oC for 1 min
for the anneal/extension step. At the end of each reaction, a dissociation curve analysis
was run to identify possible primer dimers. Dissociation curve analysis was set for one
cycle at 95oC for 60 sec; 2 min at 65oC (optics off); followed by 65oC to 95oC at 2oC/min

109

(optics on). The “optics on” indicates the temperature and time during which the
dissociation curve measures for each gene of interest and housekeeping gene collected.
To detect expression levels of genes of interest, beta-2-microglobulin (B2M)
(SABiosciences CatalogPPH01094E -200) was used as a reference standard. B2M is a
constitutively expressed housekeeping gene that has been validated in humans (26,79). In
muscle biopsy samples from control and eccentric exercised muscle in our laboratory, we
found that B2M does not change after a biopsy or eccentric exercise (28). Relative
quantitation of amplified mRNA was normalized to B2M, compensating for variations in
mRNA quantity as well as for differences in reverse transcriptase (RT) efficiency.
Protein Extraction
The skeletal muscle samples (~50 mg) were homogenized in 250 µl of
homogenization buffer (10 µl of protease inhibitor [HALT Protease Inhibitor Cocktail–
without EDTA, Thermo Fisher Scientific © Rockford, IL, Pierce Catalog 78410] for
every 1 ml T-PER [Pierce Tissue Protein Extraction Reagent, Pierce catalog
#78510,Thermo Fisher Scientific © Rockford, IL USA 61101]) with a handheld
homogenizer over liquid nitrogen. Thereafter, homogenates were centrifuged at 10,000 X
g at 4ºC for 5 min. Supernatants were removed and transferred to new 1.7 ml tubes on
ice. Total protein concentrations of the resulting supernatants were determined with a 96well flat-bottom plate using the Coomassie (Bradford) protein assay (Better Bradford
Protein Assay, Pierce, Rockford, IL).
Western Blotting
Equal amounts (30 µg) of protein extracted from ~50 mg tissue samples were
loaded into four 15% gradient Tris-HCL gels (Bio-Rad, Hercules, CA) for all proteins
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analyzed except for Tenascin-C, which was analyzed using 5% Tris-HCL gels (Bio-Rad,
Hercules, CA). Proteins were separated by electrophoresis (40–60 min at 200 V). 15 µl of
a 250 kDa Precision plus Kaleidoscope Protein Standard (Bio-Rad) was loaded into the
first and last lane of gel 1 and the first and middle lane of gel 2. Following
electrophoresis, fractionated proteins were transferred onto a polyvinylidene difluoride
(PVDF) membrane (GE Healthcare, Piscataway, NJ) for 60–120 min at room temperature
at 50–70 V; tenascin-C was transferred overnight at 4°C and then for 60 min at room
temperature at 70 V. After transfer, the membrane was blocked for 60–100 min at room
temperature with rocking motion in 5% fat-free powdered milk (Carnation® in 1XTBST
[Tris-buffered saline + 0.1 % Tween]). The membrane was washed three times for 5 min
each in 1XTBST. After washing, each membrane was individually incubated with a
rocking motion overnight at 4°C in one of the following primary antibodies that were
diluted in a solution of 5% BSA in 1X TBST: matrix metalloproteinase 9 (MMP9)
(1:1000 rabbit polyclonal, AbCam ab7299, Cambridge, MA); matrix metalloproteinase 2
(MMP2) (1:1000 rabbit polyclonal, AbCam ab37150); tissue inhibitor metallopeptidase 1
(TIMP1) (1:200 mouse monoclonal, Santa Cruz Biotechnology sc-80365, Santa Cruz,
CA); collagen 3 (COL3) (1:1000 mouse monoclonal, AbCam ab6310); collagen 4
(COL4) (1:500 mouse monoclonal, AbCam ab23975); integrin α7 (ITGA7)(1:200 goat
polyclonal, Santa Cruz Biotechnology sc-27706); integrin β1 (ITGB1) (1:100 mouse
monoclonal, Santa Cruz Biotechnology sc-73610); laminin α2 (LAMA2) (1:200 mouse
monoclonal, Novus Biologicals H00003908-M0, Littleton, CO); tenascin-C (1:200
mouse monoclonal, AbCam ab88280); focal adhesion kinase (FAK) (1:200 rabbit
polyclonal, Invitrogen AHO0502, Camarillo, CA); focal adhesion kinase phosphorylated
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at Tyrosine 861 (FAKY861) (1:000 rabbit polyclonal, AbCam ab4804); biglycan (BGN)
(1:1000 goat polyclonal, AbCam ab585621); decorin (DCN) (1:5000 mouse polyclonal,
Novus Biologicals H00001634-B01P). The membranes were washed five times for 8 min
each in 1XTBST. The membranes were incubated in secondary antibody [goat, antimouse IgG HRP (BioRad 172-1011, Hercules, CA) conjugate for TIMP1, collagen 3,
collagen 4, integrin β1, laminin α2, tenascin-C, decorin and goat, anti-rabbit IgG HRP
(BioRad 172-1019) conjugate for MMP9, MMP2, FAK, FAKY861, and donkey, anti-goat
IgG HRP (AbCam ab6885) conjugate for integrin α7 and biglycan] diluted 1:5000 5%
BSA in 1XTBST for 1 h, and then washed five times in 1XTBST for 10 min. After
washing, membranes were treated with enhanced chemiluminescence (GE Healthcare,
Piscataway, NJ) for 30 sec to 1 min, wrapped in plastic film, and exposed using a Chemi
Doc XR+ (BioRad Laboratories).
The loading control for each blot was glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) (AbCam 9484). After probing for primary antibodies of interest, membranes
were stripped and re-probed with GAPDH (1:1000 mouse monocolonal, AbCam 9484).
GAPDH has been shown to be a reliable loading control for protein evaluation after
eccentric exercise (56). Unlike genes, the loading control (e.g. GAPDH) is not as
susceptible to resident muscle cells contributing to the level of protein identified via
western blot. However, to ensure that the loading controls were similar, we probed one
gel for B2M (the loading control in qRT-PCR) and then stripped and re-probed that gel
with GAPDH; there were no differences in protein level between the loading controls
among the time points (Baseline, Bout 1, or Bout 2). Bands from each blot were
quantified via traditional densitometry methods (Image Lab version.3.0.1, BioRad
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Laboratories). To quantify protein levels at 24 h after Bout 1 and Bout 2, densitometry
values for protein bands at 24 h post-Bout 1 and post-Bout 2 were compared to baseline
for the control and exercise groups.
Zymography
Protein lysates were prepared similarly to western blot lysates without 2mercaptoethanol. 30 µg of protein were loaded onto Criterion Zymogram 10%
polyacrylamide gelatin gel (Bio-Rad, Hercules, CA) and separated by electrophoresis (60
min @ 200 V). Following electrophoresis, gels were placed in distilled water for 15 min
and then the gels were renatured. Renaturation of the proteins was accomplished by
incubating the gels overnight in renaturation buffer (2.5% Triton-X 100, 5 mM CaCl2)
with gentle agitation. The gels were then developed with a 24 h incubation at 37°C in
development buffer (50 mM Tris, pH 7.5, 200 mM NaCl, 10 mM CaCl2). Staining of the
gels was performed with the staining buffer (50% MeOH, 10% acetic acid, and 0.5%
Coomassie Blue R-250) at room temperature for 2 h with gentle agitation. Gel destaining
was performed to visualize the zones of lysis on the zymograms. Gels were destained
using destaining buffer (50% MeOH, 10% acetic acid and ddH2O) for approximately 1 h
with repeated changes of the destaining buffer until clear lysis bands were visible against
the Coomassie Blue-stained background of the gel. Gels were visualized using the Chemi
Doc XR+ (BioRad Laboratories, Hercules, CA) and then analyzed using inverse
densitometry methods (Image Lab version.3.0.1, BioRad Laboratories).
Data Analysis
The significance level was set to an alpha of 0.05 for the statistical tests. All
values are reported as mean ± SEM. Subject demographics for the exercise and control
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group were analyzed for differences between the groups using a Student’s t-test for age,
height, weight, total physical activity level, and baseline isometric strength. The Baseline
(Pre-Biopsy/MB1), Bout 1/MB2, and Bout 2/MB3 measures of muscle soreness and
maximal isometric strength for the exercise group were analyzed using an ANOVA
repeated measures analysis (rmANOVA).
The qRT-PCR gene expression data were examined for pipetting errors,
contamination from the cDNA synthesis process, and contamination from the qRT-PCR
reactants. Examining the standard deviations from the Ct values for the samples in
triplicate for the genes of interest (GOI) and the housekeeping genes (B2M) was done to
identify potential pipetting errors. The replicates of GOI and B2M samples with a
standard deviation of 1 Ct value were examined to determine which replicate had the
pipetting error and this sample was then removed. To examine contamination during the
cDNA process a separate tube was prepared at each round of cDNA synthesis with the
cDNA reactants from the kit but without any sample RNA isolated from the muscle
biopsies. RNase free water (Qiagen, Valencia, CA) was used instead of the isolated RNA
from the muscle biopsy. These cDNA synthesis controls were used as one of the no
template controls (NTC) for the qRT-PCR reaction to ensure that there was no
contamination from the cDNA synthesis process. In addition, a second set of NTC wells
were prepared for the qRT-PCR reactions with RNase water instead of the cDNA muscle
biopsy samples to ensure that there was no contamination of the qRT-PCR reactants. The
threshold counts (Ct values) for each individual sample (GOI) and the housekeeping gene
(B2M) were examined to ensure that the B2M Ct values were not elevated relative to the
other B2M Ct values on the plate; these Ct values were often close to 30 Ct which
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suggests inadequate cDNA synthesis (primer annealing). There were two subjects whose
Bout 1 time point had to be removed because the B2M expression was elevated relative
to the rest of the B2M Ct levels on the plate. Because not all subjects and time points
could fit on one plate for analysis, an intraplate control was used to examine the
expression of the same time point across multiple plates for the same GOI. The intraplate
data were analyzed for differences in expression levels among plates using a one-factor
rmANOVA and a Chi-Square one-sample test. Finally, to demonstrate that we were able
to produce repeatable qRT-PCR data, one GOI was selected (e.g. tenascin-C) and a select
number of samples were analyzed on two separate days. The results from each plate were
examined for difference between gene expression using a Students t-test, and interplate
reliability was examined using a Pearson R correlation.
The gene expression data were analyzed using a three-way rmANOVA for group
(exercise vs. control), sex (male vs. female), and leg (left vs. right) over bout/time (Bout
1/MB2 and Bout 2/MB3). All interactions were also examined. In addition, any
significant differences in the gene expression between time points were examined for a
correlation with peak soreness and isometric strength loss.
The western blot analysis data were also analyzed using a three-way rmANOVA
for group (exercise vs. control), sex (male vs. female), and leg (left vs. right) over
bout/time (Bout 1/MB2 and Bout 2/MB3). All interactions were examined. Any
significant differences in the protein expression between bouts were examined for a
correlation with peak soreness and isometric strength loss. In addition, because of the size
of the study it was not possible to run all samples on a single gel. Each gel contained two
control subjects (1 man and 1 woman) and four exercise subjects (2 men and 2 women)
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and the gels were analyzed for differences to ensure that differences found for the
significant effects were not a result of variation in immunoblotting techniques from one
membrane to the next (i.e. incubation time, antibody concentrations, transfer variability).
The zymography analysis of matrix metalloproteinase (MMP) activity was
analyzed by comparing the inverse densitometry values among the three replicate gels.
The relative change in the inverse densitometry values from Bout 1/MB2 and Bout
2/MB3 compared to baseline/MB1 were averaged among the three replicate gels and then
a three-way rmANOVA for group (exercise vs. no exercise), sex (male vs. females), and
leg (left vs. right) over bout/time (Bout 1/MB2 and Bout 2/MB3). All interactions were
examined. Any significant differences in the MMP activity expression over time were
examined for a correlation with peak soreness and isometric strength loss.
Results
Fifteen individuals completed the interview and read the informed consent for this
study; 12 individuals signed the informed consent, enrolled in the study, and completed
the study. Of the 12 enrolled individuals six were men and six were women. The physical
characteristics for the 12 subjects are (mean ± SEM): age 23.0 ± 1.6 yrs., height 174.1 ±
2.78 cm, and weight 85.68 ± 9.48 kg. Eight of the 12 subjects were randomized into the
exercise group and four were randomized into the non-exercise groups. The physical
characteristics for the two groups are shown in Table 4.1. There was no significant
difference between the groups for age (p=0.335), height (p=0.903), or weight (p=0.261).
The exercise and non-exercise groups were balanced for sex. All subjects were
randomized for leg (vastus lateralis muscle) that was biopsied first (MB1, baseline); the
contralateral leg was biopsied for the second (MB2) and third (MB3) biopsy time points
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(24 h after exercise or no-exercise bouts, Bout 1 and Bout 2). Muscle soreness was
measured prior to the bouts and then up to 120 h post-Bout 1 and Bout 2.
Table 4.1: Physical characteristics for each group (results are mean ± sem).

Age (yr)
Height (cm)
Weight (kg)

Exercise

Control

22.13 ± 1.10
173.83 ± 2.91
91.39 ± 11.76

24.75 ± 2.20
174.63 ± 5.43
74.26 ± 8.27

Muscle Soreness
We found that muscle soreness was significantly elevated after eccentric exercise
(p=0.039). We also found that muscle soreness increased to a greater extent in the
exercise group despite leg biopsied or bout compared to the control group (p <0.0001) at
each time point. Additionally, muscle soreness after Bout 1 in the exercise group was
strongly correlated to the work performed during the exercise, r=0.790 and p=0.02. The
exercise group also had significantly lower soreness levels after Bout 2 compared to Bout
1 (p <0.05), but the soreness was not strongly correlated (r=0.6192 and p=0.090) to the
work performed. Overall, the muscle soreness measure indicates that muscle soreness
from eccentric exercise and/or a muscle biopsy returns to baseline by 96 h despite an
initial or repeated bout. The repeated bout effect was achieved with the stair descent
exercise as shown by the significantly lower levels of muscle soreness in Bout 2
compared to Bout 1 (Figures 4.2.A. and 4.2.B).
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Figure 4.2: Muscle soreness of the exercise group (A) and the control group (B). *p <0.05
between hours post-bout, τ p < 0.05 for bout (Bout 0, Bout 1, Bout 2), φ p<0.05 for group
(exercise vs. control).
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Muscle Strength
Loss in maximal isometric strength after eccentric exercise has been used as a
functional indicator of damage to skeletal muscle (11,20,26,28,85). The stair descent
exercise produced an approximate 17% decrease in maximal isometric strength after
exercise compared to baseline (p=0.018), as shown in Figure 4.3. The control group did
not perform the exercise, but muscle strength was assessed and we found no change in
maximal isometric strength between baseline and 24 h prior to MB2 (Bout 1) and MB3
(Bout 2). The exercise group had less of a decrease in maximal isometric strength after
Bout 2 (13% ± 4%, p=0.290) compared to Bout 1 (18% ± 5%, p=0.018 ).

Figure 4.3: Maximal isometric strength 70° (N-m) of the exercise (A) and
control (B) groups. Values are mean ± sem. * Indicates p < 0.05.
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Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR)
All muscle biopsy samples were analyzed for the effect of leg biopsied and sex to
ensure that differences found between control vs. exercise or bouts were not due to a
difference in sex or leg biopsied. Of the nine genes related to the extracellular matrix,
four genes were found to be differentially regulated (Figures 4.4–4.8) and only one gene
had a significant relationship with DOMS. The qRT-PCR results of all nine genes of
interest are shown in Table 4.2 and Appendix D; the appendix contains the raw data for
each GOI that was normalized to the housekeeping gene, B2M, and graphs of the
resultant fold-change results for group for Bout 1 and Bout 2.
Table 4.2: Effects of a single and repeated bout of eccentric exercise on mRNA
expression (values are mean ± sem).
Bout 1
MMP2
MMP9
TIMP1
Tenascin-C
Integrin β1
Integrin α7
Laminin α2
Collagen 3
Collagen 4

Bout 2

Control

Exercise

Control

Exercise

-4.17 ± 0.20
3.00 ± 0.37
1.88 ± 0.35
1.33 ± 0.47
1.16 ± 0.47
1.13 ± 0.15
1.09 ± 0.37
1.53 ± 0.37
1.19 ± 0.03

1.36 ± 0.54
1.16 ± 0.36
1.41 ± 0.19
66.56 ± 15.98
1.27 ± 0.24
1.51 ± 0.92
1.22 ± 0.33
1.69 ± 0.36
-1.05 ± 0.25

-5.25 ± 0.14
2.24 ± 0.35
1.33 ± 0.43
2.00 ± 1.07
1.35 ± 0.30
-1.20 ± 0.10
1.26 ± 0.20
2.05 ± 0.50
1.55 ± 0.55

-1.63 ± 0.28
1.42 ± 0.58
-2.49 ± 0.18
25.80 ± 12.46
1.61 ± 0.26
2.50 ± 0.58
1.19 ± 0.25
3.03 ± 1.01
1.74 ± 0.28

MMP9 mRNA was differentially expressed (p=0.0278) between men and women
(Figure 4.4) despite group (e.g. exercise versus control, p=0.079) and bout
(baseline/MB1, Bout 1/MB2, and Bout 2/MB3; p=0.517). After Bout 1/MB2, men had a
2.15-fold increase in MMP9, while women had a 1.76-fold decrease. After Bout 2/MB3
men and women had decreased MMP9 expression compared to baseline, but MMP-9
mRNA decreased more in women than in men. For MMP9, there was no significant
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difference between the exercise and control groups (p=0.079), between the leg biopsied
(p=0.4299), or between baseline/MB1, Bout 1/MB2, and Bout 2/MB3 (p=0.517) (p
>0.160).

δ

δ

Figure 4.4: MMP9 expression for men and women after Bout 1 and Bout 2. The exercise
and control groups are collapsed within each sex. Values are mean ± sem, δ p <0.05 for
sex (men vs. women).
After a single bout (Bout 1) of eccentric exercise there was a robust increase in
tenascin-C (66-fold, p=0.016) and after a repeated bout (Bout 2) of exercise, this increase
was blunted (25-fold, p=0.016), (Figure 4.5). The muscle biopsy alone (control group)
did not cause a significant increase of tenascin-C expression compared to baseline (1.3fold increase and 2.0-fold increase, Bout 1 and Bout 2, respectively). In Bout 1 there was
a positive and moderately high correlation (r=0.531) for muscle soreness at 24 h postexercise with tenascin-C mRNA levels, but this relationship did not reach significance
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until 48 h (r=0.621, p=0.031). Following Bout 2, there was a positive and moderately
high correlation for muscle soreness with tenascin-C at 24 h (r=0.656, p=0.021) and 48 h
(r=0.935, p=0.036) post-exercise.

Figure 4.5: TNC expression for control and exercise groups after Bout 1 and Bout 2. The
exercise and control groups were significantly different at Bout 1 and Bout 2. The
exercise group was significantly different at Bout 2 compared to Bout 1. Values are mean
± sem, * p<0.05 for time, τ p <0.05 for bout (Bout 1 vs. Bout 2), φ p <0.05 for group
(exercise vs. control).
Integrin α7 mRNA expression was differentially expressed between the exercise
and the control group (p=0.012), despite bout/MB as shown in Figure 4.6.A. There was
also a significant effect for the leg biopsied and time (p=0.0028), as shown in Figure
4.6.B. In Bout 1(MB2), the left leg had a 5.46-fold increase and the right leg had a 1.77fold increase in ITGA7 mRNA. Following MB3 the left leg had a 5.23-fold increase and
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the right leg had a 2.98-fold increase (p=0.0028).

φ

φ

Figure 4.6.A: ITGA7 expression for control and exercise groups after Bout 1 and Bout 2.
Values are mean ± sem, φ p <0.05 for group (exercise vs. control).

λ

λ

Figure 4.6.B: ITGA7 expression for left and right legs after Bout 1 and Bout 2. Values
are mean ± sem, τ p <0.05 for leg (left vs. right).
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COL3 mRNA expression was significantly elevated (p=0.018) from baseline for
the exercise and control groups in MB2 (24 h post-Bout 1) and MB3 (24 h post-Bout 2)
as shown in Figure 4.7.A. COL3 mRNA was differentially expressed for men and women
between MB2 and MB3 as shown in Figure 4.7.A. Men had no increase (1.01-fold) in
MB2 compared to the 2.4-fold increase for women (p=0.008). For MB3, men had a 3.9fold increase in COL3 expression, while women decreased to an expression level of 1.8fold as compared to the 2.4-fold increase found after MB2 (p=0.008).
are mean ± sem, τ p <0.05 for leg (left vs. right).

*

*

Figure 4.7.A: COL3 mRNA expression of control and exercise groups after Bout 1 and
Bout 2. Values are mean ± sem, * p <0.05 from baseline.
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δ

δ

Figure 4.7.B: COL3 mRNA expression of men and women after Bout 1 and Bout 2.
Values are mean ± sem, δp <0.05 for sex (men vs. women).
The five genes that were not differentially expressed between group (exercise vs.
control), bout/time (Baseline/MB1, Bout 1/MB2, Bout 2/MB3), leg (biopsied left or right
leg), sex (male vs. female), or for any of these interactions (e.g. group*bout, group*leg,
group*sex, etc) are listed below and their results are shown in Table 4.2 and Appendix D.
The 72kDa type IV collagenase, MMP2, was not differentially expressed (group, bout,
leg, sex, or any of the interactions; p >0.1347), as shown in Appendix D Figure D.2. An
inhibitor of the MMPs, tissue inhibitor of metalloproteinases 2 (TIMP2) was not
differentially expressed (group, time, leg, sex or any of the interactions; p >0.1768), as
shown in Appendix D Figure D.3. The intermembrane protein, integrin β-1 mRNA, was
not differentially expressed (group, bout, leg, sex, or any of the interactions; p >0.073), as
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shown in Appendix D Figure D7. Finally, two structural ECM molecules laminin α-2
(LAMA2) and collagen 4 (COL4) were not differentially expressed (group, bout, leg, sex,
or any of the interactions), p=0.2716, LAMA2, Appendix D Figure D.8 and p >0.0986,
COL4 Appendix D Figure D.5.
Western Blotting
All muscle biopsy samples were analyzed for the effect of leg biopsied and sex to
ensure that differences found for control vs. exercise or bouts were not due to differences
in sex or leg biopsied. Because of the number of samples, 12 subjects and their three time
points, we used two gels to analyze each protein. As an intergel control, one sample time
point from one subject was used on both gels, and we found no significant differences
between this sample on each gel for any of the nine proteins analyzed.
The protein products of all nine genes examined above for differential expression
were examined using gel electrophoresis and western blotting. Of the nine proteins
examined, only integrin α7 (ITGA7) protein levels were altered as a result of the
intervention.
In the current study, we found that two control and four exercise individuals
expressed all three isoforms (7X12X2B, 7X1B, and 7X2B) of integrin α7, that two
control and two exercise individuals expressed two isoforms, and that two exercise
individuals only expressed one of the integrin α7 isoforms. The expression of the
isoforms was not dependent on group (exercise vs. control) or time point (Baseline
(MB1), Bout 1(MB2), or Bout 2 (MB3)). Each integrin α7 isoform was analyzed
separately, and in Appendix E the three identified isoforms are referred to as Band 1 for
isoform Alpha 7X12X2B, Band 2 for isoform Alpha 7X1B, and Band 3 for isoform
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Alpha 7X2B. Of the three isoforms detected, only isoform 7X2B levels were found to be
different from baseline and between bouts (p <0.05). Compared to baseline, protein levels
of integrin α7 isoform 7X2B in Bout 1 in the control and exercise groups decreased 48.5
% ± 11.4 % and 51.8 % ± 15.3 %, respectively. In Bout 2, integrin α7 isoform 7X2B
protein levels in the control and exercise group had returned to baseline levels (Appendix
E).
Zymography
There was no change in gelatinase activity for MMP9 and MMP2 pro- and active
levels. These results indicate that a muscle biopsy alone does not increase activity of the
MMPs and they suggest that at 24 h post-eccentric exercise MMP activity is not altered.
These results suggest that at 24 h post-eccentric exercise MMP2 and MMP9 do not play a
role in the repeated bout effect (Appendix F).
Discussion
The present study expanded the examination of ECM structural molecules to
include integrin β1 and integrin α7. We sought to identify acute changes (24 h postexercise) in the expression of a subset of genes and their respective protein products
located in the ECM (MMP9, MMP2, TIMP2, tenascin-C, integrin β1, integrin α7,
laminin α2, collagen 3, and collagen 4) after a single and repeated bout of stair descent
eccentric exercise. We also sought to examine the relationship between these molecules
and muscle soreness. Since the muscle biopsy procedure affects the ECM and because
muscle biopsies have an effect on inflammation and may have an effect on muscle
soreness (47) we examined changes in the expression of genes and protein products listed
above in a control group of individuals who did not exercise, but had the same number of
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biopsies as an exercise group. We demonstrated that the stair descent exercise elicited
“muscle damage” as shown by the functional indicators of muscle damage (e.g.
immediate decrease in maximal isometric strength [Figure 4.3] and DOMS [Figures
4.2.A. and 4.2.B.]). We also showed that the stair descent exercise resulted in a repeated
bout effect, shown by a decrease in functional indicators of muscle damage; a decrease in
maximal isometric strength and a decrease in the maximal level of DOMS, as well as a
faster return to baseline soreness levels after the second bout of exercise.
Skeletal Muscle Soreness
The measurement of muscle soreness allowed us to demonstrate that the stair
descent exercise provided a repeated bout effect in the vastus lateralis. The stair descent
exercise model has been used previously (21,85); however, the triceps surae was assessed
for muscle soreness and damage and not the vastus lateralis. In the control group the peak
level of muscle soreness was zero mm (no soreness), while the eccentric exercise group
had ~45 mm of muscle soreness at 24 h after the exercise in Bout 1 and ~25mm in Bout
2. As expected, we found a strong correlation between soreness and work done in Bout 1
(r=0.790 and p=0.02) but not in Bout 2 (r=0.6192 and p=0.090). Overall, we were able to
show the repeated bout effect was achieved with the stair descent exercise as shown by
the significantly lower levels of muscle soreness in Bout 2 compared to Bout 1 and the
loss of a soreness correlation with eccentric exercise in Bout 2.
Muscle Strength Measures
We found in the current study that the exercise protocol produced an approximate
17% strength loss in the quadriceps after Bout 1 and we also found that the exercise
produced a repeated bout effect. While this strength loss is less than the strength loss (20–
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40%) reported by others (6,12,26,28) in the quadriceps after an acute bout of exercise, the
achievement of the repeated bout effect indicates that the exercise protocol induced
sufficient muscle damage. The studies that found greater losses in strength after eccentric
exercise used an isokinetic dynamometer (6,12,28) or a stand-and-sit task (26) to produce
the strength loss. Previous studies (20,86) have used the same eccentric exercise protocol
that we used to examine muscle function of the calf muscles (e.g. triceps surae). Friden et
al. (20) and Yu et al. (86) found that a stair descent exercise (10 flights of stairs
descended 15 times) produces immediate strength loss in the triceps surae (20,86). We
showed that the stair descent exercise produced strength loss of the vastus lateralis and a
repeated bout effect.
Expression of Regulatory and Structural Genes and Proteins in the ECM
The role of tenascins as important adhesion molecules was first demonstrated in
1988 (10). We have learned since then that tenascins play a more complex and varied role
within the ECM (17–19,31,81). Tenascins have been shown to modulate inflammatory
processes and regulate the repair/rebuilding process of the extracellular matrix (17–
19,31,81). In the present study, we found that tenascin-C (TNC) mRNA expression
increased in the exercise group after Bout 1. Furthermore, the expression was
significantly blunted after a repeated bout of exercise compared to the first bout. Aside
from the time point used, these results are not novel, but confirm work by Mackey et al.
(45) who showed that tenascin-C mRNA and protein levels at 48 h post-exercise were
elevated after a single bout of eccentric exercise via electrical stimulation and then
reduced after a repeated bout of eccentric exercise via electrical stimulation.
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Mackey et al. (45) attributed the changes in tenascin-C at 48 h after eccentric
exercise to be associated with de-adhesion activities in preparation of remodeling the
ECM. Because the ECM surrounds the skeletal muscle, any repair or growth of the
muscle would require reorganization of the ECM, and the de-adhesion properties would
provide access to the injured site for repair and removal of the damaged material (19,45).
The de-adhesion and re-adhesion properties would also ensure that the ECM does not
confine the growing muscle and thus limit its function (e.g. strength production and
movement) (19,29). After the removal of the damaged debris and/or the remodeling
phase of the muscle the re-adhesion properties of tenascin-C would ensure that muscle is
reconnected to the ECM and that the muscle is able to transmit the force generated by the
myofilaments to the tendon (19,30).
In the present study, tenascin-C levels in Bout 1 and Bout 2 were positively
correlated to soreness levels at 24 h and 48 h post-exercise in Bout 1 and Bout 2,
respectively. The correlation between soreness and tenascin-C levels after Bout 2 would
suggest that the expression level of tenascin-C is due to the second bout of exercise and
not a result of Bout 1 and would likely indicate that re-adhesion is not the only process
that tenascin-C is promoting after a second bout of exercise. Furthermore, we did not find
that individuals with the highest mRNA expression of tenascin-C (i.e. high responders)
after a single bout of exercise had the lowest level of soreness or strength loss after a
repeated bout of exercise. These results would indicate that tenascin-C was not promoting
an enhanced adaptation to eccentric exercise in the high-responders. It’s apparent that
tenascin-C is involved in the adaptation process that produces the repeated bout effect
after eccentric exercise. Also, the de-adhesion and re-adhesion processes, as well as
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myogenic repair and growth processes affected by tenascin-C levels, are the way that
tenascin-C likely repairs and promotes adaptation to skeletal muscle after eccentric
exercise.
Tenascin-C and MMPs have been shown to co-localize at sites of inflammation
(32,69,78) and it is likely that together they orchestrate the de-adhesion and disassembly
of the ECM molecules and the de-adhesion from transmembrane proteins after damage
from mechanical strain. MMPs are regulated in three different ways to include gene
expression, cleavage of the proenzyme, and via TIMPs, which are the innate inhibitors of
the MMPs. In the present study we found that there was a significant difference in mRNA
expression of MMP9 between men and women and a trend (p=0.08) for group
differences. Combining the exercise and control group mRNA levels after Bout 1, we
found that men had a 2.1-fold increase in MMP9 gene expression and women had a 1.8fold decrease. In a mouse crush model of muscle damage, MMP9 was localized to the
endomysial area beside damaged muscle fibers during the process of regeneration (88).
These results suggest that we were amplifying MMP9 mRNA expression of invading
inflammatory cells and not just skeletal muscle expression after eccentric exercise.
Invading inflammatory cells (e.g. neutrophils, leukocytes, and macrophages) arrive
within 24 h after injury (70,75) and would have been present at the time point of the
muscle biopsy used in this study. Because MMP9 is secreted by macrophages,
neutrophils (41), and leukocytes (39) and because MMP9 has been correlated to
activation of neutrophils (41) and recruitment of pro-inflammatory macrophages (39), it
is likely that our significant increase in MMP9 mRNA expression level is due to
amplification of MMP9 from these cells. While we did not measure systemic
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inflammation or inflammatory cells in the ECM of the muscle biopsies in this study, we
believe that based on previous research (26,38,57), inflammatory cells are the probable
source of MMP9 mRNA expression.
At present, this is the first study to investigate the changes in MMP9 mRNA in
skeletal muscle after eccentric exercise in humans. Previous studies in animals (8,9) and
humans (63,64) have found increases of MMP9 mRNA levels after high-intensity aerobic
exercise, but the effect of eccentric exercise had not been investigated. Although we
found a significant difference for MMP9 mRNA expression between men and women in
MB2 and MB3, we were not sufficiently powered to conclude that there was a difference
in the regulation of MMP9 via gene expression.
The second way that the MMPs are regulated is via cleavage of the proenzyme,
which results in an activated MMP9 enzyme that degrades gelatinolytic material (e.g.
collagens). We used zymography to measure MMP9 protein activation after eccentric
exercise. We were surprised to not see any changes in the latent and active forms of the
MMP9 protein (Appendix F). Since MMP9 is up-regulated with strain, and activation of
MMP9 only requires the cleavage of the proenzyme, we expected that the eccentric
exercise stimulus would induce cleavage of the latent MMP9 form and that we would see
an increase in active MMP9 protein levels after the muscle biopsy as well as the exercise.
It is likely that the muscle resident or infiltrating inflammatory cells did not have
sufficient time to produce and secrete MMP9 in order for MMP9 to be cleaved and
detected by zymography.
We were not able to draw any firm conclusion about the biopsy and its effects on
MMP9 activation as there may have been an infiltrate (e.g. an inflammatory cell) in the
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tissue. All tissue samples were rinsed in saline immediately after collection, but we did
not isolate mononuclear or inflammatory cells from the tissue. MMP9 is highly upregulated when inflammatory cells are activated (9,62,89) and previous studies (47) have
shown that muscle biopsies can increase the number of inflammatory cells in the ECM of
skeletal muscle. The muscle also has resident inflammatory cells (71) and it is likely that
these cells and not an inflammatory response secreted the MMP9. In addition, we were
also not able to make any conclusions about the eccentric exercise and its effects on
zymography due to the variability of gelatinase activity found in the individuals after the
single and repeated exercise bouts.
Rullman et al. (64) demonstrated increased gelatinolytic activity of MMP9 after
exhaustive exercise; however, they examined tissue at 2 h after exercise and not 24 h
after exercise so it may be possible that MMP9 is secreted and activated immediately
after the insult to the muscle and not at later time points (e.g. 24 h post-exercise). It is
also likely that MMP9 is produced and secreted at later time points, but that the activation
of the MMP9-proenzyme and the enzyme activity of MMP9 were affected by regulators
called tissue inhibitor metalloproteinases (TIMPs). In the present study we examined
TIMP2’s mRNA expression level, but we did not see any change in mRNA levels of
MMP2 or TIMP2. Activated MMP9 and pro-MMP9 (60) can bind to TIMP1 and because
we found a change in mRNA expression for MMP9, we chose to examine protein
expression of TIMP1 instead of TIMP2. If the protein level of TIMP1 was up-regulated
along with MMP9, this coordinated change may suggest that TIMP1 is up-regulated so
that it can bind to MMP9 and inhibit MMP9’s gelatinolytic activity. However, we did not
see any change in TIMP1 protein expression levels and therefore we do not believe that
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the lack of MMP9 gelatinolytic activity was due to MMP9 being bound to TIMP1.
Animal models have shown the importance of integrins in protecting skeletal
muscle from damage (4), and in humans, mutations in the integrin α7 gene can cause
congenital myopathies (22). To our knowledge, this is the first study to show an increase
in integrin α7 (ITGA7) mRNA in humans at 24 h after eccentric exercise, (Figure 4.6.A
and 4.6.B). Interestingly, we found a decrease in protein levels at 24 h post-exercise
(Figure 4.8). Changes in mRNA expression do not always coincide with changes in
protein expression, and observational changes in protein products of these genes may not
appear until 24–96 h after a stimulus (e.g. exercise, injury) (40). Furthermore, posttranslational modification (e.g. ubiquitination, cleavage, addition of disulfide bridges) can
affect the ability to detect protein products of expressed genes in western blotting because
the protein may be degraded (e.g ubiquitination).
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*

Blot #1

Blot #2

Figure 4.8: Protein expression of ITGA7 X2B isoform of control and exercise groups
after Bout 1 and Bout 2. Values are mean ± sem. The representative blot is shown below
the graph, and the first six lanes of the two blots are control subjects and the last 12 lanes
represent the exercise group. Each letter represents a subject and each number represents
the muscle biopsy time point (e.g. 1 is muscle biopsy 1). *p<0.05 from baseline.
Our increase in integrin α7 mRNA after a single bout of exercise is consistent
with animal research showing increases in mRNA acutely after exercise (2,4). A mouse
model of downhill running found that the muscle damage promoted an increase of
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integrin α7 mRNA expression at 3 h post-exercise (4). We had hypothesized that mRNA
for the integrins (α7 and β1) would have increased after Bout 1 and then returned to
baseline levels after Bout 2, but instead we found that integrin α7 increased to a greater
extent after Bout 2 compared to Bout 1. Specific integrins may mediate the repeated bout
effect, as shown by the elevation in integrin α7mRNA in Bout 1 and a greater increase in
integrin α7 mRNA after Bout 2. Because integrins have also been shown to protect
against damage (2), the increase of integrin α7 mRNA found in Bout 2 for the exercise
group may be preparing the muscle for future strenuous exercise.
The control group, which did not perform exercise, showed an increase of integrin
α7 mRNA after MB2 (Bout 1) and a decrease after MB3 (Bout 2) compared to MB2
(Bout 1). The increase after MB2 may be a result of the first muscle biopsy (MB1) and
the decrease of integrin α7 after MB3 may be related to MB2. After MB1, the control
group reported muscle soreness (~20 mm) at 24 h after the biopsy in the non-biopsied
leg; the non-biopsied leg in MB1 was biopsied in MB2 and MB3. The soreness results
suggest that after a muscle biopsy, individuals may inadvertently damage the nonbiopsied leg by relying on the non-biopsied leg instead of the biopsied leg when sitting,
walking downstairs, or performing an activity that uses eccentric actions predominantly
(e.g. bending to pick up something). In animals an increased expression level of integrin
α7 protected the muscle from damage (2,4) and it’s possible that increased expression of
integrin α7 after MB2 was an effort to protect the muscle from future inadvertent
eccentric exercise events. Because the same leg was biopsied in MB2 and MB3, it’s
likely that individuals again relied on the non-biopsied leg and therefore the integrin α7
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level decreased in MB3 because the non-biopsied leg was performing the inadvertent
eccentric exercise or that a different integrin isoform was expressed at this time.
While integrin α7 gene expression increased after MB2 and decreased after MB3,
the protein results for integrin α7 after a bout of eccentric exercise (Bout 1/MB2) did not
mirror the gene expression changes. In fact, the observed decrease that we saw in integrin
α7 protein after a bout of eccentric exercise does not support previous research data or
our hypothesis (2,4). For example, mice lacking the integrin α7 protein show greater
damage after a bout of downhill running exercise (-20°, 17 m/min, 30 min) and did not
experience a repeated bout effect (4,61). We observed three isoforms of integrin α7
(7X12X2B, 7X1B, and 7X2B ) and the 7X2B isoform, an extracellular domain variant
(5), was the isoform that was deceased after MB2. Cell culture studies have shown that
the extracellular domain isoforms have different binding properties to laminin. For
example, the extracellular domain α7X2B binds preferentially to laminin-1 (90) and the
α7X1 isoform binds to laminin-8 (80). The interaction of integrins with the various
laminins can result in the clustering of receptors, the recruitment of focal adhesion
molecules, and the initiation of phosphorylation cascades (15,66). However, we did not
see a change in protein or mRNA expression in the laminin we examined (laminin α2)
and therefore we are unsure of the role of the integrin α7X2B isoform after eccentric
exercise.
Similar to the reason for the gene expression results, we believe that the protein
expression results are related to the MB1 and not the eccentric exercise because protein
expression of the integrin α7X2B isoform was decreased to the same extent in the
exercise and control group at MB2. Furthermore, the fact that protein levels for both
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groups returned to baseline levels after Bout 2/MB3 would also indicate that the decrease
in protein levels are not due to the acute or repeated bout of exercise, especially since all
exercise subjects did experience the repeated bout effect. The return to baseline levels for
both groups after MB3 compared to MB2 could indicate that individuals were more
accustomed to the effects of a muscle biopsy and returned to their daily routine sooner.
At MB3 we did not biopsy the non-biopsied leg from MB2 and therefore we cannot be
sure that our explanation above for the change in integrin α7 protein is correct. However,
the response of integrin α7 levels at MB3—integrin α7 protein level returning to
baseline—as a result of the individuals being accustomed to the effects of the biopsy is
supported by the muscle soreness data, particularly in the control group. In the control
group the biopsied leg muscle soreness after MB3 was significantly lower than muscle
soreness in the biopsied leg after MB2. Because muscle soreness is a functional indicator
of muscle damage the lower soreness level in the biopsied and non-biopsied leg after
MB3 suggest that the leg had less damage and did not require protection via an upregulation of integrin α7X2B. These results suggest that specific integrins may be
sensitive to muscle-lengthening actions that we perform on a daily basis (e.g. sitting
down, stair descent) and could therefore be a good indicator of the muscle adapting to
daily activities and eccentric exercise.
The protein results presented in this study should be viewed with caution because
the control and exercise subjects took ibuprofen, a non-selective COX inhibitor, after
each muscle biopsy (e.g. baseline/MB1, Bout 1/MB2, and Bout 2/MB3). In a population
similar to the one used in the present study, ibuprofen blunted protein synthesis in the
first 24 h after eccentric exercise, as is evidenced by a reduction in fractional synthesis
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rate (76,77). These studies administered the COX inhibitors during and/or immediately
prior to the exercise bout, and the present study did not administer the non-selective COX
inhibitor until after the eccentric exercise and subsequent muscle biopsy. In the present
study the exercise bout was 24 h prior to the biopsy and subjects did not use ibuprofen
during or after the exercise. The baseline muscle biopsy was collected 6 d prior to the
first bout of eccentric exercise and it is possible that the use of a non-selective COX
inhibitor from 120 h prior until 48 h prior to the exercise session may have affected the
protein levels after the Bout 1 exercise. At present there is no data on the use of ibuprofen
2 d to 5 d prior to an exercise bout and its effects on protein expression in the first 24 h
after eccentric exercise. It is unlikely that the use of ibuprofen after the first muscle
biopsy affected the protein synthesis rates in the first bout of exercise of our study
because we would have expected to see a decrease in all protein levels in the muscle
biopsy collected 24 h after the exercise. Because we did not see an overall reduction in all
of the protein levels examined, it is likely that the ibuprofen did not have an effect on
protein levels in the present study.
We found mRNA expression of collagen type 3A1 (COL3) in skeletal muscle to
be higher in women after a single bout of exercise compared to baseline and a repeated
bout of exercise, and in men after a single bout of exercise. However, the lower delta Ct
levels of COL3 at baseline in women compared to men suggests that a sex difference
existed at baseline. These data are similar to the levels of collagen type 1A and COL3 in
tendon, which have been reported to be lower in women compared to men (52,72),
despite no effect of the menstrual cycle on synthesis rates of collagen 1A (52). COL3
mRNA expression in men after an acute bout of exercise has been shown to be no
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different than baseline (23). We found a similar result in COL3 mRNA levels for men in
our study. In women, the elevation of COL3 mRNA expression after 24 h in Bout 1 and
the depression of COL3 mRNA expression after 24 h in Bout 2 has not been previously
reported. However, protein results via immunohistochemistry may support our COL3
mRNA results in men and women. Mackey et al. (46) found no differences in COL3
staining intensity at 4 d and 22 d post-exercise in men and women; however, the
variability of COL3 staining was greater than the variability found for the other collagens
measured at these time points. The variability for COL3 protein in that study may
indirectly support the mRNA results from the present study, sex difference at MB2 and
MB3, because Mackey et al. (46) had both men and women in that study (5 men and 4
women) and it is possible that the high level of variability seen for COL3 protein at 4 d
and 22 d post-exercise was due to sex differences.
Conclusion
This is the first study to examine the gene and protein expression levels of ECM
molecules and their role in the development of muscle soreness using a voluntary single
and repeated bout of eccentric exercise. We did find a repeated bout “effect” for muscle
soreness and maximal isometric strength measured post-exercise compared to baseline
for the quadriceps using the stair descent exercise model. When comparing our strength
loss and DOMS results to other eccentric exercise studies, we found that the stair descent
exercise model produced a moderate amount of muscle damage to the vastus lateralis
(26,28,36,44). We found that skeletal muscle ECM is affected by a single and repeated
bout of eccentric exercise as shown by the change in mRNA expression levels of an ECM
remodeling molecule (e.g. TNC) and the mechanotransduction molecules (integrin α7
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and COL3). Our study confirmed the elevation of tenascin-C after a single and repeated
bout of eccentric exercise and found a strong correlation with soreness at 24 h and 48 h
after both exercise bouts. Furthermore, the correlation with soreness is specific to damage
as a result of eccentric exercise and not due to minor surgery (e.g. muscle biopsy) as
tenascin-C was not correlated to peak soreness from a muscle biopsy.
The increased mRNA expression of COL3 and integrin α7 after both bouts of
exercise was unexpected, as we had expected only to see an increase in the mRNA
expression of COL3 and integrin α7 after the first bout of exercise. We are the first study
to report changes in MMP9 mRNA in skeletal muscle after eccentric exercise in humans.
We identified three integrin α7 isoforms in human skeletal muscle via western blotting.
This finding was novel and unexpected as some of the control and exercise subjects
expressed all three isoforms and some subjects expressed only two isoforms.
Additionally, the decrease of the integrin α7X2B isoform was unexpected because
Boppart et al. (4) found in animals that integrin α7 expression increased after a bout of
eccentric exercise.
While we have contributed new information to the literature on eccentric exercise,
our results do not support our hypothesis. We identified that tenascin-C mRNA
expression is positively related to muscle soreness after eccentric exercise, but not muscle
soreness after a muscle biopsy. In the exercise group, the mRNA of tenascin-C was
significantly lower after Bout 2 compared to Bout 1, indicating that there is an adaptation
to the initial exercise bout that attenuates the response to a subsequent bout (i.e. a
“repeated bout effect”). Although we were not sufficiently powered to determine if there
was a sex effect for MMP9 and COL3, our data suggest that there is a difference in gene
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expression between men and women for these two genes. Because the animal literature
suggests that an increased expression of integrin α7 plays a role in protecting the muscle
from damage (4), our finding of an increase in integrin α7 gene expression after eccentric
exercise suggests that integrin α7 may perform a similar role in human skeletal muscle.
The observation of three isoforms of integrin α7 being expressed differently (e.g. some
exercise and control subjects expressed all three isoforms and some subjects expressed
only two) were unexpected and these data suggest that even at baseline there was a
difference within the exercise and control subjects. Because there was no change in the
number of isoforms an individual expressed between bouts/MBs, it is possible that
integrin α7 isoform expression was related to previous adaptations the skeletal muscle
had made before this exercise insult. Understanding the role of the different isoforms in
human skeletal muscle may provide information on how skeletal muscle adapts to
strenuous exercise. Since integrins play an important role in signal transduction, it is
possible that the different isoforms initiate a different adaptation processes via their
interactions with laminins and potential downstream effectors (e.g. phosphorylation of
FAK and AKT). Based on our findings, we suggest that future studies should focus on
the integrins, understanding the relationship between integrin isoform expression and
exercise intensity, and their interaction with signal transduction molecules (e.g. laminins,
AKT, FAK). This information may help identify why individuals adapt differently to
eccentric exercise. It is possible that these integrin isoforms are involved in the repeated
bout effect. By examining the effects of exercise intensity on integrin α7 expression, we
may be able to create better exercise programs that allow individuals to adapt to exercise
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without the dramatic loss in muscle strength or elevation in DOMS that occurs after
performing an exercise involving eccentric actions.
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CHAPTER 5
PRELIMINARY INVESTIGATION OF MUSCLE SORENESS
USING A SYSTEMS BIOLOGY APPROACH (Study 3)
Introduction
Skeletal muscle soreness is a common consequence following exercise if an
individual is naïve to the activity or if the activity is strenuous. Eccentric, or lengthening,
contractions are likely to result in muscle soreness due to the high forces associated with
this type of exercise (9,39). While ultrastructural damage to muscle can be evident during
or immediately following exercise (16,41,47), muscle soreness typically appears after a
delay, peaking in the hours to days following exercise (9,17,26). Though most cases of
delayed onset muscle soreness (DOMS) resolve on their own, muscle soreness can be
clinically relevant when it presents in diseases of muscle (34), diseases of connective
tissue (22), and as a side effect of one of the most widely prescribed medications—statins
for high cholesterol (13,21,37,43,50,54).
Since the initial reporting of the phenomenon of DOMS after exercise by Hough
et al. (26), researchers have attempted to understand its origins and to test potential
treatments. At present, researchers have not been able to explicitly state why muscle
soreness lags behind the structural damage and the strength loss evident immediately
after eccentric exercise (5,9,11,17,35). Proposed mechanisms have included changes in
biochemical signaling (45,46,51), mechanical disruption (11,18,19,32,39,47,55), and
increased neural sensitivity (14,25). These potential mechanisms likely work in concert
with other exercise-induced changes within muscle to produce the complex phenomenon
of DOMS, which is also known to be widely variable across individual responses (28,29).
To better target potential therapies, we sought to better understand the molecular profile
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of skeletal muscle as it relates to the degree of muscle soreness experienced by
individuals following a standardized eccentric exercise protocol.
Gene expression profiling has previously been used to study the molecular events
taking place in skeletal muscle after eccentric exercise-induced muscle damage
(5,20,33,44,53). Using microarray technology to better understand the biological
processes after eccentric contractions has illuminated the up-regulation of novel
inflammatory targets in skeletal muscle (6,31), down-regulation of muscle degrading
enzymes (33,53), and up-regulation of unique repair and remodeling molecules/enzymes
(33,35), demonstrating an organized effort from the muscle to respond to the damaging
event and repair itself. However, to date, these molecular profiles have not been used to
study changes as they specifically relate to the severity of muscle soreness.
Muscle soreness typically peaks 24–48 h post-eccentric contractions; however,
the peak of muscle soreness has been shown to be variable among individuals even when
controlling for the type of exercise performed (e.g. downhill running vs. eccentric
resistance exercise) (10). Individuals who “respond” to eccentric contractions with
greater strength loss, greater soreness, and/or higher creatine kinase CK levels have been
reported to be high-responders: These individuals were greater than two standard
deviations above the mean (8). To identify novel molecular processes related to the
magnitude of exercise-induced DOMS, we re-examined gene expression data from our
previous study (31): (35 males with paired exercised and control muscle biopsy samples
following standardized exercise) using an unbiased clustering technique to select high
and low outliers for peak soreness evoked by the exercise. We compared gene expression
changes in the high-responders to those in the low-responder group and also correlated
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changes in gene expression to the amount of peak muscle soreness experienced by each
subject. We then created a table containing the most robustly up-regulated and downregulated genes (p >0.01), their location, their molecular processes, and their correlation
with peak muscle soreness so that we could identify molecular targets for future research
in muscle soreness studies.
The overall goal of the study was to identify novel genes and their resultant
protein products associated with peak DOMS. I hypothesized that the high-soreness
individuals would have different genes up- and down-regulated compared to the lowsoreness individuals. Specifically, I hypothesized that the up-regulated genes in the high
high-soreness group would be primarily located in muscle resident cells and involved in
muscle growth and adaptation processes (e.g. collagens,matrix metalloproteinases) and
that the down-regulated genes would be primarily located within the muscle cell,
specifically the nucleus, and involved in transcription and translational processes
associated with inflammation.
Materials and Methods
Approach
We re-analyzed mRNA microarray data from a previous study (Hyldahl et al.
(31); N=35; damage evoked by eccentric contractions on an isokinetic dynamometer;
biopsy at 3 h post-exercise) with a new focus; instead of looking at differential gene
expression after eccentric exercise, we examined differential gene expression between
subjects who developed high levels of muscle soreness compared to low levels of muscle
soreness after eccentric exercise. Subjects were clustered into the soreness groups using a
hierarchical cluster analysis program with a Euclidean distance similarity metric. We
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consider this a preliminary investigation because we were only able to identify target
genes and pathways that are related to muscle soreness variability following a
standardized exercise since the protein products would not be up-regulated at the time
point (3 h post-exercise) used by Hyldahl et al. (31).
All subjects had signed a written informed consent document approved by the
University of Massachusetts Amherst Institutional Review Board. All study procedures
conformed to the standards outlined in the Declaration of Helsinki. All subjects had no
prior history of musculoskeletal injury of the lower extremity and were willing to refrain
from participating in new physical activities or taking oral or topical analgesics for the
duration of the study. Excluded were those who had been involved in a strength-training
program in the past 6 mo or routinely lifted heavy objects or engaged in activity with a
heavy eccentric component.
Exercise
Hyldahl et al. (31) examined the biological processes of skeletal muscle damage 3
h after eccentric exercise by microarray to identify differentially expressed genes.
Detailed methods have been previously published. Briefly, subjects performed a single
leg extension eccentric exercise at 30°/sec that consisted of 10 sets of 10 repetitions using
the Biodex System 4 dynamometer (Biodex Medical Systems, Shirley, NY, USA).
Subjects were instructed to “kick” throughout the ~75° of motion and were given a 1-sec
rest between repetitions and a 1-min rest between sets. (31) Biopsies were performed at 3
h post-exercise.
Muscle Soreness
Detailed methods have been previously published (31). Briefly, the subjects were
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asked to perform the task described below using the leg that was eccentrically exercised
and then record their soreness using a visual analog scale (VAS). The VAS is a 100 mm
horizontal line where one end of the line (0 mm) indicates no soreness and the other end
(100 mm) indicates severe soreness (great pain and difficulty while completing the task).
For the VAS muscle soreness task, subjects performed two stand-to-sit (STS-VAS)
motions using only a single leg (the leg eccentrically exercised). After the task, subjects
were then asked to record the peak soreness of their quadriceps muscle by placing a
vertical line on the VAS. Muscle soreness was measured before the exercise and at 24 h
increments post-exercise up to 120 h post-exercise using the above protocol.
Muscle Strength
Detailed methods have been previously published. In brief, following the preexercise soreness evaluations, the subjects performed a baseline maximal isometric
strength test. They sat on the Biodex machine (Biodex System 4 Pro, Biodex Medical
Systems, Shirley, NY), with their legs relaxed and the knee flexed in a 90o angle. The
chair, back support, and lever arm of the Biodex were positioned so that the axis of
rotation of the Biodex lever arm was in line with the lateral condyle of the femur. The leg
was then secured in the knee attachment with the foot in a flexed position. Knee
extension range of motion (ROM) was set from the knee in a flexed position at 90o until
the knee was extended to 0o of knee flexion. For the maximal isometric test, the Biodex
lever arm moved the leg to a 70° position and subjects were asked to first maximally
extend their leg for 3 sec and then maximally flex their leg for 3 sec; they repeated this
action three times for one set. The isometric strength test was repeated until three trials
were within 10% of each other. A 1-min rest was given after each maximal isometric set.
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A pre-exercise and post-exercise maximal isometric strength test was performed in the
same manner as described above after each eccentric exercise protocol.
Muscle Biopsy Procedure
A licensed physician performed the needle biopsy procedure on the vastus
lateralis under local anesthesia using a Bergstrom needle with suction. A small incision
(about 0.5–2.0 cm) was made into the skin and fascia of the vastus lateralis. The
Bergstrom 5-6 mm biopsy needle was then inserted into the muscle, and suction was used
to obtain a small "plug" of tissue when the needle was removed from the muscle.
Approximately 150–200 mg of muscle tissue was collected from each subject and, after
rinsing the muscle sample with sterile saline solution to remove excess blood, the
samples were flash frozen in liquid nitrogen. The muscle biopsy samples were stored at 80°C until analysis.
Hyldahl et al. (31) collected muscle biopsy samples for the microarray analysis
from the eccentric exercised leg and control leg (non-eccentric exercised) at 3 h postexercise from 35 healthy male subjects aged 18–30 y. The subjects arrived fasted on the
day of the biopsy visit. At 4 h prior to the muscle biopsy they were given a standardized
snack. They were not allowed to eat after this snack until the biopsy was completed. The
caloric content of the standardized snack was 400 calories, (approximately
55% carbohydrate, 30% fat, and 15% protein (equivalent to about two cereal bars, one
box of juice, and one box of 2% milk).
Total RNA Isolation and Microarray Hybridization
Detailed methods have been previously published. In brief, Hyldahl et al. (31)
extracted total RNA from skeletal muscle samples of 35 subjects using the standard
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TRIzol (Invitrogen, Carlsbad, CA, USA) method. Of the 35 subjects, only 30 subjects
had viable RNA for cDNA synthesis. Double-stranded cDNA was created using the
Ovation Pico WTA system (NuGEN, San Carlos, CA, USA) according to the
manufacturer’s instructions. Cy3 labeling and hybridization onto an Agilent Whole
Genome Microarray (Agilent, Santa Clara, CA, USA) were done at Gene Logic
(Gaithersburg, MD, USA) according to the manufacturer’s specifications.
Data Analysis
Subject demographics for the two soreness groups were analyzed for differences
between the groups using a Student’s t-test for age, height, weight, and baseline isometric
strength. The pre- and post-exercise measures of muscle soreness and maximal isometric
strength for both groups were analyzed using an ANOVA repeated measures analysis.
Peak skeletal muscle soreness values from Hyldahl et al. (31) (peak values
occurred 24–48 h post-exercise) were clustered using hierarchical cluster analysis
(Cluster 3.0, Stanford University and Human Genome Center, University of Tokyo), with
a Euclidean distance similarity metric. The results of the clustering method described
above were viewed in Java Tree. The high-soreness group (HSG) and the low-soreness
group (LSG) were selected visually from the clusters identified in Java Tree View. The
hierarchical clustering program uses a Euclidean distance similarity metric to put the
soreness data into clusters based on the distance between each data point. To visually
represent the process, data would be arranged along a ruler and the cluster at the upper
end would comprise the HSG with the cluster at the opposite end representing the LSG.
The microarray data from Hyldahl et al. (31) were log transformed and then each
subject’s exercise leg was normalized to the sample from their control leg. An ANOVA
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(p <0.05) was performed on the microarray data between the HSG and LSG using Partek
Genomics Suite software (Partek, Inc, Version 6.4). The outputs were then filtered on pvalue (p <0.01) for fold change between the high soreness and low soreness individuals
prior to examining the Pearson product moment correlations of these genes. Only the
corrected p-values for the Pearson correlations are shown in Table 5.1 and Table 5.2.
Detailed baseline results have been previously published. In brief, there were 35
males (mean ± SEM) (20.9 ± 0.5 yr, 178.9 ± 1.2 cm, and 80.6 ± 2.9 kg) and their
baseline isometric strength was 237.422 ± 9.74 N-m. The HSG cluster had five males
(20.3 ± 0.3 yr, 177.1 ± 2.7 cm, and 88.8 ± 9.5 cm) and the LSG cluster had seven males
(22.6 ± 1.7 yr, 185.8 ± 4.3 cm, and 91.5 ± 8.5 cm). There was no significant difference
among the baseline measures for age (p=0.268), height (p=0.096), or weight (p=0.846)
between the HSG and LSG. There was no significant difference (p=0.509) between
baseline isometric strength of the HSG (246.5 ± 21.9 N⋅m) and LSG (219.9 ± 28.5 N⋅m).
Cluster Analysis
The results of Java Tree View from the hierarchical cluster analysis (Cluster 3.0)
with a Euclidean distance similarity metric are shown in Figure 5.1. The cluster analysis
identified the uppermost cluster (i.e. top cluster) in Figure 5.1, which contained five
individuals from Hyldahl et al. (31) with a soreness level >63mm. The lowermost levelone cluster (i.e. bottom cluster) in Figure 5.1 contained seven individuals from Hyldahl et
al. (31) with a soreness level less than 21 mm. Based on the hierarchical cluster analysis,
the HSG had a peak soreness cutoff level of ≥63 mm on the VAS and the LSG had peak
soreness cutoff level of ≤21 mm. Overall, the HSG had a soreness level of 66.94 mm ±
2.89 mm (mean ± SEM) and the LSG had a soreness level of 14.43 mm ± 1.35mm. The
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cluster levels identified by the cluster analysis were used to create the histogram bins
shown by Figure 5.2 for demonstrating the variability of peak muscle soreness values.

Figure 5.1: Hierarchical cluster analysis of soreness from Hyldahl et al., 2011.
Individuals with peak VAS soreness levels >63 mm were clustered in the high-soreness
group (HSG) and individuals with peak VAS soreness levels <21 mm were clustered into
the low-soreness group (LSG).
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Figure 5.2: Histogram of peak muscle soreness VAS showing the bins used in the
hierarchical cluster analysis to generate the HSG and LSG.

Indirect Markers of Muscle Damage
Skeletal muscle soreness and isometric strength loss were both significantly
affected after the eccentric exercises performed by Hyldahl et al. (31), shown in Figure
5.3.A (muscle soreness) and 5.3.B (isometric strength). At 24–96 h post-exercise,
Hyldahl et al. (31) found a significantly (p <0.05) elevated muscle soreness level
compared to before the exercise. Skeletal muscle isometric strength was significantly
reduced after eccentric exercise.
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Figure 5.3: Functional indicators of muscle damage from Hyldahl et al., 2011. A)
Delayed onset muscle soreness in Hyldahl et al. and HSG and LSG after eccentric
exercise. B) Maximal isometric strength 70° in Hyldahl et al. and HSG and LSG before
and after eccentric exercise. Values are mean ± sem. *p >0.05 for effects of time. τ p
>0.05 for effects of group (HSG vs. LSG).
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Microarray Analysis
Microarray analysis identified 41,000 genes that were differentially regulated
after eccentric exercise compared to the control leg in Hyldahl et al. (31) at p <0.05.
When we examined the ratio of these “eccentric exercise genes” in individuals with high
soreness compared to those with low soreness we were able to identify 1517 genes that
were differentially regulated at p <0.05. To examine correlations between the
differentially regulated genes we used a more stringent p <0.01, which yielded 546 genes
differentially regulated between individuals with high vs. low soreness after eccentric
exercise. Of the 546 genes, 409 were up-regulated while 137 were down-regulated. The
top 100 up-regulated and down-regulated genes at p <0.01 are shown in Tables 5.1 and
5.2, respectively (located at the end of the chapter).
Of the top 100 up-regulated genes, 67 were found using the Gene Ontology
Database (GEO) to have known biological location(s) and function(s) and 33 were
classified as unknown genes (Table 5.1). Of these 67 known genes, 16 were located in the
nucleus, 22 were cytosolic (cytosol, cytoskeleton, and cytosolic membranes), and 25
were associated with the plasma membrane (e.g. extracellular region, apical,
intermembrane, and internal side of the membrane), and four were located in the
extracellular region. The top up-regulated gene was serine protease kazal type 1 (SPINK)
located in the extracellular region and was increased 18.68-fold between the highsoreness and low-soreness individuals. SPINK1 had a correlation of 0.643 (p=0.001) with
peak muscle soreness, as shown in Figure 5.4. However, the strongest significant
correlation (p <0.0001) was short statue homeobox 2 (SHOX2), which had a moderate
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positive correlation (r=0.694) with peak muscle soreness and was increased 3.85-fold in
high-soreness compared to the low-soreness individuals (Appendix G).

Figure 5.4: SPINK1 microarray mRNA fold-change correlation with muscle soreness of
Hyldahl et al., 2011. mRNA expression was correlated to muscle soreness using the
entire cohort.
Of the top 100 down-regulated genes, 62 were found, using GEO, to have known
biological location(s) and function(s) and 38 were classified as unknown genes (Table
5.2). Of these 62 known genes, 17 were located in the nucleus, 28 were cytosolic
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(cytosol, cytoskeleton, endoplasmic reticulum, and mitochondrion), 13 were associated
with the plasma membrane (e.g. extracellular region, apical, intermembrane, and internal
side of the membrane), and four were located in the extracellular region. The top downregulated gene was zinc finger protein 621 (ZNF621) located in the nucleus, and was
decreased 4.75-fold between the high-soreness and low-soreness individuals. ZNF621
had a moderate negative correlation of r= -0.39 (p=0.03). Of the down-regulated genes
the strongest significant correlation (p=0.02) was ENST00000378624, also known as
Threonylcarbamoyladenosine tRNA methylthiotransferase (CDKAL1), which had a
moderate negative correlation (r= -0.42) with peak muscle soreness and was decreased
2.05-fold between the high-soreness and low-soreness individuals.
These microarray results indicate that muscle soreness after eccentric exercise
involves a greater number of up-regulated (409) genes than down-regulated (137). There
was also a greater fold change in the up-regulated genes (e.g. SPINK1 was up-regulated
18-fold) compared to down-regulation (e.g. ZNF621 was down-regulated by 4.75-fold).
The top 10 up-regulated genes were all up-regulated by at least 4.2-fold.
Discussion
The origins of DOMS after eccentric exercise have eluded researchers since 1908
(27), as evident by the inconclusive results when investigating the proposed mechanisms
underlying DOMS (3,7,12,15,23,24,30,38,52). It is likely that the development of DOMS
after eccentric exercise is multifactorial, which may explain why previous studies have
not resulted in an evidence-based treatment for DOMS. In studies using eccentric
exercise as a model to examine muscle damage, researchers have reported an overall
greater up-regulation of genes compared to down-regulated genes when assessed using
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microarray analysis (6,33), and the present examination clustering subjects by soreness
level after eccentric exercise found a similar response. Of the 546 genes with significant
changes, more than 70% (409 genes) were up-regulated. The up-regulated genes are
involved in the events of lipid and cholesterol synthesis (35), protein synthesis (33),
cellular growth (33), inflammation (6,35), and muscle repair (2,35). These changes in
gene regulation are consistent with remodeling of skeletal muscle to better enable it to
withstand the strain of high-force eccentric exercise.
In addition to discovering which genes differentially regulated in the presence or
absence of high soreness, we also identified biological functions and networks using
Ingenuity Pathway Analysis (IPA; Appendix H). The top biological functions identified
by IPA contained molecules (either genes or proteins) that are involved in the events of
protein synthesis and cellular growth. In addition to the top biological functions being
involved in synthesis and growth, the top two networks (score of 51 and 41) identified
molecules involved in development, metabolism, and tissue morphology. Networks
identify the strongest interrelationships between the molecules that were altered
according to the microarray and the current literature. However, the networks also
include molecules that were not altered that may be relevant based on the relationships
identified by previous researchers. The high-scoring network (>50) identified molecules
involved in carbohydrate metabolism, tissue morphology, and cardiovascular tissue
development and function in the high-soreness responders. Of these, the molecules
involved in cardiovascular tissue development seem unusual because our analysis was
done in skeletal muscle. But because IPA network creations are based on previous
research and the great majority of prior work in this area has been done in heart tissue, it
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is not surprising that the top network identified by IPA has been more frequently
observed in cardiovascular tissue. Further, many of the molecules in the top network are
involved in both cardiac and skeletal muscle tissue development and function (e.g.
vascular endothelial growth factor [VEGF], endothelial growth factor [EGF], and
Vitamin D receptor [VDR]).
Previous studies on exercise-induced muscle damage (1,4,11,40,49) have
proposed that muscle soreness after eccentric exercise was due to mechanical damage in
the muscle and connective tissue after eccentric exercise. The biological functions and
networks we identified with IPA suggest that muscle soreness may be related to
molecules involved in metabolism, development, and tissue morphology. It is possible
that the networks we identified are in response to damage of the muscle and connective
tissue and that muscle soreness is a side effect of the remodeling and repair process.
Unlike previous microarray studies, the larger sample size of the present study
(n=30) allowed us to perform correlations between muscle soreness (one functional
indicator of muscle damage) and the differentially regulated genes from a microarray
analysis. Despite finding that the up-regulated genes had more significant correlations
and a greater number of genes with significant correlations compared to the downregulated genes, these up-regulated genes were not more commonly found in one
pathway compared to another (e.g. the inflammation pathway contained both up- and
down-regulated genes). The variability in muscle soreness among individuals after
eccentric exercise suggested that the gene and protein expression involved in muscle
soreness may also differ. Because previous investigations of muscle soreness after
eccentric exercise have focused on a single cellular event (46) (e.g. elevation of cellular
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Ca2+) or biochemical signaling (45,46,51), mechanical disruption (11,18,19,32,39,47,55),
or increased neural sensitivity (14,25) we had expected to find that the high-soreness
individuals would have a greater elevation of genes involved in one of these processes
compared to the low-soreness individuals. Our use of microarray analysis to examine two
disparate groups of muscle soreness provided us an unbiased examination of genes
involved in the potential events and pathways that other researchers previously examined.
However, we were unable to identify a leading cellular event or pathway that contributed
to the variability in muscle soreness. Based on prior literature, including differential
responses in men and women (48), inflammatory processes were a likely candidate to
play an important role in muscle soreness, and we expected that molecules involved in
the acute inflammation pathway would be elevated in the HSG. Instead, our results
suggest that DOMS after eccentric exercise is not simply due to one molecule or cellular
function/pathway (e.g. inflammation), but likely multiple overlapping pathways and
events as shown by the biological functions and networks we found using IPA. We did
identify the gene SPINK1 to be significantly up-regulated in the high-soreness
individuals compared to the low-soreness individuals. SPINK1 is a protease inhibitor that
has mitogenic capabilities in fibroblasts (42) and endothelial cells (36) and is involved in
a cell migration process, epithelial restitution, wherein healthy cells from the border of
the injury migrate to the damaged site. These biological functions—mitogenesis and
restitution of SPINK—may play an important role in repairing skeletal muscle after
eccentric exercise damage, and in the processes of repairing the muscle, SPINK1 may
contribute to muscle soreness. Unfortunately however, we did not have enough tissue to
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confirm this up-regulation and further examine the role, if any, of SPINK1 in muscle
soreness.
In conclusion, understanding the role muscle soreness plays in the muscle
remodeling and repair process may provide further clues to the variability in muscle
soreness among individuals who perform eccentric exercise. Unpublished data in our lab
has shown that low-soreness individuals (n=13) compared to high-soreness individuals
(n=13) had less of a loss in isometric strength after a single and repeated bout of exercise.
However, after the repeated bout of exercise, isometric strength in the high-soreness
individuals did not return to baseline strength unlike the low-soreness individuals. These
unpublished results along with the present study suggest that up-regulation of genes
involved in mediating tissue repair (e.g. SPINK1, C7, DLL1, SPINT2, and AGER) in the
high-soreness individuals results in a repair and remodeling process that ensures
adaptation to the strenuous exercise. It is possible that the variability of muscle soreness
after eccentric exercise is a consequence of the variability in the repair and adaptation of
skeletal muscle after eccentric exercise. This variability in remodeling and repair may
have functional consequences in mediating the return of strength loss in high-soreness
individuals compared to low-soreness individuals (unpublished data).
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Table 5.1. Fold differences and correlations of statistically significant (p >0.01) normalized gene expression of the top
100 up-regulated probe sets between the high-soreness and low-soreness individuals. Continued onto next few pages.

Gene Symbol

Probeset ID

Full Name

Biological and Molecular Processes

FoldChange
(FC)

p-value
(FC)

Correlation ( r )

p-value
(r)

18.68

0.0017

0.643

0.0001

3.07

0.0000

0.284

0.1217

2.63

0.0000

0.237

0.2002

2.67

0.0004

0.370

0.0407

2.63

0.0024

0.386

0.0321

4.27

0.0000

0.349

0.0540

Extracellular Region

SPINK1

A_23_P214079

Serine protease
inhibitor Kazal type1

C7

A_32_P384246

Complement
component C7

DLL1

A_23_P167920

Delta-like protein 1

SPINT2

A_23_P27795

Kunitz-type protease
inhibitor 2

Negative regulator of: Ca import, NO
mediated signaling, Serine
endopeptidase activity,Mitogenesis,
Cell migration
Complement activation, Cytolysis,
Innate immune response, Regulation
of complement activation
Cell differentiation, Cell-cell
signaling, Notch signaling pathway,
Positive regulation of transcription
from RNA polymerase II promoter,
Calcium ion binding, Notch binding,
Protein binding
Serine-type endopeptidase inhibitor
activity, Cellular component
movement, Negative regulation of
endopeptidase activity

Prominin-1
Trem-like transcript
2 protein

Actinin binding, Cadherin binding,
Protein binding
T-cell activation, protein binding,
receptor activity

Apical Plasma Membrane
PROM1

A_23_P258463

TREML2

A_23_P7932

THBD

AGER

A_23_P91390

Thrombomodulin

A_23_P93360

Advanced
glycosylation end
product-specific
receptor

SELP
A_23_P137697
Plasma Membrane

P-selectin

RRAD

A_23_P88849

GTP-binding protein
RAD

RAP1B

A_23_P2661

Ras-related protein
Rap-1b

Transmembrane signaling receptor
activity, Protein binding,
Carbohydrate binding, Calcium ion
binding, Leukocyte migration,
Negative regulation of blood
coagulation, Negative regulation of
fibrinolysis, Negative regulation of
platelet activation, Blood coagulation,
Embryo development, Female
pregnancy
Protein binding, Receptor activity,
Transmembrane signaling, Response
to wounding, Positive regulation of
NF-kappa B transcription factor
activity, Innate immune response,
Inflammatory response, Cell surface
receptor signaling pathway, Induction
of positive chemotaxis
Cell adhesion, Carbohydrate binding,
Inflammatory response, Leukocyte
cell-cell adhesion, Leukocyte
migration, Regulation of integrin
activation, Positive regulation of
platelet activation, PI3K signaling,
Protein binding, Lipopolysaccharide
binding, Glycosphingolipid binding
Signal transduction, GTP binding,
GTPase activity, Small GTPase
mediated signal transduction
GTP binding, GTPase activity, Small
GTPase mediated signal transduction,
Cell proliferation
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3.36

0.0022

0.520

0.0027

2.43

0.0041

0.354

0.0504

2.42

0.0000

0.370

0.0404

2.66

0.0097

0.360

0.0465

2.22

0.0000

0.350

0.0539

LRP8

A_23_P200222

SLC4A4

A_32_P358887

Low-density
lipoprotein receptorrelated protein 8
Electrogenic sodium
bicarbonate
cotransporter 1

MPP3

A_23_P141346

MAGUK p55
subfamily member 3

CACNA2D
2

A_23_P346900

Voltage-dependent
calcium channel
subunit alpha2/delta-2

SEMA4C

A_23_P114057

Semaphorin-4C

Integral to Membrane, Ca ion binding,
transmembrane signaling,
apolipoprotein binding, very low
density lipoprotein particle receptor
activity, Cytokine mediated signaling
pathway
Integral to plasma membrane,
Bicarbonate transport, Ion transport,
protein binding
Signal transduction, PDZ domain
binding, guanylate kinase activity
Energy reserve metabolic process,
Muscle fiber development,
Neuromuscular junction development,
Regulation of insulin secretion, Metal
ion binding, Voltage-gated calcium
channel activity
Semaphorin-plexin signaling pathway,
Cerebellum development, Receptor
activity

7.91

0.0010

0.532

0.0020

6.18

0.0008

0.570

0.0008

4.15

0.0091

0.388

0.0310

2.52

0.0087

0.365

0.0433

2.45

0.0036

0.357

0.0487

2.21

0.0038

0.229

0.2154

4.26

0.0088

0.508

0.0035

Integral component of membrane

PXK

A_32_P115606

PX domaincontaining protein
kinase-like protein

SLC45A3

A_24_P208345

Solute carrier family
45 member 3

Phosphatidylinositol binding, ATP
binding, Cell communication, Protein
kinase activity,
Integral to plasma membrane,
Bicarbonate transport, Ion transport,
protein binding
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A_23_P2640

C-type lectin
domain family 7
member A

BTN2A2

A_24_P337592

Butyrophilin
subfamily 2 member
A2

GRIK4

A_23_P116249

Glutamate receptor
ionotropic, kainate 4

ADCY3

A_23_P67864

Adenylate cyclase
type 3

PLXNA1

A_23_P57667

Plexin-A1

GALNAC4
S-6ST

A_23_P383986

Carbohydrate
sulfotransferase 15

CLEC7A

Carbohydrate mediated signaling, Cell
recognition, Cell-cell adhesion,
Inflammatory response, Innate
immune response, Leukocyte
activation, Positive regulation of
phagocytosis, T-cell activation,
Carbohydrate binding, Metal ion
binding, MHC protein binding
Negative regulation of activated T cell
proliferation, Negative regulation of
cellular metabolic process, Negative
regulation of cytokine secretion
Glutamate receptor signaling pathway,
Extracellular-glutamate-gated ion
channel activity, Synaptic
transmission
Intracellular signal transduction,
Integral component of membrane,
Nucleotide binding, Phosphorusoxygen lyase activity, Transmembrane
transport, Synaptic transmission,
Synaptic transmission,
Semaphorin receptor activity,
Multicellular organismal development
Small molecule metabolic process,
Chondroitin sulfate biosynthetic
process, Hexone biosynthetic process,
N-acetylgalactosamine 4-sulfate 6-Osulfotransferase activity, 3'phosphoadenosine 5'-phosphosulfate
binding
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2.46

0.0000

0.226

0.2211

2.58

0.0098

0.418

0.0194

2.56

0.0000

0.264

0.1517

2.52

0.0035

0.326

0.0738

2.51

0.0075

0.468

0.0079

3.15

0.0002

0.392

0.0294

Cytosolic: Plasma Membranes
CD44

A_23_P24870

CD44 antigen

RAB43

A_32_P86318

SAMD9

A_23_P355244

MAP1LC3C

A_24_P216456

Ras-related protein
Rab-43
Sterile alpha motif
domain-containing
protein 9
Microtubuleassociated proteins
1A/1B light chain
3C

BBS1

A_23_P150267

Bardet-Biedl
syndrome 1 protein

HLCS

A_23_P304991

Biotin-[methylmalonylCoAcarboxytransferase]
ligase

TBC1D24

A_23_P391637

TBC1 domain
family member 24

KLHL21

A_23_P341223

C14orf140

A_23_P99785

Kelch-like protein
21
Zinc finger C2HC
domain-containing
protein 1C

RBBP9

A_23_P257538

Putative hydrolase

Cell adhesion, Hyaluronic acid
binding, Wnt signaling pathway,
Positive regulation of gene expression

2.80

0.0078

0.532

0.0021

GTP binding, Small GPTase mediated
signal transduction, Protein transport

2.46

0.0000

0.364

0.0444

Protein binding

3.03

0.0055

0.228

0.2168

Autophagy, Protein binding
Protein binding, Patched binding,
Photoreceptor cell maintenance,
Response to stimulus, Cilium
assembly,

3.51

0.0067

0.459

0.0095

3.29

0.0055

0.448

0.0114

2.54

0.0000

0.152

0.4140

3.56

0.0000

0.521

0.0027

2.67

0.0076

0.372

0.0392

Metal ion binding

2.25

0.0065

0.507

0.0036

Hydrolase activity, Regulation of cell

2.60

0.0072

0.366

0.0432

Cytosolic
Response to biotin, Protein
homodimerization activity, Cell
proliferation, ATP binding, Biotinprotein ligase activity, Histone
modification, Small molecule
metabolic process,
Neuron projection development,
Protein binding, Rab GTPase activator
activity
Mitosis, Protein ubiquination,
Ubiquitin protein ligase activity,
Regulation of cytokinesis
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RBBP9

ENST00000
227451

A_24_P158718

PPAT

A_23_P80940

SPAG1

A_23_P146066

E3 ubiquitin-protein
ligase DTX4

NUDT11

A_23_P62387

Amidophosphoribos
yltransferase
Sperm-associated
antigen 1
Diphosphoinositol
polyphosphate
phosphohydrolase 3beta

NEFH

A_23_P300600

Neurofilament
heavy polypeptide

GM2A

A_23_P144872

Ganglioside GM2
activator

XDH

A_23_P39590

RASGEF1B

A_23_P331186

Xanthine
dehydrogenase/oxid
ase
Ras-GEF domaincontaining family
member 1B

proliferation

1

Innate immune response, Notch
signaling pathway, Positive regulation
of type I interferon production, Protein
ubiquination, Ligase activity, Zinc ion
binding
Metabolic processes, Sulfur cluster
binding, Metal ion binding, Organ
regeneration
GTP binding, Hydrolase activity,
Single fertilization
Small molecule metabolic process,
Metal ion binding, Diphosphatase
activity
Cell death, Cytoskeleton organization,
Peripheral nervous system neuron
axongenesis, Structural molecular
activity
Lipid storage, Sphingolipid processes,
small molecule metabolic processes,
Lactation, Negative regulation of
endothelial cell 177ifferentiation and
proliferation, Negative regulation of
gene expression, Negative regulation
of PKB signaling, Negative regulation
of protein phosphorylation, Position
regulation of p38MAPK cascade,
Small molecule metabolic processes,
Xanthine catabolic processes, Electron
carrier activity, Protein
homodimerization activity, Iron ion
binding
GTPase mediated signal transduction
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2.79

0.0050

0.471

0.0075

2.25

0.0039

0.318

0.0817

8.11

0.0085

0.463

0.0088

4.61

0.0044

0.504

0.0039

2.68

0.0091

0.394

0.0281

5.13

0.0088

0.402

0.0251

3.39

0.0084

0.290

0.1139

3.65

0.0000

0.405

0.0236

C20orf172

A_23_P165937

Kinetochoreassociated protein
DSN1 homolog

NEK3

A_23_P333705

Serine/threonineprotein kinase Nek3

BIRC3

A_23_P98350

Baculoviral IAP
repeat-containing
protein 3

MXD1

A_24_P379750

Max dimerization
protein 1

MT1M

A_23_P66241

Metallothionein

RPS15A
A_32_P175580
Cytosolic: Cytoskeleton

40S ribosomal
protein S15a

Protein binding, Chromosome
segregation, Mitosis
ATP binding, Protein kinase activity,
Protein phosphorylation, Protein
binding, Metal ion binding
Negative Regulation of Apoptotic
processes, Cell surface receptor
signaling pathway, Innate Immune
response, Toll-like receptor signaling
pathway, Negative Regulation of
necrosis, Negative regulation of ROS
metabolic processes, NIK/NF-kappa B
cascade, Regulation of inflammatory
processes, Zinc ion binding,
Ubiquitin-protein ligase activity,
Protein binding
Protein dimerization activity,
Transcription-DNA templated, Cell
proliferation, DNA binding,
Transcription cofactor activity
Metal ion binding, Negative
regulation of growth
Translation, Cellular protein metabolic
process, mRNA metabolic process,
Positive regulation of cell
proliferation, RNA metabolic process,
RNA binding
Actin binding, zinc ion binding,
Oxidation reduction processes,
Oxidoreductase activity

5.77

0.0074

0.349

0.0545

Defense response to fungus, Actin
binding, Enzyme binding

2.92

0.0000

0.442

0.0127

MICAL2

A_23_P13442

Protein-methionine
sulfoxide oxidase

COTL1

A_23_P3866

Coactosin-like
protein 1
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3.28

0.0038

0.326

0.0734

2.99

0.0059

0.286

0.1182

3.69

0.0045

0.536

0.0019

2.54

0.0084

0.463

0.0087

2.99

0.0044

0.299

0.1027

2.41

0.0067

0.340

0.0611

COTL1

A_32_P158385

Coactosin-like
protein 1

Defense response to fungus, Actin
binding, Enzyme binding

2.89

0.0000

0.453

0.0105

DNA binding, Transcription
regulation, Organ system development

3.85

0.0010

0.694

0.0000

3.26

0.0087

0.376

0.0371

3.12

0.0062

0.298

0.1033

2.50

0.0061

0.368

0.0419

2.49

0.0024

0.380

0.0349

2.23

0.0000

0.424

0.0175

2.29

0.0045

0.443

0.0126

2.79

0.0013

0.426

0.0168

3.67

0.0002

0.241

0.1924

3.29

0.0000

0.234

0.2051

Nucleus
SHOX2

A_23_P124384

C11orf17

A_23_P52161

ZNF682

A_24_P944588

Short stature
homeobox protein 2
A-kinase-interacting
protein 1
Zinc finger protein
682

DENND4A

A_23_P420092

C-myc promoterbinding protein

MAFB

A_23_P17345

PCGF5

A_24_P880043

TRIB1

A_24_P252497

Z21967

A_24_P876352

XPO5

A_23_P256855

NFE2

A_23_P13753

Transcription factor
MafB
Polycomb group
RING finger protein
5

Tribbles homolog 1
POU domain, class
6, transcription
factor 1
Exportin-5
Transcription factor
NF-E2 45 kDa
subunit

Protein binding
Regulation of transcription, Nucleic
acid binding
Regulation of transcription, Rab
guanyl-nucleotide exchange factor
activity, DNA binding
Protein binding, Sequence-specific
DNA binding, Transcription factor
activity
Protein binding, DNA-templated
transcription
ATP binding, Protein kinase activity,
Transcription factor binding,
Ubiquitin protein ligase binding, JNK
cascade, Mitogen-activated protein
kinase binding
Organ development, Sequencespecific DNA binding, Transcription
factor activity
Protein transporter, tRNA binding,
Protein binding
Cell-cell signaling, Negative
regulation of bone mineralization,
Sequence-specific DNA binding

179

A_23_P3237

RNA polymerase II
elongation factor
ELL3

GNL3

A_23_P41025

Guanine nucleotidebinding protein-like
3

PRIM2A

A_24_P282237

DNA primase large
subunit

GEMIN4

A_23_P66867

NEDD4L

A_24_P108311

Gem-associated
protein 4
E3 ubiquitin-protein
ligase

A_24_P296698

Dual specificity
mitogen-activated
protein kinase
kinase 3

ELL3

MAP2K3

Positive regulation of DNA templated
transcription, Transcription from RNA
polymerase II promoter, Enhancer
binding, Negative regulation of
apoptotic process
Regulation of cell proliferation, GTP
binding, GTPase activity, GTP
catabolic processes, Potein binding,
Ribosome biogenesis
DNA replication initiation, DNA
strand elongation, Mitotic cell cycle,
DNA binding, DNA primase activity,
Metal ion binding
RNA metabolic processes, rRNA
processing, Gene expression, Protein
binding

2.56

0.0075

0.380

0.0349

2.88

0.0034

0.442

0.0129

2.45

0.0000

0.383

0.0336

3.51

0.0025

0.376

0.0371

Ubiquitin-dependent ligase activity
Activation of MAPK activity,
Inflammatory response, Innate
immune response, MyD88 dependent
toll-like receptor signaling pathway,
Positive regulation of protein kinase
activity, Positive regulation of
transcription, Signal transduction,
Stress-activated MAPK cascade,
MAPK kinase kinase activity, Protein
binding, Protein kinase activity,

2.58

0.0008

0.403

0.0245

2.77

0.0011

0.403

0.0244

Unknown transcripts
FAM43B
ENST00000
375284

A_32_P125338

-

-

3.06

0.0034

0.417

0.0197

A_24_P106910

-

-

3.04

0.0002

0.511

0.0033

MGC40579

A_23_P258582

-

-

3.03

0.0100

0.226

0.2214

A_24_P933

A_24_P933027

-

-

2.86

0.0071

0.238

0.1973
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027
AL133627

A_32_P114372

-

-

2.69

0.0000

0.251

0.1731

C14orf28

A_24_P33048

-

-

2.68

0.0073

0.043

0.8192

C15orf34

A_23_P37455

-

-

2.63

0.0000

0.284

0.1218

LOC285535
THC231847
4
ENST00000
334827

A_32_P491904

-

-

2.62

0.0043

0.345

0.0573

A_32_P46456

-

-

2.59

0.0018

0.244

0.1865

A_23_P435904

-

-

2.59

0.0077

0.315

0.0845

CXorf38
A_32_P100
475
A_32_P190
864

A_24_P36745

-

-

2.54

0.0088

0.411

0.0216

A_32_P100475

-

-

2.50

0.0000

0.195

0.2923

A_32_P190864

-

-

2.46

0.0089

0.545

0.0015

BC044628

A_32_P117453

-

-

2.42

0.0003

0.492

0.0050

BX101252

A_32_P56463

-

-

2.41

0.0086

0.477

0.0067

AI431972
A_24_P929
279

A_32_P165823

-

-

2.36

0.0034

0.334

0.0662

A_24_P929279

-

-

2.35

0.0031

0.314

0.0856

KBTBD11
THC231913
8

A_23_P94319

-

-

2.34

0.0064

0.314

0.0859

A_32_P27097

-

-

2.23

0.0000

0.194

0.2957

LOC647131
THC234495
6

A_32_P88905

-

-

9.04

0.0020

0.639

0.0001

A_23_P35546

-

-

6.81

0.0011

0.351

0.0525

AK125361
ENST00000
357283

A_24_P245838

-

-

5.92

0.0022

0.446

0.0118

A_24_P186401

-

-

5.48

0.0033

0.583

0.0006

C15orf37

A_32_P85330

-

-

4.63

0.0084

0.506

0.0037

FAM102A

A_23_P112531

-

-

3.53

0.0058

0.347

0.0559

AK022016

A_24_P762767

-

-

3.52

0.0035

0.282

0.1241
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LOC200312
THC234106
0

A_32_P420563

-

-

3.51

0.0000

0.268

0.1450

A_32_P174629

-

-

3.49

0.0077

0.493

0.0049

AA344632
THC231735
3

A_32_P29140

-

-

3.17

0.0065

0.478

0.0065

A_24_P748389

-

-

3.17

0.0065

0.391

0.0295

WDR89

A_24_P301186

-

-

3.12

0.0000

0.328

0.0715

U92817

A_23_P44534

-

-

3.11

0.0025

0.453

0.0105

AK023663

A_32_P83256

-

-

3.10

0.0091

0.502

0.0040

GRRP1

A_23_P46131

-

-

3.10

0.0041

0.423

0.0176
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Table 5.2: Fold differences and correlations of statistically significant (p < 0.01) normalized gene expression of the top 100
down-regulated probe sets between the high-soreness and low-soreness individuals. Continued onto next few pages.

Gene Symbol

Probeset ID

Full Name

Biological and Molecular Processes

FoldChange
(FC)

Erythrocyte differentiation, Vesicle
docking exocytosis,

-2.13

0.01

-0.13

0.50

-2.09

0.01

-0.08

0.67

-3.19

0.01

0.23

0.20

-1.52

0.00

-0.10

0.59

Organ development, Protein
localization, Smoothened signaling
pathway, Protein binding

-2.27

0.00

0.26

0.15

Unknown

-1.52

0.00

0.09

0.61

Unknown

-1.38

0.00

-0.11

0.57

Rab GTPase activator activity

-1.50

0.00

-0.22

0.24

GTPase activator activity

-1.50

0.00

-0.22

0.24

p-value
(FC)

Correlation ( r )

p-value
(r)

Extracellular Region
EXOC6

A_32_P58280

FAM108A1

A_24_P324563

Exocyst complex
component 6
Alpha/beta
hydrolase domaincontaining protein
17A

MLN

A_23_P19523

Promotilin

UCN3

A_23_P136184

Urocortin-3

Hydrolase activity, Protein binding
Cell-cell signaling, G-protein
coupled receptor pathway, Hormone
activity, Receptor binding
Adenylate cyclase-activation GProtein coupled receptor signaling
pathway, Cellular response,
Corticotropin-releasing hormone
receptor 2 binding, Hormone activity

Plasma membrane
BBS7

A_23_P252913

CDRT15

A_24_P756766

C9orf71
ENST00000229
088
ENST00000229
088

A_24_P132633
A_32_P206050
A_32_P206050

Bardet-Biedl
syndrome 7 protein
CMT1A duplicated
region transcript 15
protein-like protein
Transmembrane
protein 252
TBC1 domain
family member 30
TBC1 domain
family member 30
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ITGB8

A_24_P273599

Integrin beta-8

PAPPA

A_23_P216742

PKD1

A_24_P477127

Pappalysin-1
Serine/threonineprotein kinase D1

SEMA3F

A_23_P6878

Semaphorin-3F

SLC6A7

A_23_P343766

SLC26A3

A_23_P123228

TAS2R48

A_23_P340308

TMUB2

A_23_P36647

Sodium-dependent
proline transporter
Solute carrier
family 26, member
3, isoform CRA_a
Taste receptor type
2 member 19
Transmembrane
and ubiquitin-like
domain-containing
protein 2

A_23_P202894

Acrosomal protein
SP-10

Cell adhesion, Cell Matrix Adhesion,
Extracellular matrix organization,
Integrin mediated signaling pathway,
Placenta blood vessel development,
Receptor activity
Cell differentiation, Glucocorticoid
Stimulus, Endopeptidase Activity,
Proteolysis, Zinc ion binding,
Metallopeptidase activity
Carbohydrate binding, Neuropeptide
signaling pathway
Receptor activity, Multicellular
organismal development
Transmembrane transport,
Neurotransmitter: sodium symporter
activity, Proline transport

-1.75

0.00

-0.20

0.27

-2.36

0.00

-0.07

0.70

-1.91

0.00

-0.08

0.68

-1.54

0.00

0.14

0.44

-1.71

0.00

-0.09

0.64

-1.41

0.00

-0.03

0.89

-1.66

0.00

-0.18

0.34

Unknown

-1.43

0.00

-0.12

0.52

Multicellular organismal
development

-1.38

0.00

0.04

0.83

Sulfate transport, Anion antiporter
activity
Sensory perception of taste, Protein
coupled receptor activity

Cytosolic
ACRV1
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CMAH

A_23_P351467

C11orf60

A_23_P116207

C16orf44

A_23_P88802

BAG family
molecular
chaperone
regulator 4
Bardet-Biedl
syndrome 7 protein
Calcium and
integrin-binding
family member 4
Putative cytidine
monophosphate-Nacetylneuraminic
acid hydroxylaselike protein
Intraflagellar
transport protein 46
homolog
Kelch-like protein
36

DDX19B

A_23_P140994

ATP-dependent
RNA helicase
DDX19B

EEF2

A_24_P87763

EXOD1

A_23_P129717

KIAA0652

A_23_P95292

KIAA1967

A_24_P38446

BAG4

A_23_P146217

BBS7

A_23_P252913

CIB4

A_23_P56913

Elongation factor 2
ERI1
exoribonuclease 2
Autophagy-related
protein 13
DBIRD complex
subunit KIAA1967

Cellular response to tumor necrosis
factor, Negative regulation of
apoptotic process, Positive regulation
of fibroblast migration, Positive
regulation of cell adhesion, Positive
regulation of protein kinase B
signaling cascade, Positive regulation
of protein kinase B signaling
cascade, Chaperone binding,
Organ development, Smoothened
Signaling pathway
Calcium ion binding
CMP-N-acetylneuraminate
monooxygenase activity, Iron-sulfur
cluster binding
Intraflagellar transport, Protein
stabilization, Protein C-terminus
binding
Protein ubiquitination
ATP binding, ATP-dependent
helicase, Nucleic acid binding,
Protein transport, mRNA export from
nucleus,
GTP binding, GTPase , Translation
elongation factor activity
Exonuclease activity, Nucleic acid
binding, Zinc ion binding
Autophagic vacuole assembly,
Protein binding, Protein kinase
binding
Apoptotic processes, Enzyme
inhibitor activity
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-2.10

0.00

-0.20

0.28

-2.27

0.00

0.26

0.15

-1.56

0.00

-0.25

0.17

-1.54

0.00

-0.12

0.53

-1.33

0.00

-0.09

0.63

-1.70

0.01

0.36

0.05

-1.54

0.00

-0.04

0.84

-2.01

0.00

-0.18

0.34

-1.96

0.00

-0.36

0.04

-1.54

0.01

-0.22

0.23

-1.40

0.00

0.10

0.58

MKRN3

A_23_P21333

OR5H1

A_24_P366566

PLEKHA7

A_24_P109487

Probable E3
ubiquitin-protein
ligase makorin-3
Olfactory receptor
5H1
Pleckstrin
homology domaincontaining family
A member 7

A_23_P60811

5' AMP-activated
kinase catalyic
subunit alpha-2

PRKAA2

PSMD3

A_24_P289726

RIOK3

A_23_P55578

RUNDC2A

A_24_P150665

ZCCHC14

A_24_P176484

26S proteasome
non-ATPase
regulatory subunit
3
Serine/threonineprotein kinase
RIO3
Sorting nexin-29
Zinc finger CCHC
domain-containing
protein 14

Protein ubiquination, Ligase activity,
Protein binding, Zinc ion binding
G-protein coupled receptor activity,
Olfactory receptor activity

Phospholipid binding, Cell junction
Autophagy, Metabolic processes,
Cellular response to nutrient levels,
Lipid & Cholesterol biosynthesis,
Regulation of glycolysis, Protein
phosphorylation, Signal transduction,
Wnt receptor signaling pathway,
ATP binding, Chromatin binding,
Protein binding, Metal ion binding
Regulation of proteasomal ubiquitindependent catabolic processes,
Regulation of apoptotic processes,
Regulation metabolic processes,
Gene expression, Mitotic cell cycle,
Protein polyubiquitination
ATP binding, Catalytic activity,
Protein binding, Chromosome
segregation
Cell communication,
Phosphatidylinositol binding
Cell communication, Nucleic Acid
binding, Phosphatidylinositol
binding, Zinc ion binding

186

-2.35

0.00

-0.31

0.09

-1.38

0.00

-0.23

0.20

-2.96

0.00

-0.11

0.55

-1.97

0.01

0.13

0.49

-1.52

0.00

-0.15

0.44

-1.41

0.00

0.03

0.88

-2.75

0.00

-0.20

0.29

-2.22

0.00

0.12

0.51

Cytosolic, Cytoskeleton

EVL

A_23_P129038

KIAA1731

A_32_P31256

Ena/VASP-like
protein
Centrosomal
protein KIAA1731

Profilin binding, Organ development,
Cell surface receptor signaling
pathway, Actin filament
organization, Axon guidance,

-1.53

0.00

-0.04

0.83

Unknown

-2.06

0.00

-0.12

0.52

Electron carrier activity, Heme
binding, Iron ion binding,
Monooxygenase activity,
Oxidoreductase activity, Small
molecule metabolic processes,
Metabolic processes, Aromatase
activity, Heme binding, Electron
carrier activity, Iron binding, Oxygen
binding,

-1.53

0.00

0.14

0.44

-2.01

0.00

-0.17

0.37

-2.05

0.00

-0.42

0.02

-2.88

0.00

-0.37

0.04

-1.94

0.00

-0.11

0.56

-1.87

0.00

-0.20

0.28

Endoplasmic reticulum

CYP4A11

A_24_P191013

CYP3A7

A_23_P358917

ENST00000378
624

A_23_P44781

MCFD2

A_24_P103060

Cytochrome P450
4A11
Cytochrome P450
3A7
Threonylcarbamoyl
adenosine tRNA
methylthiotransfera
se
Multiple
coagulation factor
deficiency protein
2

RNA modification, tRNA
processing, Metal ion
binding,transferase activity
Post-translational protein
modification, Protein transport,
Metabolic processes, Calcium ion
binding, Vesicle mediated transport

Mitochondrion

ARS2

A_24_P383080

SARDH

A_24_P35400

Alanine--tRNA
ligase,
mitochondrial
Sarcosine
dehydrogenase,
mitochondrial

Gene expresison, tRNA
aminoacylation, tRNA ligase
activity, Metal ion binding, tRNA
binding
Aminomethyltransferase activity,
Oxidoreductase activity, Glycine
catabolic process

187

Nucleus
BUB3

A_23_P46924

Mitotic checkpoint
protein BUB3

DLG7

A_23_P88331

Disks large
homolog 7

ENST00000265
271

A_24_P927222

RNA-binding
protein 27

HELB

A_23_P2294

DNA helicase B

MAFK

A_23_P111698

Transcription
factor MafK

MBNL1

A_24_P128057

Muscleblind-like
protein 1

POLD3

A_24_P75056

SAPS3

A_24_P261488

DNA polymerase
delta subunit 3
Serine/threonineprotein
phosphatase 6
regulatory subunit
3

SIM1

A_23_P214743

Single-minded
homolog 1

Regulation of chromosome
segregation
Cell proliferation, Cell-cell signaling,
M phase of mitotic cell cycle,
Positive regulation of mitosis
transitions, Phosphoprotein
phosphatase activity, Protein binding,
mRNA processing, Metal ion
binding, Nucleotide binding, RNA
binding
DNA replication, DNA helicase
activity, DNA polymerase, ATP
binding
Sequence specific binding, DNAdependent transcription, Blood
coagulation, DNA transcription
factor activity
Metal ion binding, Regulation of
mRNA splicing, Skeletal muscle
tissue development
DNA dependent replication, DNA
repair, Mitotic cell cycle, Telomere
maintenance,
Regulation of phosphoprotein
phosphatase activity, Protein
188hosphatase binding, Protein
binding
Cell differentiation, DNA dependent
transcription, DNA binding, Protein
heterodimerization activity,
Sequence specific DNA binding
transcription factor activity, Signal
transducer activity
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-1.49

0.00

-0.10

0.59

-1.68

0.00

-0.10

0.60

-1.41

0.00

-0.10

0.58

-2.14

0.00

-0.17

0.37

-1.36

0.00

0.00

0.98

-1.77

0.01

0.10

0.58

-1.56

0.00

-0.10

0.59

-1.51

0.00

0.01

0.94

-1.59

0.00

-0.21

0.26

A_23_P38365

Serine/threonineprotein kinase
tousled-like 2

VCP

A_24_P127828

Transitional
endoplasmic
reticulum ATPase

XRCC3

A_23_P48470

ZIM2

A_23_P78479

ZNF621

A_24_P340800

ZNF664

A_24_P232659

ZNF670

A_23_P74981

ZNF585A

A_23_P90220

TLK2

Unknown transcripts

DNA repair protein
XRCC3
Zinc finger
imprinted 2
Zinc finger protein
621
Zinc finger protein
664
Zinc finger protein
670
Zinc finger protein
585A

ATP binding, serine/threonine kinase
activity
Aggresome assembly, Positive
regulation of proteosomal ubiquitindependent catabolic process, ATPase
activity, Polyubiquitin binding,
Response to organic substance, DNA
metabolic processes, ATP binding,
DNA binding
DNA dependent transcription, DNA
binding, Zinc ion binding
Regulation of transcription, DNA
binding, Metal ion binding
Regulation of transcription, DNA
binding, Metal ion binding,
Regulation of transcription, Nucleic
acid binding
Regulation of transcription, Metal
ion binding, Nucleic acid binding,

Unknown

Unknown

-1.61

0.00

-0.09

0.63

-1.91

0.00

-0.08

0.67

-1.75

0.00

-0.11

0.55

-1.47

0.00

0.02

0.91

-4.75

0.00

-0.39

0.03

-1.34

0.00

0.03

0.88

-1.83

0.00

0.00

0.99

-2.73

0.00

-0.08

0.68

A_23_P300563

A_23_P300563

""

""

-1.35

0.00

0.03

0.87

A_24_P152566

A_24_P152566

""

""

-2.02

0.00

-0.13

0.47

A_24_P187365

A_24_P187365

""

""

-1.41

0.00

-0.06

0.77

A_24_P316059

A_24_P316059

""

""

-1.58

0.00

-0.07

0.70

A_24_P75408

A_24_P75408

""

""

-2.04

0.00

-0.22

0.22

A_24_P934975

A_24_P934975

""

""

-2.84

0.01

0.29

0.11

A_32_P208533

A_32_P208533

""

""

-1.58

0.00

-0.02

0.91

A_32_P44932

A_32_P44932

""

""

-1.53

0.00

0.06

0.74

AK094167

A_23_P344655

""

""

-1.70

0.00

-0.12

0.50

AK096129

A_24_P247872

""

""

-1.57

0.00

-0.22

0.23

AK097351

A_32_P188850

""

""

-2.75

0.00

-0.15

0.41
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AK097371

A_24_P661612

""

""

-3.22

0.00

0.12

0.51

ATXN7L4

A_23_P356109

""

""

-1.82

0.00

-0.15

0.41

BC034812

A_32_P125803

""

""

-1.42

0.00

-0.01

0.95

BF928446

A_32_P136588

""

""

-1.34

0.00

0.10

0.59

BQ064481

A_32_P163937

""

""

-1.45

0.00

-0.22

0.23

CA420688

A_24_P602052

""

""

-1.44

0.00

0.13

0.48

CN418636
ENST00000280
576
ENST00000310
146
ENST00000377
226
ENST00000379
870
ENST00000379
879

A_24_P935045

""

""

-2.66

0.01

0.13

0.47

A_32_P228268

""

""

-2.47

0.01

-0.20

0.28

A_24_P417831

""

""

-1.63

0.00

-0.04

0.83

A_24_P494425

""

""

-1.73

0.00

0.00

0.98

A_32_P69475

""

""

-1.46

0.00

-0.05

0.78

A_32_P51988

""

""

-3.91

0.00

-0.19

0.32

FLJ30851

A_24_P169386

""

""

-2.19

0.00

-0.26

0.16

KIAA1875

A_24_P282363

""

""

-2.44

0.00

-0.19

0.31

LOC339105

A_24_P73817

""

""

-1.67

0.00

-0.19

0.30

LOC390211

A_24_P890995

""

""

-2.93

0.00

0.00

0.99

LOC401351

A_32_P123804

""

""

-1.80

0.00

0.04

0.82

MAGEB4

A_24_P83272

""

""

-1.47

0.00

-0.15

0.43

QSER1

A_23_P139059

""

""

-1.45

0.00

0.06

0.74

T75585

A_24_P536974

""

""

-1.56

0.00

-0.22

0.24

THC2280383

A_32_P128974

""

""

-2.86

0.01

0.04

0.82

THC2316466

A_24_P681250

""

""

-1.86

0.00

-0.25

0.17

THC2344984

A_32_P184667

""

""

-1.40

0.00

-0.17

0.36

THC2391003

A_32_P226449

""

""

-2.01

0.00

-0.02

0.90

THC2406779

A_32_P81806

""

""

-1.68

0.00

0.01

0.96
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THC2420896

A_24_P600371

""

""

-1.41

0.00

-0.22

0.24

U85992

A_24_P17011

""

""

-1.46

0.00

-0.07

0.73
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CHAPTER 6
SUMMARY
Introduction
The studies presented in this dissertation answered the following questions: 1)
What is the effect of a single muscle biopsy and repeated muscle biopsies on skeletal
muscle soreness? 2) Is the muscle soreness resultant from a biopsy similar to eccentric
exercise muscle soreness? 3) What are the effects of a single and repeated bout of stair
descent exercise on extracellular matrix selected gene expression, protein expression, and
zymography at 24 h after exercise bout? and 4) Does a systems biology approach identify
novel genes and or pathways that are associated with high soreness responders compared
to low soreness responders? This chapter will provide a summary of how these questions
were examined, the results from these studies, and suggestions for future research.
Study 1
Specific Aim: To examine the effects of a single and repeated muscle biopsies
compared to eccentric exercise on muscle soreness
Muscle biopsy procedures are commonly used to examine the underlying
molecular mechanisms of muscle soreness. Although muscle biopsy procedures are often
used in kinesiology research, little information is known regarding the effects of a biopsy
on muscle soreness and daily physical activity, both of which could confound
interpretation of study results. Muscle soreness was examined using the visual analog
scale and two tasks (e.g. stand-to-sit-to stand and stair descent), two questionnaires (the
Brief Pain Inventory Short Form and the McGill Pain questionnaire) and on daily
physical activity using an activity monitor and daily physical activity levels in 12 healthy
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adults (6 men and 6 women) after a single muscle biopsy of the vastus lateralis. Muscle
soreness was measured prior to the muscle biopsy and at 24 h intervals until 120 h.
Hypothesis #1: A skeletal muscle biopsy will produce a significant elevation in
muscle soreness.
The rationale for this hypothesis is that because the extracellular matrix (ECM) is
a scaffold for fine nerve endings, a muscle biopsy will disrupt the ECM and likely affect
the fine nerve endings (34,39). The results from Study 1 show that there was a significant
increase in muscle soreness after the biopsy (23%), but that this soreness was less and
resolved earlier than that reported for a moderate bout of eccentric exercise soreness (40–
80%) (6,10,19). Therefore, when researchers are studying the underlying mechanisms of
muscle soreness, they should account for a modest increase in muscle soreness due to the
biopsy.
Hypothesis #2: A muscle biopsy and eccentric exercise would produce significantly
greater levels of delayed onset muscle soreness (DOMS) compared to a muscle
biopsy alone in skeletal muscle.
In support of this hypothesis, the first hypothesis found that muscle soreness after
a biopsy was lower compared to previously reported soreness values after eccentric
exercise (19). We examined muscle soreness from the control group and the exercise
group and found that muscle soreness was less for the control group after a muscle biopsy
compared to the exercise group at 24 h post-biopsy/exercise. Furthermore, we also found
that after a repeated bout of exercise the soreness levels from the exercise group were not
significantly different from the control group soreness levels. This study shows that
muscle biopsy soreness levels are significantly lower than after a bout of naïve exercise,
but similar to the soreness level after a repeated bout of exercise.
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Hypothesis #3: A skeletal muscle biopsy will produce a significant decrease in
physical activity.
The rationale for this hypothesis is that studies of patients recovering from
surgery have found that physical activity measured using activity monitors increased as
the patients recovered from the surgery (20,33,49). And because a muscle biopsy is a
minor surgery (46), we thought that the physical activity monitors would provide a
quantitative measure of how the muscle biopsy affected the subjects’ daily life. I found
that there were no differences in physical activity levels (sedentary, light, moderate, and
vigorous) after a muscle biopsy compared to baseline. There was a significant decrease in
steps and physical activity count. However, subjects were instructed to take it easy after
the muscle biopsy, and these results reflect their adherence to the post-biopsy instructions
and are likely not indicative of muscle soreness affecting their daily activity level.
Study 2
Specific Aim: To examine the effects of a single and repeated bout of eccentric
exercise on ECM genes, proteins, and zymography
After a second bout of eccentric exercise, the muscle becomes “accustomed” to
the strain, such that there is less soreness and strength loss in response to a repeated bout
(9,32). Stauber et al. (42) showed that in cross sections from skeletal muscle biopsy
samples, the tight packing of the muscle fibers were widened, and thus the ECM
appeared to be disrupted after eccentric exercise. While that study did not investigate
specific components of the ECM, others have shown that a few molecules of the ECM
are affected by eccentric exercise (11,12,27,28,38). Expression of laminin, collagens, and
integrins have been shown to be increased after stretching or exercise (1,22,36). Focal
adhesion kinase (FAK) phosphorylation has been linked to activating second messengers
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(e.g. PI3K), which promote muscle synthesis. FAK phosphorylation has been found to
increase after exercise. Present studies on the ECM (11,12,27,28,38) have focused on
molecular changes that occurred 2–10 d post-exercise, or if they examined earlier time
points it was using an endurance exercise model (38) instead of eccentric exercise. It is
possible that the muscle adaptation to eccentric exercise has begun as early as 48 h (40)
and is evident by 120 h (15). In addition to exercise causing an increase in mRNA and
protein expression levels, exercise has also been shown to increase gelatinolytic activity
of matrix metalloproteinases (MMPs) (7,38). However, the studies on MMPs only
investigated MMPs in response to endurance exercise(37,38). At present, only one study
has investigated changes in the ECM molecules after a repeated bout (27), but they
electrically stimulated (eSTIM) the muscle to perform the eccentric exercise. To
understand the role of the ECM in muscle adaptation, the ECM must be examined after a
single and repeated bout of eccentric exercise without electrical stimulation, especially
since the repeated eSTIM bout did not confer a repeated bout effect for muscle soreness
(27). To examine these alterations in Study 2, eight individuals (4 men and 4 women,
exercise group) descended 10 flights of stairs 15 times. They repeated this exercise two
weeks later. At 24 h after each bout of exercise, the subjects had a muscle biopsy of the
vastus lateralis. A baseline muscle biopsy was collected one week prior to the first
exercise bout. Four additional individuals (2 men and 2 women, control group) were
recruited for this study and served as controls. All subjects were recruited at the same
time and then randomized into the exercise or control group. The control group did not
complete the exercise, but had a muscle biopsy at the same time points as the exercise
group. Muscle biopsies were analyzed at both the message (qRT-PCR analysis) and
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signal (western blotting and zymography) level to identify changes in gene expression
and respective protein products of the selected ECM targets proposed to promote skeletal
muscle adaptation to eccentric exercise.
Hypothesis: ECM remodeling molecules (MMP9, MMP2, TIMP1, TIMP2, and
TNC) and mechanotransduction molecules (ITGA7, ITGB1, COL3, COL4, and
LAMA2) are involved in the adaptation process that occurs after a single bout of
exercise and provide protection to the muscle after a second bout.
In support of this hypothesis we found that skeletal muscle ECM is affected by an
acute bout of eccentric exercise, and that the expression of MMP9, tenascin-C (TNC),
collagen 3, and integrin α7 likely contribute to this adaptation. We found that TNC was
one of the four genes that were significantly changed at 24 h after eccentric exercise.
Furthermore, the expression was significantly blunted at 24 h after a repeated bout of
exercise compared to Bout 1. Aside from the time point used, these results are not novel,
but confirm work by Mackey et al. (27) who showed that TNC mRNA and protein
expression at 48 h was elevated after a single bout of eccentric exercise via eSTIM and
then reduced after a repeated bout of eccentric exercise via eSTIM.
The expression of MMP9 mRNA was significantly different between men and
women, and a trend (p=0.08) for group (e.g. exercise and control) differences was found.
Combining the exercise and control group mRNA levels after Bout 1, we found that men
had a 2.1-fold increase in MMP9 gene expression, and women had a 1.8-fold decrease.
MMP9 is secreted by neutrophils (25) and leukocytes (24), and MMP9 has been
correlated to activation of neutrophils (25) and recruitment of pro-inflammatory
macrophages (24). In view of previous work showing differences in inflammation
between men and women after exercise (26,43,44), the differential regulation of MMP9
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found in the current study is not surprising and would also explain the differences in
mRNA levels between men and women after an acute and repeated bout of exercise.
While we were not sufficiently powered to detect differences between men and women,
this study provides compelling data that suggest there is a difference between MMP
levels in men and women after eccentric exercise. At present, this is the first study to
investigate the changes in MMP9 mRNA in skeletal muscle after eccentric exercise in
humans.
To our knowledge, this is the first study to show an increase in integrin α7
(ITGA7) mRNA in humans. Our increase in integrin α7 mRNA after a single bout of
exercise is consistent with animal research showing acute increases in mRNA after
exercise (4,5). However, we found a decrease in the protein level of α7 integrin at this
same time point (Bout 1/MB2), and these results do not support previous research (4,5).
But we identified three isoforms (7X12X2B, 7X1B, and 7X2B) of integrin α7 being
expressed in the exercise and control individuals. The 7X2B isoform of integrin α7 was
the protein that we found to decrease at MB2 and return to baseline at MB3. This isoform
has an extracellular domain, and animal and cell literature indicate that the isoforms bind
to different extracellular molecules, promote clustering of focal adhesion molecules, and
initiate phosphorylation cascades (2,5,41). It is likely that the observed changes in protein
levels for α7 integrin after Bout 1/MB2 are actually related to the baseline muscle biopsy
(MB1) and not due to the exercise, as both the control and exercise group showed this
decrease.
Finally, we found mRNA expression of collagen type 3A1 (COL3) in skeletal
muscle to be higher in women after a single bout of exercise compared to baseline, a
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repeated bout, and in men after a single bout. These results suggest that remodeling after
eccentric exercise may be initiated earlier in women than men as shown by the elevated
mRNA levels for COL3 in women after Bout 1 compared to men. However, at baseline,
women had significantly lower levels of COL3 mRNA compared to men. I must again
state that we were not sufficiently powered to detect differences between men and
women, but our data are in agreement with results from studies examining COL3 and
differences between men and women (17,18,45).
Overall, these results confirm only one aspect of our initial hypothesis, as we
found TNC to be increased after Bout 1, decreased after Bout 2, and it was correlated to
muscle soreness. We did not find any changes in skeletal muscle zymography levels at 24
h after a single or repeated bout of exercise. But we did identify that TNC was not
correlated to peak soreness from a muscle biopsy, and therefore its expression is related
to eccentric exercise, and potentially, the adaptation process as it was decreased in Bout 2
for the exercise group. While we were not sufficiently powered to detect sex differences,
our data suggest that the mRNA expression levels of MMP9 and COL3 were
differentially regulated between men and women after eccentric exercise. Finally, we
identified that three isoforms of integrin α7 are expressed in humans via western blotting,
and that the expression is likely very sensitive to eccentric actions because both the
exercise and control groups showed a decrease in the 7X2B isoform after MB2 compared
to MB1. The leg that was biopsied in MB2 was not biopsied in MB1, and it is likely that
subjects relied on the non-biopsied leg when sitting, descending stairs, or bending down
to pick something up after MB1. These subjects may have inadvertently performed
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eccentric exercise with this muscle and initiated the expression change we observed at
MB2.
Study 3
Specific Aim: To examine delayed onset muscle soreness
using a systems approach
To examine further the relationship of soreness and the ECM, this experiment
analyzed existing microarray data in a novel way. Presently, 14 microarray studies
(3,8,13,14,16,21,23,29–31,35,47,48), aside from the recent study performed in our lab
(19), have been published that investigated human skeletal muscle after eccentric exercise.
The goal of many of these previous microarray studies was to identify novel targets
differentially regulated after eccentric exercise. While these previous microarray studies
informed the targeted approach used in Study 2, none of the studies used a systems
approach to identify targets associated with muscle soreness. To identify novel targets
and pathways associated with muscle soreness I used microarray data collected in our lab
from a previous study (19). This study had 30 men with viable RNA for microarray
analysis, and these subjects performed one bout of eccentric exercise (100 unilateral
contractions) on the Biodex® dynamometer and had a muscle biopsy taken 3 h after the
exercise bout. The non-exercised leg was also biopsied and used as a control. The peak
soreness response reported at 24 h or 48 h post-eccentric exercise was clustered using
hierarchical cluster analysis to identify soreness response clusters. Of the 30 males, five
clustered into a high-soreness group (HSG) and seven clustered into a low-soreness group
(LSG). The microarray data were log transformed, and then each subject’s exercised leg
was normalized to the control leg. An ANOVA was performed on the microarray data
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between the HSG and LSG using Partek Genomics Suite software (Version 6.4), and the
outputs were filtered on p-value (p=0.01). These results were then uploaded into
Ingenuity Pathway Analysis (IPA) to identify novel targets associated with muscle
soreness after eccentric exercise.
Hypothesis: The high-soreness individuals would have a unique set of differentially
regulated genes compared to the lower-soreness individuals.
Of the 41,000 genes that were differentially regulated after eccentric exercise
compared to the control leg at p <0.05 using microarray analysis, 1517 genes were
differentially regulated in individuals with high soreness compared to those with low
soreness. However, using IPA, we wanted to identify only the most significant
differentially regulated networks and novel genes, so we used a more stringent p-value (p
<0.01) that yielded 546 differentially regulated genes. Of the 546 genes, the up-regulated
genes were more robustly altered (10 genes were up-regulated by at least 4.2-fold) than
the down-regulated genes (the top gene [ZNF44] was down-regulated by 3.3-fold) in the
HSG relative to the LSG. The top target, serine protease inhibitor Kazal-type 1 (SPINK1),
was differently up-regulated by 18.67-fold, and the second target, sperm-associated
antigen (SPAG1), was up-regulated by 8.10-fold.
Limitations
The studies presented in this dissertation have several limitations that should be
taken into account when interpreting the results or designing future experiments. Studies
2 and 3 in particular have several limitations that must be addressed. A major limitation
for both studies was the availability of skeletal muscle biopsy material obtained for
analysis. At each muscle biopsy we were able to collect 100–175 mg of muscle tissue. In
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Study 2, the analysis of the nine genes via qRT-PCR analysis and 11 proteins in Study 2
required 25–50 mg of tissue for each analysis technique. And zymography required 25–
50 mg of muscle tissue. The amount of muscle tissue was problematic in the
zymography. Because zymography had to be in replicated, the analysis was performed on
a subset of subjects (n=7 exercise and n=3 control) for two of the time points analyzed
(control and Bout 2). In Study 3, although I had access to the published microarray data, I
was unable to perform any confirmational analysis on these samples due to a lack of
muscle tissue available for RNA isolation and subsequent qRT-PCR analysis.
The reported changes in gene and protein expression from Study 2 must be
viewed with caution, because it is possible that changes shown in the Bout 1 and Bout 2
biopsy data may not be due to the acute bout of exercise. For example, the control and
exercise group changed from baseline in the same direction despite the exercise session
24 h prior to the muscle biopsy in the exercise group.
Factors that affected the analysis included the variability in response observed
between men and women at the gene and protein expression level as evident in the
MMP9 and COL3 mRNA results. It was thought that the exercise would produce changes
in gene and protein expression in the same direction (e.g. both men and women downregulated the gene), but that the magnitude of change might be different. However, we
found that both direction and magnitude were different between men and women for the
control and exercise group at baseline/MB1, Bout 1/MB2, and Bout 2/MB3. The results
indicate that although measures of muscle function (e.g. immediate strength loss or peak
muscle soreness) after eccentric exercise are not different between men and women, the
underlying mechanisms to muscle adaptation may be.
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Finally, in Study 2 all subjects were randomized to having their left or right leg
biopsied at baseline, resulting in the contralateral leg being biopsied in Bout 1 and Bout
2. The control and exercise groups were balanced for left or right leg biopsies at baseline.
While all subjects were right-leg dominant, the stair descent exercise that subjects
performed resulted in them always making a right turn to descend the next flight of stairs,
and it is possible that the workload to each leg during that exercise was unequal. This
may explain the differences seen for INTGA7 mRNA levels between leg for Bout 1 and
Bout 2. Because I had collected muscle soreness data on the left and right leg after the
exercise, I was able to determine if the exercise resulted in a significant difference in
muscle soreness development between legs, but as shown in Figures 2A and 3A of Study
2 at 24 h, the range of muscle soreness indicates that there was not a difference in muscle
soreness between legs. However, the measurement of muscle soreness may not be
sensitive enough to detect a difference between legs and therefore we believe that the
observed differences in mRNA levels between legs are not spurious.
Future Directions
The overall findings from these three studies suggest that muscle soreness
development due to eccentric exercise is different from a minor surgery, and that the
variability in muscle soreness levels is likely due to the expression and depression of
specific genes. Studies examining muscle soreness treatments via muscle biopsies should
be aware that the muscle biopsy introduces a 20% increase in recorded muscle soreness
levels at 24 h post-biopsy.
Future studies should include men and women in their analysis of muscle
adaptation. The results from this study suggest that men and women have a different
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muscle response to eccentric exercise at the molecular level. At present, very few studies
have examined the response of skeletal muscle at the molecular level in men and women
after eccentric exercise. This information would help both men and women use
appropriate measures to promote muscle adaptation and recovery from a naïve and
strenuous exercise or activity (e.g. snow shoveling or raking).
The microarray analysis performed in Study 3 of the HSG and LSG found 546
differentially expressed genes. This study has provided future researchers with many
tools to generate new hypotheses regarding differences in soreness levels among
individuals.
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APPENDIX A
SAMPLE SIZE ESTIMATES
The sample size estimates below were calculated using the Cohen’s d Effect Size
and Cohen’s f Effect Size to determine sample size estimates for Study 1 and Study 2.
Because Study 1 was examining muscle soreness measures of all subjects it was expected
that by calculating the effect size for Study 2, Study 1 would be more than sufficiently
powered. We calculated effect size for Study 1 based on muscle soreness between
baseline, Eccentric exercise bout 1, and Eccentric exercise bout 2. Study 2 had to be
sufficiently powered to detect a difference in molecular outcomes (mRNA and protein
levels) among baseline, Eccentric exercise bout 1, and Eccentric exercise bout 2.
The Cohen’s d Effect Size calculation is the commonly used calculation, however
it is only able to estimate a sample size for a paired t-test (e.g. pre vs. post) and the
present study has at least 3 time-points (Baseline, Bout 1 and Bout 2) for analysis in
Study 2. Therefore a second Effect Size calculation as used to ensure that the samples
size estimate was appropriate for the present population and the time-points. The Cohen’s
d Effect Sizes were input into the G*Power calculator (1) to determine the Effect Size for
a paired t-test. The Cohen’s f Effect Sizes were input into the G*Power calculator to
determine Effect Size for a repeated measures ANOVA between and within interactions
group, based on 2 groups and 2 time points.
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Table A.1: Calculating sample size estimate for muscle soreness. Please note
all values (mean and SD) were derived or reported from Marginson et al. (4).
Variable
Baseline muscle soreness –visual analog scale (VAS)
Bout 1 (24 hr Post-Exercise) muscle soreness VAS
Bout 2 (24 hr Post-Exercise) muscle soreness VAS
Effect Size (f)
Sample Size Estimate
Paired t-test Effect Size (d)
Paired t-test Sample Size Estimate (d)

Exercise Group
N=10
0±0
5.7 ± 1.58
2.7 ± 1.58
1.054
6.0
-1.33
7.0

Table A.2: Calculating sample size estimate for tenascin-C
immunohistochemistry protein. Please note all % values (mean and SD)
were derived or reported from Crameri et al. (1).
Voluntary Exercise
N=8 (left leg)
Voluntary Exercise
0% ± 0%
0.4% ± 0.3%
2.0% ± 0.7%
1.745
4
3.18
4

Variable
Time 1 (Baseline)
Time 2 (6 hr Post-Exercise)
Time 3 (24 hr Post-Exercise)
rm ANOVA Effect Size (f)
rm ANOVA Sample Size Estimate (f)
Paired t-test Effect Size (d)
Paired t-test Sample Size Estimate (d)

Table A.3: Calculating sample size estimate for CSRP mRNA. Please note all
values (mean and SD) were derived or reported from Kostek et al. (3).
Variable
Time 1 (Baseline- used to normalize Time 2 and 3)
Time 2 (4 hr Post-Exercise)
Time 3 (24 hr Post-Exercise)
rm ANOVA Effect Size (f)
rm ANOVA Sample Size Estimate
Paired t-test Effect Size (d)
Paired t-test Sample Size Estimate (d)
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Exercise
N=5
2.9 ± 0.67
4.2 ± 2.02
1.7449
4.0
2.166
4.0
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QRT-PCR INDIVIDUAL AND MEAN RESULTS FOR CONTROL AND
EXERCISE GROUP

214

215

216

217

218

219

220

221

222

223

224

Table D.1: Mean CT values from interplate calibrator (e.g. same subject) for qRT-PCR
analysis.
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APPENDIX G
TOP 10 UP- AND DOWN-REGULATED GENES IN HSG VS. LSG

Table G.1 Top 10 up-regulated genes in HSG vs. LSG, p <0.05.

Gene
SPINK1
A-24-P937936
AQP9
ZNF708
LOC647131
SPAG1
FGFR1
LRP8
RAB31P
SENP6

HS
Least Squares
Mean
4.4123
1.4125
2.0699
1.1537
4.0939
2.0527
2.6307
2.1224
1.6791
1.1058

LS
Least Squares
Mean
0.1910
-2.0566
-1.3114
-2.1852
0.91780
-0.9667
-0.3868
-0.8609
-1.2912
-1.7903
	
  

p Value
0.001746
0.041102
0.012575
0.035606
0.001952
0.008520
0.018492
0.001000
0.038268
0.033275

Fold
Change
18.6770
11.0743
10.4197
10.1182
9.0377
8.1084
8.0975
7.9079
7.8368
7.4443

Table G.2 Top 10 down-regulated genes in HSG vs. LSG, p <0.05.

Gene
MTG1
ZNF621
WBP2
A1042062
GPR137
SLC41A1
C21orf119
UBE2E1
CXorf21
A_24_P918454

HS
Least Squares
Mean
-1.72782
-1.71472
-0.966156
-2.39327
-0.372891
-1.44948
-1.86022
-1.39578
-1.07156
-1.22839

LS
Least Squares
Mean
0.53698
0.53283
1.15275
-0.309382
1.6514
0.571611
0.135117
0.59303
0.911525
0.740385
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p Value
0.0188601
0.0010537
0.0417093
0.0039793
0.0177804
0.0469249
0.0167561
0.0302372
0.0454999
0.0107892

Fold
Change
-4.80589
-4.784893
-4.34364
-4.23949
-4.06792
-4.0589
-3.98709
-3.96909
-3.95337
-3.91434

APPENDIX H
TOP IPA NETWORK FUNCTIONS AND NETWORK SCORE

Table H.1. Top IPA network functions and network score.
Top Networks
1. Carbohydrate metabolism, cardiovascular system development & function,
tissue morphology
2. Cell to cell signaling & interaction, cellular development, hematological
system development & function
3. Cancer, renal & urological disease, reproductive system disease
4. Cellular compromise, infection mechanism, endocrine system disorders
5. Nervous system development & function, cellular growth & proliferation,
cellular movement
6. Hematological System Development and Function, Tissue Morphology,
Cellular Development
7. Cancer, Gene Expression, Infection Mechanism
8. Cellular Development, Gene Expression, Cell Death
9. Gene Expression, Cell Morphology, Cellular Development
10. Cellular Movement, Hematopoiesis, Immune Cell Trafficking
11. Hematological System Development and Function, Immune Cell Trafficking,
Inflammatory Response
12. Cellular Development, Cellular Growth and Proliferation, Hematological
System Development and Function
13. Cell-To-Cell Signaling and Interaction, Hematological System Development
and Function, Inflammatory Response
14. Hematological System Development and Function, Immune Cell Trafficking,
Inflammatory Response
15. Gene Expression, Organismal Injury and Abnormalities, Cancer
16. Gene Expression, Genetic Disorder, Hematological Disease
17. Gene Expression, Cell Signaling, Cell Cycle
18. Cellular Growth and Proliferation, Cell-To-Cell Signaling and Interaction,
Lipid Metabolism
19. Cell-To-Cell Signaling and Interaction, Embryonic Development, Hair and
Skin Development and Function
20. Lipid Metabolism, Small Molecule Biochemistry, Nucleic Acid Metabolism
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Score
51
41
38
34
27
25
21
20
20
19
18
16
16
15
13
13
13
13
11
2
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